id	sid	tid	token	lemma	pos
ajmsi-1283	1	1	pa	pa	PROPN
ajmsi-1283	1	2	ge	ge	PROPN
ajmsi-1283	1	3	1	1	NUM
ajmsi-1283	1	4	pa	pa	PROPN
ajmsi-1283	1	5	ge	ge	PROPN
ajmsi-1283	1	6	26	26	NUM
ajmsi-1283	1	7	american	american	PROPN
ajmsi-1283	1	8	journal	journal	PROPN
ajmsi-1283	1	9	of	of	ADP
ajmsi-1283	1	10	medical	medical	ADJ
ajmsi-1283	1	11	science	science	NOUN
ajmsi-1283	1	12	and	and	CCONJ
ajmsi-1283	1	13	innovation	innovation	NOUN
ajmsi-1283	1	14	(	(	PUNCT
ajmsi-1283	1	15	ajmsi	ajmsi	NOUN
ajmsi-1283	1	16	)	)	PUNCT
ajmsi-1283	1	17	cancer	cancer	NOUN
ajmsi-1283	1	18	genetic	genetic	ADJ
ajmsi-1283	1	19	markers	marker	NOUN
ajmsi-1283	1	20	among	among	ADP
ajmsi-1283	1	21	school	school	NOUN
ajmsi-1283	1	22	children	child	NOUN
ajmsi-1283	1	23	in	in	ADP
ajmsi-1283	1	24	relation	relation	NOUN
ajmsi-1283	1	25	to	to	ADP
ajmsi-1283	1	26	urogenital	urogenital	ADJ
ajmsi-1283	1	27	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	1	28	chinweike	chinweike	NOUN
ajmsi-1283	1	29	-	-	PUNCT
ajmsi-1283	1	30	umeh	umeh	PROPN
ajmsi-1283	1	31	s.n.1	s.n.1	NOUN
ajmsi-1283	1	32	,	,	PUNCT
ajmsi-1283	1	33	ekwunife	ekwunife	NOUN
ajmsi-1283	1	34	c.a.1	c.a.1	NOUN
ajmsi-1283	1	35	*	*	NOUN
ajmsi-1283	1	36	,	,	PUNCT
ajmsi-1283	1	37	onwuachusi	onwuachusi	X
ajmsi-1283	1	38	g.l1	g.l1	NOUN
ajmsi-1283	1	39	volume	volume	NOUN
ajmsi-1283	1	40	2	2	NUM
ajmsi-1283	1	41	issue	issue	NOUN
ajmsi-1283	1	42	1	1	NUM
ajmsi-1283	1	43	,	,	PUNCT
ajmsi-1283	1	44	year	year	NOUN
ajmsi-1283	1	45	2023	2023	NUM
ajmsi-1283	1	46	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	1	47	article	article	NOUN
ajmsi-1283	1	48	information	information	NOUN
ajmsi-1283	1	49	abstract	abstract	ADV
ajmsi-1283	1	50	received	receive	VERB
ajmsi-1283	1	51	:	:	PUNCT
ajmsi-1283	1	52	february	february	PROPN
ajmsi-1283	1	53	08	08	NUM
ajmsi-1283	1	54	,	,	PUNCT
ajmsi-1283	1	55	2023	2023	NUM
ajmsi-1283	1	56	accepted	accept	VERB
ajmsi-1283	1	57	:	:	PUNCT
ajmsi-1283	1	58	february	february	PROPN
ajmsi-1283	1	59	26	26	NUM
ajmsi-1283	1	60	,	,	PUNCT
ajmsi-1283	1	61	2023	2023	NUM
ajmsi-1283	1	62	published	publish	VERB
ajmsi-1283	1	63	:	:	PUNCT
ajmsi-1283	1	64	march	march	PROPN
ajmsi-1283	1	65	10	10	NUM
ajmsi-1283	1	66	,	,	PUNCT
ajmsi-1283	1	67	2023	2023	NUM
ajmsi-1283	1	68	chronic	chronic	ADJ
ajmsi-1283	1	69	infection	infection	NOUN
ajmsi-1283	1	70	with	with	ADP
ajmsi-1283	1	71	urogenital	urogenital	ADJ
ajmsi-1283	1	72	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	1	73	can	can	AUX
ajmsi-1283	1	74	lead	lead	VERB
ajmsi-1283	1	75	to	to	ADP
ajmsi-1283	1	76	severe	severe	ADJ
ajmsi-1283	1	77	complications	complication	NOUN
ajmsi-1283	1	78	such	such	ADJ
ajmsi-1283	1	79	as	as	ADP
ajmsi-1283	1	80	bladder	bladder	NOUN
ajmsi-1283	1	81	cancer	cancer	NOUN
ajmsi-1283	1	82	.	.	PUNCT
ajmsi-1283	2	1	hence	hence	ADV
ajmsi-1283	2	2	,	,	PUNCT
ajmsi-1283	2	3	this	this	DET
ajmsi-1283	2	4	study	study	NOUN
ajmsi-1283	2	5	determined	determine	VERB
ajmsi-1283	2	6	the	the	DET
ajmsi-1283	2	7	presence	presence	NOUN
ajmsi-1283	2	8	of	of	ADP
ajmsi-1283	2	9	cancer	cancer	NOUN
ajmsi-1283	2	10	genetic	genetic	ADJ
ajmsi-1283	2	11	markers	marker	NOUN
ajmsi-1283	2	12	among	among	ADP
ajmsi-1283	2	13	school	school	NOUN
ajmsi-1283	2	14	children	child	NOUN
ajmsi-1283	2	15	in	in	ADP
ajmsi-1283	2	16	relation	relation	NOUN
ajmsi-1283	2	17	to	to	ADP
ajmsi-1283	2	18	urogenital	urogenital	ADJ
ajmsi-1283	2	19	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	2	20	.	.	PUNCT
ajmsi-1283	3	1	all	all	DET
ajmsi-1283	3	2	36	36	NUM
ajmsi-1283	3	3	s.	s.	PROPN
ajmsi-1283	3	4	haematobium	haematobium	PROPN
ajmsi-1283	3	5	positive	positive	ADJ
ajmsi-1283	3	6	cases	case	NOUN
ajmsi-1283	3	7	from	from	ADP
ajmsi-1283	3	8	an	an	DET
ajmsi-1283	3	9	earlier	early	ADJ
ajmsi-1283	3	10	study	study	NOUN
ajmsi-1283	3	11	and	and	CCONJ
ajmsi-1283	3	12	randomly	randomly	ADV
ajmsi-1283	3	13	selected	select	VERB
ajmsi-1283	3	14	156	156	NUM
ajmsi-1283	3	15	negative	negative	ADJ
ajmsi-1283	3	16	samples	sample	NOUN
ajmsi-1283	3	17	were	be	AUX
ajmsi-1283	3	18	used	use	VERB
ajmsi-1283	3	19	.	.	PUNCT
ajmsi-1283	4	1	immunogens	immunogen	NOUN
ajmsi-1283	4	2	tested	test	VERB
ajmsi-1283	4	3	for	for	ADP
ajmsi-1283	4	4	,	,	PUNCT
ajmsi-1283	4	5	included	include	VERB
ajmsi-1283	4	6	glyceraldehyde-3	glyceraldehyde-3	VERB
ajmsi-1283	4	7	-	-	ADJ
ajmsi-1283	4	8	phosphate	phosphate	ADJ
ajmsi-1283	4	9	dehydrogenase	dehydrogenase	NOUN
ajmsi-1283	4	10	(	(	PUNCT
ajmsi-1283	4	11	gapdh	gapdh	NOUN
ajmsi-1283	4	12	)	)	PUNCT
ajmsi-1283	4	13	and	and	CCONJ
ajmsi-1283	4	14	fibroblast	fibroblast	ADJ
ajmsi-1283	4	15	growth	growth	NOUN
ajmsi-1283	4	16	factor	factor	NOUN
ajmsi-1283	4	17	receptor	receptor	NOUN
ajmsi-1283	4	18	(	(	PUNCT
ajmsi-1283	4	19	fgfr3	fgfr3	PROPN
ajmsi-1283	4	20	)	)	PUNCT
ajmsi-1283	4	21	.	.	PUNCT
ajmsi-1283	5	1	mean	mean	VERB
ajmsi-1283	5	2	optical	optical	ADJ
ajmsi-1283	5	3	density	density	NOUN
ajmsi-1283	5	4	(	(	PUNCT
ajmsi-1283	5	5	od	od	NOUN
ajmsi-1283	5	6	)	)	PUNCT
ajmsi-1283	5	7	was	be	AUX
ajmsi-1283	5	8	0.73	0.73	NUM
ajmsi-1283	5	9	and	and	CCONJ
ajmsi-1283	5	10	0.79	0.79	NUM
ajmsi-1283	5	11	for	for	ADP
ajmsi-1283	5	12	gapdh	gapdh	NOUN
ajmsi-1283	5	13	and	and	CCONJ
ajmsi-1283	5	14	fgfr3	fgfr3	NOUN
ajmsi-1283	5	15	respectively	respectively	ADV
ajmsi-1283	5	16	.	.	PUNCT
ajmsi-1283	6	1	a	a	DET
ajmsi-1283	6	2	total	total	NOUN
ajmsi-1283	6	3	of	of	ADP
ajmsi-1283	6	4	21	21	NUM
ajmsi-1283	6	5	(	(	PUNCT
ajmsi-1283	6	6	10.94	10.94	NUM
ajmsi-1283	6	7	%	%	NOUN
ajmsi-1283	6	8	)	)	PUNCT
ajmsi-1283	6	9	participants	participant	NOUN
ajmsi-1283	6	10	,	,	PUNCT
ajmsi-1283	6	11	16	16	NUM
ajmsi-1283	6	12	females	female	NOUN
ajmsi-1283	6	13	and	and	CCONJ
ajmsi-1283	6	14	5	5	NUM
ajmsi-1283	6	15	males	male	NOUN
ajmsi-1283	6	16	were	be	AUX
ajmsi-1283	6	17	positive	positive	ADJ
ajmsi-1283	6	18	for	for	ADP
ajmsi-1283	6	19	gapdh	gapdh	NOUN
ajmsi-1283	6	20	marker	marker	NOUN
ajmsi-1283	6	21	.	.	PUNCT
ajmsi-1283	7	1	fifty	fifty	NUM
ajmsi-1283	7	2	(	(	PUNCT
ajmsi-1283	7	3	26.04	26.04	NUM
ajmsi-1283	7	4	%	%	NOUN
ajmsi-1283	7	5	)	)	PUNCT
ajmsi-1283	7	6	participants	participant	NOUN
ajmsi-1283	7	7	were	be	AUX
ajmsi-1283	7	8	positive	positive	ADJ
ajmsi-1283	7	9	for	for	ADP
ajmsi-1283	7	10	fgfr3	fgfr3	NOUN
ajmsi-1283	7	11	via	via	ADP
ajmsi-1283	7	12	elisa	elisa	PROPN
ajmsi-1283	7	13	cutoff	cutoff	NOUN
ajmsi-1283	7	14	.	.	PUNCT
ajmsi-1283	8	1	mean	mean	VERB
ajmsi-1283	8	2	od	od	PROPN
ajmsi-1283	8	3	for	for	ADP
ajmsi-1283	8	4	s.	s.	PROPN
ajmsi-1283	8	5	haematobium	haematobium	PROPN
ajmsi-1283	8	6	positive	positive	ADJ
ajmsi-1283	8	7	individuals	individual	NOUN
ajmsi-1283	8	8	tested	test	VERB
ajmsi-1283	8	9	for	for	ADP
ajmsi-1283	8	10	gapdh	gapdh	NOUN
ajmsi-1283	8	11	was	be	AUX
ajmsi-1283	8	12	0.938	0.938	NUM
ajmsi-1283	8	13	,	,	PUNCT
ajmsi-1283	8	14	minimum	minimum	ADJ
ajmsi-1283	8	15	value	value	NOUN
ajmsi-1283	8	16	was	be	AUX
ajmsi-1283	8	17	0.119	0.119	NUM
ajmsi-1283	8	18	while	while	SCONJ
ajmsi-1283	8	19	maximum	maximum	ADJ
ajmsi-1283	8	20	value	value	NOUN
ajmsi-1283	8	21	was	be	AUX
ajmsi-1283	8	22	4.507	4.507	NUM
ajmsi-1283	8	23	.	.	PUNCT
ajmsi-1283	9	1	for	for	ADP
ajmsi-1283	9	2	fgfr3	fgfr3	PROPN
ajmsi-1283	9	3	mean	mean	NOUN
ajmsi-1283	9	4	od	od	PROPN
ajmsi-1283	9	5	was	be	AUX
ajmsi-1283	9	6	0.896	0.896	NUM
ajmsi-1283	9	7	,	,	PUNCT
ajmsi-1283	9	8	maximum	maximum	ADJ
ajmsi-1283	9	9	2.882	2.882	NUM
ajmsi-1283	9	10	and	and	CCONJ
ajmsi-1283	9	11	minimum	minimum	NOUN
ajmsi-1283	9	12	0.28	0.28	NUM
ajmsi-1283	9	13	,	,	PUNCT
ajmsi-1283	9	14	while	while	SCONJ
ajmsi-1283	9	15	females	female	NOUN
ajmsi-1283	9	16	showed	show	VERB
ajmsi-1283	9	17	higher	high	ADJ
ajmsi-1283	9	18	gapdh	gapdh	NOUN
ajmsi-1283	9	19	od	od	NOUN
ajmsi-1283	9	20	.	.	PUNCT
ajmsi-1283	10	1	more	more	ADJ
ajmsi-1283	10	2	females	female	NOUN
ajmsi-1283	10	3	than	than	ADP
ajmsi-1283	10	4	males	male	NOUN
ajmsi-1283	10	5	who	who	PRON
ajmsi-1283	10	6	were	be	AUX
ajmsi-1283	10	7	positive	positive	ADJ
ajmsi-1283	10	8	for	for	ADP
ajmsi-1283	10	9	s.	s.	PROPN
ajmsi-1283	10	10	haematobium	haematobium	PROPN
ajmsi-1283	10	11	were	be	AUX
ajmsi-1283	10	12	also	also	ADV
ajmsi-1283	10	13	positive	positive	ADJ
ajmsi-1283	10	14	for	for	ADP
ajmsi-1283	10	15	gapdh	gapdh	NOUN
ajmsi-1283	10	16	(	(	PUNCT
ajmsi-1283	10	17	11.1	11.1	NUM
ajmsi-1283	10	18	%	%	NOUN
ajmsi-1283	10	19	)	)	PUNCT
ajmsi-1283	10	20	and	and	CCONJ
ajmsi-1283	10	21	fgfr3	fgfr3	NOUN
ajmsi-1283	10	22	(	(	PUNCT
ajmsi-1283	10	23	25	25	NUM
ajmsi-1283	10	24	%	%	NOUN
ajmsi-1283	10	25	)	)	PUNCT
ajmsi-1283	10	26	.	.	PUNCT
ajmsi-1283	11	1	fgfr3	fgfr3	NOUN
ajmsi-1283	11	2	and	and	CCONJ
ajmsi-1283	11	3	gapdh	gapdh	NOUN
ajmsi-1283	11	4	marker	marker	NOUN
ajmsi-1283	11	5	prevalence	prevalence	NOUN
ajmsi-1283	11	6	for	for	ADP
ajmsi-1283	11	7	individuals	individual	NOUN
ajmsi-1283	11	8	positive	positive	ADJ
ajmsi-1283	11	9	for	for	ADP
ajmsi-1283	11	10	s.	s.	PROPN
ajmsi-1283	11	11	haematobium	haematobium	PROPN
ajmsi-1283	11	12	is	be	AUX
ajmsi-1283	11	13	25	25	NUM
ajmsi-1283	11	14	%	%	NOUN
ajmsi-1283	11	15	and	and	CCONJ
ajmsi-1283	11	16	16.7	16.7	NUM
ajmsi-1283	11	17	%	%	NOUN
ajmsi-1283	11	18	respectively	respectively	ADV
ajmsi-1283	11	19	.	.	PUNCT
ajmsi-1283	12	1	the	the	DET
ajmsi-1283	12	2	age	age	NOUN
ajmsi-1283	12	3	group	group	NOUN
ajmsi-1283	12	4	11	11	NUM
ajmsi-1283	12	5	-	-	SYM
ajmsi-1283	12	6	15	15	NUM
ajmsi-1283	12	7	years	year	NOUN
ajmsi-1283	12	8	were	be	AUX
ajmsi-1283	12	9	the	the	DET
ajmsi-1283	12	10	only	only	ADJ
ajmsi-1283	12	11	group	group	NOUN
ajmsi-1283	12	12	positive	positive	ADJ
ajmsi-1283	12	13	for	for	ADP
ajmsi-1283	12	14	gapdh	gapdh	NOUN
ajmsi-1283	12	15	.	.	PUNCT
ajmsi-1283	13	1	there	there	PRON
ajmsi-1283	13	2	was	be	VERB
ajmsi-1283	13	3	a	a	DET
ajmsi-1283	13	4	slight	slight	ADJ
ajmsi-1283	13	5	positive	positive	ADJ
ajmsi-1283	13	6	correlation	correlation	NOUN
ajmsi-1283	13	7	between	between	ADP
ajmsi-1283	13	8	age	age	NOUN
ajmsi-1283	13	9	and	and	CCONJ
ajmsi-1283	13	10	fgfr3	fgfr3	NOUN
ajmsi-1283	13	11	and	and	CCONJ
ajmsi-1283	13	12	age	age	NOUN
ajmsi-1283	13	13	and	and	CCONJ
ajmsi-1283	13	14	gapdh	gapdh	NOUN
ajmsi-1283	13	15	.	.	PUNCT
ajmsi-1283	14	1	the	the	DET
ajmsi-1283	14	2	presence	presence	NOUN
ajmsi-1283	14	3	of	of	ADP
ajmsi-1283	14	4	these	these	DET
ajmsi-1283	14	5	markers	marker	NOUN
ajmsi-1283	14	6	is	be	AUX
ajmsi-1283	14	7	an	an	DET
ajmsi-1283	14	8	indicator	indicator	NOUN
ajmsi-1283	14	9	that	that	SCONJ
ajmsi-1283	14	10	the	the	DET
ajmsi-1283	14	11	children	child	NOUN
ajmsi-1283	14	12	in	in	ADP
ajmsi-1283	14	13	the	the	DET
ajmsi-1283	14	14	selected	select	VERB
ajmsi-1283	14	15	communities	community	NOUN
ajmsi-1283	14	16	maybe	maybe	ADV
ajmsi-1283	14	17	at	at	ADP
ajmsi-1283	14	18	risk	risk	NOUN
ajmsi-1283	14	19	of	of	ADP
ajmsi-1283	14	20	developing	develop	VERB
ajmsi-1283	14	21	bladder	bladder	NOUN
ajmsi-1283	14	22	cancer	cancer	NOUN
ajmsi-1283	14	23	in	in	ADP
ajmsi-1283	14	24	the	the	DET
ajmsi-1283	14	25	future	future	NOUN
ajmsi-1283	14	26	if	if	SCONJ
ajmsi-1283	14	27	the	the	DET
ajmsi-1283	14	28	disease	disease	NOUN
ajmsi-1283	14	29	is	be	AUX
ajmsi-1283	14	30	not	not	PART
ajmsi-1283	14	31	properly	properly	ADV
ajmsi-1283	14	32	managed	manage	VERB
ajmsi-1283	14	33	and	and	CCONJ
ajmsi-1283	14	34	controlled	control	VERB
ajmsi-1283	14	35	.	.	PUNCT
ajmsi-1283	15	1	keywords	keyword	VERB
ajmsi-1283	15	2	bladder	bladder	NOUN
ajmsi-1283	15	3	cancer	cancer	NOUN
ajmsi-1283	15	4	,	,	PUNCT
ajmsi-1283	15	5	genetic	genetic	ADJ
ajmsi-1283	15	6	markers	marker	NOUN
ajmsi-1283	15	7	,	,	PUNCT
ajmsi-1283	15	8	urogenital	urogenital	ADJ
ajmsi-1283	15	9	,	,	PUNCT
ajmsi-1283	15	10	schistosoma	schistosoma	ADJ
ajmsi-1283	15	11	haematobium	haematobium	NOUN
ajmsi-1283	15	12	1	1	NUM
ajmsi-1283	15	13	department	department	NOUN
ajmsi-1283	15	14	of	of	ADP
ajmsi-1283	15	15	parasitology	parasitology	NOUN
ajmsi-1283	15	16	and	and	CCONJ
ajmsi-1283	15	17	entomology	entomology	NOUN
ajmsi-1283	15	18	,	,	PUNCT
ajmsi-1283	15	19	nnamdi	nnamdi	PROPN
ajmsi-1283	15	20	azikiwe	azikiwe	PROPN
ajmsi-1283	15	21	university	university	PROPN
ajmsi-1283	15	22	,	,	PUNCT
ajmsi-1283	15	23	awka	awka	NOUN
ajmsi-1283	15	24	,	,	PUNCT
ajmsi-1283	15	25	anambra	anambra	PROPN
ajmsi-1283	15	26	state	state	PROPN
ajmsi-1283	15	27	,	,	PUNCT
ajmsi-1283	15	28	nigeria	nigeria	PROPN
ajmsi-1283	15	29	*	*	PUNCT
ajmsi-1283	15	30	corresponding	correspond	VERB
ajmsi-1283	15	31	author	author	NOUN
ajmsi-1283	15	32	’s	’s	PART
ajmsi-1283	15	33	e	e	NOUN
ajmsi-1283	15	34	-	-	NOUN
ajmsi-1283	15	35	mail	mail	NOUN
ajmsi-1283	15	36	:	:	PUNCT
ajmsi-1283	15	37	ca.ekwunife@unizik.edu.ng	ca.ekwunife@unizik.edu.ng	NUM
ajmsi-1283	15	38	introduction	introduction	NOUN
ajmsi-1283	15	39	schistosomes	schistosome	NOUN
ajmsi-1283	15	40	are	be	AUX
ajmsi-1283	15	41	parasitic	parasitic	ADJ
ajmsi-1283	15	42	trematodes	trematode	NOUN
ajmsi-1283	15	43	that	that	PRON
ajmsi-1283	15	44	cause	cause	VERB
ajmsi-1283	15	45	the	the	DET
ajmsi-1283	15	46	disease	disease	NOUN
ajmsi-1283	15	47	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	15	48	;	;	PUNCT
ajmsi-1283	15	49	they	they	PRON
ajmsi-1283	15	50	are	be	AUX
ajmsi-1283	15	51	found	find	VERB
ajmsi-1283	15	52	in	in	ADP
ajmsi-1283	15	53	subtropical	subtropical	ADJ
ajmsi-1283	15	54	and	and	CCONJ
ajmsi-1283	15	55	tropical	tropical	ADJ
ajmsi-1283	15	56	regions	region	NOUN
ajmsi-1283	15	57	of	of	ADP
ajmsi-1283	15	58	the	the	DET
ajmsi-1283	15	59	world	world	NOUN
ajmsi-1283	15	60	including	include	VERB
ajmsi-1283	15	61	nigeria	nigeria	PROPN
ajmsi-1283	15	62	(	(	PUNCT
ajmsi-1283	15	63	ekwunife	ekwunife	NOUN
ajmsi-1283	15	64	et	et	PROPN
ajmsi-1283	15	65	al	al	PROPN
ajmsi-1283	15	66	.	.	PROPN
ajmsi-1283	15	67	,	,	PUNCT
ajmsi-1283	15	68	2004	2004	NUM
ajmsi-1283	15	69	;	;	PUNCT
ajmsi-1283	15	70	ndukwe	ndukwe	PROPN
ajmsi-1283	15	71	et	et	PROPN
ajmsi-1283	15	72	al	al	PROPN
ajmsi-1283	15	73	.	.	PROPN
ajmsi-1283	15	74	,	,	PUNCT
ajmsi-1283	15	75	2019	2019	NUM
ajmsi-1283	15	76	)	)	PUNCT
ajmsi-1283	15	77	.	.	PUNCT
ajmsi-1283	16	1	anambra	anambra	PROPN
ajmsi-1283	16	2	state	state	PROPN
ajmsi-1283	16	3	,	,	PUNCT
ajmsi-1283	16	4	nigeria	nigeria	PROPN
ajmsi-1283	16	5	,	,	PUNCT
ajmsi-1283	16	6	offer	offer	VERB
ajmsi-1283	16	7	numerous	numerous	ADJ
ajmsi-1283	16	8	favourable	favourable	ADJ
ajmsi-1283	16	9	habitats	habitat	NOUN
ajmsi-1283	16	10	for	for	ADP
ajmsi-1283	16	11	aquatic	aquatic	ADJ
ajmsi-1283	16	12	snails	snail	NOUN
ajmsi-1283	16	13	that	that	PRON
ajmsi-1283	16	14	serve	serve	VERB
ajmsi-1283	16	15	as	as	ADP
ajmsi-1283	16	16	intermediate	intermediate	ADJ
ajmsi-1283	16	17	hosts	host	NOUN
ajmsi-1283	16	18	to	to	ADP
ajmsi-1283	16	19	schistosoma	schistosoma	ADJ
ajmsi-1283	16	20	species	specie	NOUN
ajmsi-1283	16	21	(	(	PUNCT
ajmsi-1283	16	22	ekwunife	ekwunife	NOUN
ajmsi-1283	16	23	et	et	PROPN
ajmsi-1283	16	24	al	al	PROPN
ajmsi-1283	16	25	.	.	PROPN
ajmsi-1283	16	26	,	,	PUNCT
ajmsi-1283	16	27	2004	2004	NUM
ajmsi-1283	16	28	)	)	PUNCT
ajmsi-1283	16	29	.	.	PUNCT
ajmsi-1283	17	1	children	child	NOUN
ajmsi-1283	17	2	have	have	AUX
ajmsi-1283	17	3	been	be	AUX
ajmsi-1283	17	4	identified	identify	VERB
ajmsi-1283	17	5	to	to	PART
ajmsi-1283	17	6	harbour	harbour	VERB
ajmsi-1283	17	7	the	the	DET
ajmsi-1283	17	8	greatest	great	ADJ
ajmsi-1283	17	9	number	number	NOUN
ajmsi-1283	17	10	of	of	ADP
ajmsi-1283	17	11	worms	worm	NOUN
ajmsi-1283	17	12	leading	lead	VERB
ajmsi-1283	17	13	to	to	ADP
ajmsi-1283	17	14	reduced	reduced	ADJ
ajmsi-1283	17	15	growth	growth	NOUN
ajmsi-1283	17	16	,	,	PUNCT
ajmsi-1283	17	17	impaired	impaired	ADJ
ajmsi-1283	17	18	memory	memory	NOUN
ajmsi-1283	17	19	and	and	CCONJ
ajmsi-1283	17	20	cognition	cognition	NOUN
ajmsi-1283	17	21	and	and	CCONJ
ajmsi-1283	17	22	reduced	reduce	VERB
ajmsi-1283	17	23	school	school	NOUN
ajmsi-1283	17	24	attendance	attendance	NOUN
ajmsi-1283	17	25	(	(	PUNCT
ajmsi-1283	17	26	crompton	crompton	PROPN
ajmsi-1283	17	27	and	and	CCONJ
ajmsi-1283	17	28	nesheim	nesheim	PROPN
ajmsi-1283	17	29	,	,	PUNCT
ajmsi-1283	17	30	2002	2002	NUM
ajmsi-1283	17	31	;	;	PUNCT
ajmsi-1283	17	32	miguel	miguel	PROPN
ajmsi-1283	17	33	and	and	CCONJ
ajmsi-1283	17	34	kremer	kremer	PROPN
ajmsi-1283	17	35	,	,	PUNCT
ajmsi-1283	17	36	2004	2004	NUM
ajmsi-1283	17	37	;	;	PUNCT
ajmsi-1283	17	38	bundy	bundy	PROPN
ajmsi-1283	17	39	et	et	PROPN
ajmsi-1283	17	40	al	al	PROPN
ajmsi-1283	17	41	.	.	PROPN
ajmsi-1283	17	42	,	,	PUNCT
ajmsi-1283	17	43	2013	2013	NUM
ajmsi-1283	17	44	)	)	PUNCT
ajmsi-1283	17	45	.	.	PUNCT
ajmsi-1283	18	1	also	also	ADV
ajmsi-1283	18	2	,	,	PUNCT
ajmsi-1283	18	3	cases	case	NOUN
ajmsi-1283	18	4	of	of	ADP
ajmsi-1283	18	5	chronic	chronic	ADJ
ajmsi-1283	18	6	infection	infection	NOUN
ajmsi-1283	18	7	with	with	ADP
ajmsi-1283	18	8	urogenital	urogenital	ADJ
ajmsi-1283	18	9	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	18	10	can	can	AUX
ajmsi-1283	18	11	lead	lead	VERB
ajmsi-1283	18	12	to	to	ADP
ajmsi-1283	18	13	adverse	adverse	ADJ
ajmsi-1283	18	14	health	health	NOUN
ajmsi-1283	18	15	outcomes	outcome	NOUN
ajmsi-1283	18	16	including	include	VERB
ajmsi-1283	18	17	the	the	DET
ajmsi-1283	18	18	development	development	NOUN
ajmsi-1283	18	19	of	of	ADP
ajmsi-1283	18	20	urogenital	urogenital	ADJ
ajmsi-1283	18	21	cancer	cancer	NOUN
ajmsi-1283	18	22	.	.	PUNCT
ajmsi-1283	19	1	(	(	PUNCT
ajmsi-1283	19	2	ishida	ishida	PROPN
ajmsi-1283	19	3	and	and	CCONJ
ajmsi-1283	19	4	hsieh	hsieh	PROPN
ajmsi-1283	19	5	,	,	PUNCT
ajmsi-1283	19	6	2018	2018	NUM
ajmsi-1283	19	7	)	)	PUNCT
ajmsi-1283	19	8	.	.	PUNCT
ajmsi-1283	20	1	there	there	PRON
ajmsi-1283	20	2	are	be	VERB
ajmsi-1283	20	3	certain	certain	ADJ
ajmsi-1283	20	4	genetic	genetic	ADJ
ajmsi-1283	20	5	factors	factor	NOUN
ajmsi-1283	20	6	that	that	PRON
ajmsi-1283	20	7	could	could	AUX
ajmsi-1283	20	8	also	also	ADV
ajmsi-1283	20	9	play	play	VERB
ajmsi-1283	20	10	important	important	ADJ
ajmsi-1283	20	11	role	role	NOUN
ajmsi-1283	20	12	in	in	ADP
ajmsi-1283	20	13	the	the	DET
ajmsi-1283	20	14	pathology	pathology	NOUN
ajmsi-1283	20	15	of	of	ADP
ajmsi-1283	20	16	infection	infection	NOUN
ajmsi-1283	20	17	with	with	ADP
ajmsi-1283	20	18	schistosomes	schistosome	NOUN
ajmsi-1283	20	19	including	include	VERB
ajmsi-1283	20	20	the	the	DET
ajmsi-1283	20	21	possibility	possibility	NOUN
ajmsi-1283	20	22	of	of	ADP
ajmsi-1283	20	23	the	the	DET
ajmsi-1283	20	24	development	development	NOUN
ajmsi-1283	20	25	of	of	ADP
ajmsi-1283	20	26	urogenital	urogenital	ADJ
ajmsi-1283	20	27	cancer	cancer	NOUN
ajmsi-1283	20	28	as	as	ADP
ajmsi-1283	20	29	a	a	DET
ajmsi-1283	20	30	result	result	NOUN
ajmsi-1283	20	31	of	of	ADP
ajmsi-1283	20	32	granuloma	granuloma	ADJ
ajmsi-1283	20	33	formation	formation	NOUN
ajmsi-1283	20	34	(	(	PUNCT
ajmsi-1283	20	35	barosum	barosum	NOUN
ajmsi-1283	20	36	,	,	PUNCT
ajmsi-1283	20	37	2021	2021	NUM
ajmsi-1283	20	38	)	)	PUNCT
ajmsi-1283	20	39	.	.	PUNCT
ajmsi-1283	21	1	the	the	DET
ajmsi-1283	21	2	general	general	ADJ
ajmsi-1283	21	3	activity	activity	NOUN
ajmsi-1283	21	4	in	in	ADP
ajmsi-1283	21	5	an	an	DET
ajmsi-1283	21	6	individual	individual	NOUN
ajmsi-1283	21	7	is	be	AUX
ajmsi-1283	21	8	controlled	control	VERB
ajmsi-1283	21	9	by	by	ADP
ajmsi-1283	21	10	the	the	DET
ajmsi-1283	21	11	genetic	genetic	ADJ
ajmsi-1283	21	12	expression	expression	NOUN
ajmsi-1283	21	13	of	of	ADP
ajmsi-1283	21	14	that	that	DET
ajmsi-1283	21	15	individual	individual	NOUN
ajmsi-1283	21	16	therefore	therefore	ADV
ajmsi-1283	21	17	information	information	NOUN
ajmsi-1283	21	18	on	on	ADP
ajmsi-1283	21	19	the	the	DET
ajmsi-1283	21	20	roles	role	NOUN
ajmsi-1283	21	21	played	play	VERB
ajmsi-1283	21	22	by	by	ADP
ajmsi-1283	21	23	some	some	DET
ajmsi-1283	21	24	genetic	genetic	ADJ
ajmsi-1283	21	25	markers	marker	NOUN
ajmsi-1283	21	26	in	in	ADP
ajmsi-1283	21	27	relation	relation	NOUN
ajmsi-1283	21	28	to	to	ADP
ajmsi-1283	21	29	age	age	NOUN
ajmsi-1283	21	30	of	of	ADP
ajmsi-1283	21	31	individuals	individual	NOUN
ajmsi-1283	21	32	predisposed	predispose	VERB
ajmsi-1283	21	33	to	to	ADP
ajmsi-1283	21	34	urogenital	urogenital	ADJ
ajmsi-1283	21	35	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	21	36	will	will	AUX
ajmsi-1283	21	37	give	give	VERB
ajmsi-1283	21	38	vital	vital	ADJ
ajmsi-1283	21	39	information	information	NOUN
ajmsi-1283	21	40	on	on	ADP
ajmsi-1283	21	41	the	the	DET
ajmsi-1283	21	42	immune	immune	ADJ
ajmsi-1283	21	43	protective	protective	ADJ
ajmsi-1283	21	44	response	response	NOUN
ajmsi-1283	21	45	to	to	ADP
ajmsi-1283	21	46	the	the	DET
ajmsi-1283	21	47	parasite	parasite	NOUN
ajmsi-1283	21	48	among	among	ADP
ajmsi-1283	21	49	group	group	NOUN
ajmsi-1283	21	50	of	of	ADP
ajmsi-1283	21	51	people	people	NOUN
ajmsi-1283	21	52	that	that	PRON
ajmsi-1283	21	53	are	be	AUX
ajmsi-1283	21	54	at	at	ADP
ajmsi-1283	21	55	risk	risk	NOUN
ajmsi-1283	21	56	to	to	ADP
ajmsi-1283	21	57	the	the	DET
ajmsi-1283	21	58	development	development	NOUN
ajmsi-1283	21	59	of	of	ADP
ajmsi-1283	21	60	severe	severe	ADJ
ajmsi-1283	21	61	disease	disease	NOUN
ajmsi-1283	21	62	pathology	pathology	NOUN
ajmsi-1283	21	63	.	.	PUNCT
ajmsi-1283	22	1	therefore	therefore	ADV
ajmsi-1283	22	2	,	,	PUNCT
ajmsi-1283	22	3	this	this	DET
ajmsi-1283	22	4	study	study	NOUN
ajmsi-1283	22	5	aimed	aim	VERB
ajmsi-1283	22	6	to	to	PART
ajmsi-1283	22	7	determined	determined	VERB
ajmsi-1283	22	8	the	the	DET
ajmsi-1283	22	9	presence	presence	NOUN
ajmsi-1283	22	10	of	of	ADP
ajmsi-1283	22	11	cancer	cancer	NOUN
ajmsi-1283	22	12	genetic	genetic	ADJ
ajmsi-1283	22	13	markers	marker	NOUN
ajmsi-1283	22	14	among	among	ADP
ajmsi-1283	22	15	school	school	NOUN
ajmsi-1283	22	16	children	child	NOUN
ajmsi-1283	22	17	in	in	ADP
ajmsi-1283	22	18	relation	relation	NOUN
ajmsi-1283	22	19	to	to	ADP
ajmsi-1283	22	20	urogenital	urogenital	ADJ
ajmsi-1283	22	21	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	22	22	in	in	ADP
ajmsi-1283	22	23	anambra	anambra	PROPN
ajmsi-1283	22	24	north	north	PROPN
ajmsi-1283	22	25	senatorial	senatorial	PROPN
ajmsi-1283	22	26	district	district	NOUN
ajmsi-1283	22	27	,	,	PUNCT
ajmsi-1283	22	28	nigeria	nigeria	PROPN
ajmsi-1283	22	29	literature	literature	PROPN
ajmsi-1283	22	30	review	review	PROPN
ajmsi-1283	22	31	cancer	cancer	NOUN
ajmsi-1283	22	32	is	be	AUX
ajmsi-1283	22	33	a	a	DET
ajmsi-1283	22	34	disease	disease	NOUN
ajmsi-1283	22	35	of	of	ADP
ajmsi-1283	22	36	importance	importance	NOUN
ajmsi-1283	22	37	because	because	SCONJ
ajmsi-1283	22	38	it	it	PRON
ajmsi-1283	22	39	is	be	AUX
ajmsi-1283	22	40	a	a	DET
ajmsi-1283	22	41	genetic	genetic	ADJ
ajmsi-1283	22	42	disorder	disorder	NOUN
ajmsi-1283	22	43	that	that	PRON
ajmsi-1283	22	44	can	can	AUX
ajmsi-1283	22	45	come	come	VERB
ajmsi-1283	22	46	about	about	ADP
ajmsi-1283	22	47	as	as	ADP
ajmsi-1283	22	48	a	a	DET
ajmsi-1283	22	49	results	result	NOUN
ajmsi-1283	22	50	genetic	genetic	ADJ
ajmsi-1283	22	51	or	or	CCONJ
ajmsi-1283	22	52	epigenetic	epigenetic	ADJ
ajmsi-1283	22	53	alterations	alteration	NOUN
ajmsi-1283	22	54	in	in	ADP
ajmsi-1283	22	55	the	the	DET
ajmsi-1283	22	56	somatic	somatic	ADJ
ajmsi-1283	22	57	cells	cell	NOUN
ajmsi-1283	22	58	and	and	CCONJ
ajmsi-1283	22	59	is	be	AUX
ajmsi-1283	22	60	associated	associate	VERB
ajmsi-1283	22	61	with	with	ADP
ajmsi-1283	22	62	abnormal	abnormal	ADJ
ajmsi-1283	22	63	cell	cell	NOUN
ajmsi-1283	22	64	growth	growth	NOUN
ajmsi-1283	22	65	,	,	PUNCT
ajmsi-1283	22	66	it	it	PRON
ajmsi-1283	22	67	could	could	AUX
ajmsi-1283	22	68	be	be	AUX
ajmsi-1283	22	69	invasive	invasive	ADJ
ajmsi-1283	22	70	or	or	CCONJ
ajmsi-1283	22	71	noninvasive	noninvasive	ADJ
ajmsi-1283	22	72	(	(	PUNCT
ajmsi-1283	22	73	soria	soria	PROPN
ajmsi-1283	22	74	et	et	PROPN
ajmsi-1283	22	75	al	al	PROPN
ajmsi-1283	22	76	.	.	PROPN
ajmsi-1283	22	77	,	,	PUNCT
ajmsi-1283	22	78	2019	2019	NUM
ajmsi-1283	22	79	;	;	PUNCT
ajmsi-1283	22	80	zhang	zhang	PROPN
ajmsi-1283	22	81	et	et	PROPN
ajmsi-1283	22	82	al	al	PROPN
ajmsi-1283	22	83	.	.	PROPN
ajmsi-1283	22	84	,	,	PUNCT
ajmsi-1283	22	85	2015	2015	NUM
ajmsi-1283	22	86	)	)	PUNCT
ajmsi-1283	22	87	.	.	PUNCT
ajmsi-1283	23	1	cancer	cancer	NOUN
ajmsi-1283	23	2	has	have	AUX
ajmsi-1283	23	3	been	be	AUX
ajmsi-1283	23	4	identified	identify	VERB
ajmsi-1283	23	5	to	to	PART
ajmsi-1283	23	6	be	be	AUX
ajmsi-1283	23	7	caused	cause	VERB
ajmsi-1283	23	8	by	by	ADP
ajmsi-1283	23	9	a	a	DET
ajmsi-1283	23	10	lot	lot	NOUN
ajmsi-1283	23	11	of	of	ADP
ajmsi-1283	23	12	factors	factor	NOUN
ajmsi-1283	23	13	including	include	VERB
ajmsi-1283	23	14	but	but	CCONJ
ajmsi-1283	23	15	not	not	PART
ajmsi-1283	23	16	limited	limit	VERB
ajmsi-1283	23	17	to	to	ADP
ajmsi-1283	23	18	tobacco	tobacco	NOUN
ajmsi-1283	23	19	smoking	smoking	NOUN
ajmsi-1283	23	20	,	,	PUNCT
ajmsi-1283	23	21	infections	infection	NOUN
ajmsi-1283	23	22	like	like	ADP
ajmsi-1283	23	23	hiv	hiv	PROPN
ajmsi-1283	23	24	,	,	PUNCT
ajmsi-1283	23	25	hepatitis	hepatitis	PROPN
ajmsi-1283	23	26	b	b	PROPN
ajmsi-1283	23	27	,	,	PUNCT
ajmsi-1283	23	28	epstein	epstein	NOUN
ajmsi-1283	23	29	-	-	PUNCT
ajmsi-1283	23	30	barretc	barretc	NOUN
ajmsi-1283	23	31	,	,	PUNCT
ajmsi-1283	23	32	poor	poor	ADJ
ajmsi-1283	23	33	diet	diet	NOUN
ajmsi-1283	23	34	,	,	PUNCT
ajmsi-1283	23	35	obesity	obesity	NOUN
ajmsi-1283	23	36	,	,	PUNCT
ajmsi-1283	23	37	excessive	excessive	ADJ
ajmsi-1283	23	38	consumption	consumption	NOUN
ajmsi-1283	23	39	of	of	ADP
ajmsi-1283	23	40	alcohol	alcohol	NOUN
ajmsi-1283	23	41	,	,	PUNCT
ajmsi-1283	23	42	exposure	exposure	NOUN
ajmsi-1283	23	43	to	to	ADP
ajmsi-1283	23	44	ionizing	ionize	VERB
ajmsi-1283	23	45	radiation	radiation	NOUN
ajmsi-1283	23	46	,	,	PUNCT
ajmsi-1283	23	47	and	and	CCONJ
ajmsi-1283	23	48	gases	gas	NOUN
ajmsi-1283	23	49	,	,	PUNCT
ajmsi-1283	23	50	bladder	bladder	NOUN
ajmsi-1283	23	51	inflammation	inflammation	NOUN
ajmsi-1283	23	52	due	due	ADP
ajmsi-1283	23	53	to	to	ADP
ajmsi-1283	23	54	microbial	microbial	ADJ
ajmsi-1283	23	55	and	and	CCONJ
ajmsi-1283	23	56	parasitic	parasitic	ADJ
ajmsi-1283	23	57	infections	infection	NOUN
ajmsi-1283	23	58	,	,	PUNCT
ajmsi-1283	23	59	as	as	ADV
ajmsi-1283	23	60	well	well	ADV
ajmsi-1283	23	61	as	as	ADP
ajmsi-1283	23	62	some	some	DET
ajmsi-1283	23	63	adverse	adverse	ADJ
ajmsi-1283	23	64	side	side	NOUN
ajmsi-1283	23	65	-	-	PUNCT
ajmsi-1283	23	66	effects	effect	NOUN
ajmsi-1283	23	67	of	of	ADP
ajmsi-1283	23	68	medications	medication	NOUN
ajmsi-1283	23	69	(	(	PUNCT
ajmsi-1283	23	70	saini	saini	PROPN
ajmsi-1283	23	71	et	et	PROPN
ajmsi-1283	23	72	al	al	PROPN
ajmsi-1283	23	73	.	.	PROPN
ajmsi-1283	23	74	,	,	PUNCT
ajmsi-1283	23	75	2020	2020	NUM
ajmsi-1283	23	76	)	)	PUNCT
ajmsi-1283	23	77	.	.	PUNCT
ajmsi-1283	24	1	there	there	PRON
ajmsi-1283	24	2	are	be	VERB
ajmsi-1283	24	3	different	different	ADJ
ajmsi-1283	24	4	forms	form	NOUN
ajmsi-1283	24	5	of	of	ADP
ajmsi-1283	24	6	cancer	cancer	NOUN
ajmsi-1283	24	7	of	of	ADP
ajmsi-1283	24	8	which	which	DET
ajmsi-1283	24	9	bladder	bladder	NOUN
ajmsi-1283	24	10	cancer	cancer	NOUN
ajmsi-1283	24	11	is	be	AUX
ajmsi-1283	24	12	inclusive	inclusive	ADJ
ajmsi-1283	24	13	.	.	PUNCT
ajmsi-1283	25	1	bladder	bladder	NOUN
ajmsi-1283	25	2	cancer	cancer	NOUN
ajmsi-1283	25	3	is	be	AUX
ajmsi-1283	25	4	a	a	DET
ajmsi-1283	25	5	disease	disease	NOUN
ajmsi-1283	25	6	that	that	PRON
ajmsi-1283	25	7	can	can	AUX
ajmsi-1283	25	8	arise	arise	VERB
ajmsi-1283	25	9	from	from	ADP
ajmsi-1283	25	10	various	various	ADJ
ajmsi-1283	25	11	factors	factor	NOUN
ajmsi-1283	25	12	including	include	VERB
ajmsi-1283	25	13	infection	infection	NOUN
ajmsi-1283	25	14	with	with	ADP
ajmsi-1283	25	15	schistosoma	schistosoma	ADJ
ajmsi-1283	25	16	haematobium	haematobium	NOUN
ajmsi-1283	25	17	which	which	PRON
ajmsi-1283	25	18	has	have	VERB
ajmsi-1283	25	19	significant	significant	ADJ
ajmsi-1283	25	20	diagnostic	diagnostic	ADJ
ajmsi-1283	25	21	,	,	PUNCT
ajmsi-1283	25	22	therapeutic	therapeutic	ADJ
ajmsi-1283	25	23	and	and	CCONJ
ajmsi-1283	25	24	prognostic	prognostic	ADJ
ajmsi-1283	25	25	challenges	challenge	NOUN
ajmsi-1283	25	26	(	(	PUNCT
ajmsi-1283	25	27	kamat	kamat	PROPN
ajmsi-1283	25	28	et	et	PROPN
ajmsi-1283	25	29	al	al	PROPN
ajmsi-1283	25	30	.	.	PROPN
ajmsi-1283	25	31	,	,	PUNCT
ajmsi-1283	25	32	2013	2013	NUM
ajmsi-1283	25	33	)	)	PUNCT
ajmsi-1283	25	34	cases	case	NOUN
ajmsi-1283	25	35	of	of	ADP
ajmsi-1283	25	36	which	which	PRON
ajmsi-1283	25	37	squamous	squamous	ADJ
ajmsi-1283	25	38	cell	cell	NOUN
ajmsi-1283	25	39	cancers	cancer	NOUN
ajmsi-1283	25	40	of	of	ADP
ajmsi-1283	25	41	the	the	DET
ajmsi-1283	25	42	urinary	urinary	ADJ
ajmsi-1283	25	43	bladder	bladder	NOUN
ajmsi-1283	25	44	were	be	AUX
ajmsi-1283	25	45	identified	identify	VERB
ajmsi-1283	25	46	to	to	PART
ajmsi-1283	25	47	be	be	AUX
ajmsi-1283	25	48	proportionately	proportionately	ADV
ajmsi-1283	25	49	more	more	ADV
ajmsi-1283	25	50	common	common	ADJ
ajmsi-1283	25	51	in	in	ADP
ajmsi-1283	25	52	populations	population	NOUN
ajmsi-1283	25	53	with	with	ADP
ajmsi-1283	25	54	a	a	DET
ajmsi-1283	25	55	high	high	ADJ
ajmsi-1283	25	56	prevalence	prevalence	NOUN
ajmsi-1283	25	57	of	of	ADP
ajmsi-1283	25	58	s.	s.	PROPN
ajmsi-1283	25	59	haematobium	haematobium	PROPN
ajmsi-1283	25	60	infection	infection	NOUN
ajmsi-1283	25	61	and	and	CCONJ
ajmsi-1283	25	62	a	a	DET
ajmsi-1283	25	63	high	high	ADJ
ajmsi-1283	25	64	proportion	proportion	NOUN
ajmsi-1283	25	65	of	of	ADP
ajmsi-1283	25	66	urinary	urinary	ADJ
ajmsi-1283	25	67	bladder	bladder	NOUN
ajmsi-1283	25	68	cancers	cancer	NOUN
ajmsi-1283	25	69	(	(	PUNCT
ajmsi-1283	25	70	iarc	iarc	NOUN
ajmsi-1283	25	71	,	,	PUNCT
ajmsi-1283	25	72	2012	2012	NUM
ajmsi-1283	25	73	)	)	PUNCT
ajmsi-1283	25	74	.	.	PUNCT
ajmsi-1283	26	1	the	the	DET
ajmsi-1283	26	2	estimated	estimate	VERB
ajmsi-1283	26	3	incidence	incidence	NOUN
ajmsi-1283	26	4	of	of	ADP
ajmsi-1283	26	5	urinary	urinary	ADJ
ajmsi-1283	26	6	bladder	bladder	NOUN
ajmsi-1283	26	7	cancer	cancer	NOUN
ajmsi-1283	26	8	has	have	AUX
ajmsi-1283	26	9	been	be	AUX
ajmsi-1283	26	10	related	relate	VERB
ajmsi-1283	26	11	to	to	ADP
ajmsi-1283	26	12	the	the	DET
ajmsi-1283	26	13	proportion	proportion	NOUN
ajmsi-1283	26	14	of	of	ADP
ajmsi-1283	26	15	cancerous	cancerous	ADJ
ajmsi-1283	26	16	urinary	urinary	ADJ
ajmsi-1283	26	17	bladder	bladder	NOUN
ajmsi-1283	26	18	specimens	specimen	NOUN
ajmsi-1283	26	19	which	which	PRON
ajmsi-1283	26	20	contains	contain	VERB
ajmsi-1283	26	21	s.	s.	PROPN
ajmsi-1283	26	22	haematobium	haematobium	PROPN
ajmsi-1283	26	23	eggs	egg	NOUN
ajmsi-1283	26	24	or	or	CCONJ
ajmsi-1283	26	25	egg	egg	NOUN
ajmsi-1283	26	26	remnants	remnant	NOUN
ajmsi-1283	26	27	(	(	PUNCT
ajmsi-1283	26	28	iarc	iarc	NOUN
ajmsi-1283	26	29	,	,	PUNCT
ajmsi-1283	26	30	2012	2012	NUM
ajmsi-1283	26	31	)	)	PUNCT
ajmsi-1283	26	32	.	.	PUNCT
ajmsi-1283	27	1	also	also	ADV
ajmsi-1283	27	2	,	,	PUNCT
ajmsi-1283	27	3	the	the	DET
ajmsi-1283	27	4	sex	sex	NOUN
ajmsi-1283	27	5	ratio	ratio	NOUN
ajmsi-1283	27	6	of	of	ADP
ajmsi-1283	27	7	urinary	urinary	ADJ
ajmsi-1283	27	8	bladder	bladder	NOUN
ajmsi-1283	27	9	cancer	cancer	NOUN
ajmsi-1283	27	10	cases	case	NOUN
ajmsi-1283	27	11	show	show	VERB
ajmsi-1283	27	12	some	some	DET
ajmsi-1283	27	13	variation	variation	NOUN
ajmsi-1283	27	14	although	although	SCONJ
ajmsi-1283	27	15	it	it	PRON
ajmsi-1283	27	16	corresponded	correspond	VERB
ajmsi-1283	27	17	to	to	ADP
ajmsi-1283	27	18	the	the	DET
ajmsi-1283	27	19	relative	relative	ADJ
ajmsi-1283	27	20	involvement	involvement	NOUN
ajmsi-1283	27	21	of	of	ADP
ajmsi-1283	27	22	men	man	NOUN
ajmsi-1283	27	23	and	and	CCONJ
ajmsi-1283	27	24	women	woman	NOUN
ajmsi-1283	27	25	in	in	ADP
ajmsi-1283	27	26	agricultural	agricultural	ADJ
ajmsi-1283	27	27	work	work	NOUN
ajmsi-1283	27	28	which	which	PRON
ajmsi-1283	27	29	has	have	AUX
ajmsi-1283	27	30	been	be	AUX
ajmsi-1283	27	31	identified	identify	VERB
ajmsi-1283	27	32	as	as	ADP
ajmsi-1283	27	33	a	a	DET
ajmsi-1283	27	34	risk	risk	NOUN
ajmsi-1283	27	35	factor	factor	NOUN
ajmsi-1283	27	36	for	for	ADP
ajmsi-1283	27	37	s.	s.	PROPN
ajmsi-1283	27	38	haematobium	haematobium	PROPN
ajmsi-1283	27	39	infection	infection	NOUN
ajmsi-1283	27	40	(	(	PUNCT
ajmsi-1283	27	41	iarc	iarc	NOUN
ajmsi-1283	27	42	,	,	PUNCT
ajmsi-1283	27	43	2012	2012	NUM
ajmsi-1283	27	44	)	)	PUNCT
ajmsi-1283	27	45	.	.	PUNCT
ajmsi-1283	28	1	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	28	2	pa	pa	PROPN
ajmsi-1283	28	3	ge	ge	PROPN
ajmsi-1283	28	4	27	27	NUM
ajmsi-1283	28	5	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	28	6	am	be	AUX
ajmsi-1283	28	7	.	.	PUNCT
ajmsi-1283	29	1	j.	j.	PROPN
ajmsi-1283	29	2	med	med	PROPN
ajmsi-1283	29	3	.	.	PUNCT
ajmsi-1283	30	1	sci	sci	PROPN
ajmsi-1283	30	2	.	.	PUNCT
ajmsi-1283	30	3	innov	innov	PROPN
ajmsi-1283	30	4	.	.	PUNCT
ajmsi-1283	31	1	2(1	2(1	NUM
ajmsi-1283	31	2	)	)	PUNCT
ajmsi-1283	31	3	26	26	NUM
ajmsi-1283	31	4	-	-	SYM
ajmsi-1283	31	5	31	31	NUM
ajmsi-1283	31	6	,	,	PUNCT
ajmsi-1283	31	7	2023	2023	NUM
ajmsi-1283	31	8	adult	adult	NOUN
ajmsi-1283	31	9	worms	worm	NOUN
ajmsi-1283	31	10	in	in	ADP
ajmsi-1283	31	11	schistosoma	schistosoma	ADJ
ajmsi-1283	31	12	haematobium	haematobium	NOUN
ajmsi-1283	31	13	infection	infection	NOUN
ajmsi-1283	31	14	are	be	AUX
ajmsi-1283	31	15	seen	see	VERB
ajmsi-1283	31	16	to	to	PART
ajmsi-1283	31	17	reside	reside	VERB
ajmsi-1283	31	18	in	in	ADP
ajmsi-1283	31	19	the	the	DET
ajmsi-1283	31	20	urinary	urinary	ADJ
ajmsi-1283	31	21	system	system	NOUN
ajmsi-1283	31	22	where	where	SCONJ
ajmsi-1283	31	23	they	they	PRON
ajmsi-1283	31	24	lay	lay	VERB
ajmsi-1283	31	25	eggs	egg	NOUN
ajmsi-1283	31	26	that	that	PRON
ajmsi-1283	31	27	cause	cause	VERB
ajmsi-1283	31	28	disease	disease	NOUN
ajmsi-1283	31	29	pathology	pathology	NOUN
ajmsi-1283	31	30	.	.	PUNCT
ajmsi-1283	32	1	studies	study	NOUN
ajmsi-1283	32	2	reported	report	VERB
ajmsi-1283	32	3	in	in	ADP
ajmsi-1283	32	4	the	the	DET
ajmsi-1283	32	5	international	international	ADJ
ajmsi-1283	32	6	agency	agency	NOUN
ajmsi-1283	32	7	for	for	ADP
ajmsi-1283	32	8	research	research	NOUN
ajmsi-1283	32	9	on	on	ADP
ajmsi-1283	32	10	cancer	cancer	NOUN
ajmsi-1283	32	11	(	(	PUNCT
ajmsi-1283	32	12	iarc	iarc	NOUN
ajmsi-1283	32	13	)	)	PUNCT
ajmsi-1283	32	14	and	and	CCONJ
ajmsi-1283	32	15	other	other	ADJ
ajmsi-1283	32	16	studies	study	NOUN
ajmsi-1283	32	17	(	(	PUNCT
ajmsi-1283	32	18	badawi	badawi	PROPN
ajmsi-1283	32	19	et	et	PROPN
ajmsi-1283	32	20	al	al	PROPN
ajmsi-1283	32	21	.	.	PROPN
ajmsi-1283	32	22	,	,	PUNCT
ajmsi-1283	32	23	1995	1995	NUM
ajmsi-1283	32	24	;	;	PUNCT
ajmsi-1283	32	25	mostafa	mostafa	PROPN
ajmsi-1283	32	26	et	et	PROPN
ajmsi-1283	32	27	al	al	PROPN
ajmsi-1283	32	28	.	.	PROPN
ajmsi-1283	32	29	,	,	PUNCT
ajmsi-1283	32	30	1999	1999	NUM
ajmsi-1283	32	31	;	;	PUNCT
ajmsi-1283	32	32	mayer	mayer	PROPN
ajmsi-1283	32	33	and	and	CCONJ
ajmsi-1283	32	34	fried	fry	VERB
ajmsi-1283	32	35	,	,	PUNCT
ajmsi-1283	32	36	2007	2007	NUM
ajmsi-1283	32	37	;	;	PUNCT
ajmsi-1283	32	38	ekwunife	ekwunife	NOUN
ajmsi-1283	32	39	et	et	PROPN
ajmsi-1283	32	40	al	al	PROPN
ajmsi-1283	32	41	.	.	PROPN
ajmsi-1283	32	42	,	,	PUNCT
ajmsi-1283	32	43	2009	2009	NUM
ajmsi-1283	32	44	)	)	PUNCT
ajmsi-1283	32	45	have	have	AUX
ajmsi-1283	32	46	supported	support	VERB
ajmsi-1283	32	47	an	an	DET
ajmsi-1283	32	48	association	association	NOUN
ajmsi-1283	32	49	between	between	ADP
ajmsi-1283	32	50	the	the	DET
ajmsi-1283	32	51	occurrence	occurrence	NOUN
ajmsi-1283	32	52	of	of	ADP
ajmsi-1283	32	53	urinary	urinary	ADJ
ajmsi-1283	32	54	bladder	bladder	NOUN
ajmsi-1283	32	55	cancer	cancer	NOUN
ajmsi-1283	32	56	and	and	CCONJ
ajmsi-1283	32	57	s.	s.	PROPN
ajmsi-1283	32	58	haematobium	haematobium	PROPN
ajmsi-1283	32	59	infection	infection	NOUN
ajmsi-1283	32	60	.	.	PUNCT
ajmsi-1283	33	1	studies	study	NOUN
ajmsi-1283	33	2	have	have	AUX
ajmsi-1283	33	3	shown	show	VERB
ajmsi-1283	33	4	that	that	SCONJ
ajmsi-1283	33	5	:	:	PUNCT
ajmsi-1283	33	6	the	the	DET
ajmsi-1283	33	7	estimated	estimate	VERB
ajmsi-1283	33	8	incidence	incidence	NOUN
ajmsi-1283	33	9	of	of	ADP
ajmsi-1283	33	10	urinary	urinary	ADJ
ajmsi-1283	33	11	bladder	bladder	NOUN
ajmsi-1283	33	12	cancer	cancer	NOUN
ajmsi-1283	33	13	was	be	AUX
ajmsi-1283	33	14	higher	high	ADJ
ajmsi-1283	33	15	in	in	ADP
ajmsi-1283	33	16	areas	area	NOUN
ajmsi-1283	33	17	with	with	ADP
ajmsi-1283	33	18	a	a	DET
ajmsi-1283	33	19	high	high	ADJ
ajmsi-1283	33	20	prevalence	prevalence	NOUN
ajmsi-1283	33	21	of	of	ADP
ajmsi-1283	33	22	s.	s.	PROPN
ajmsi-1283	33	23	haematobium	haematobium	PROPN
ajmsi-1283	33	24	infection	infection	NOUN
ajmsi-1283	33	25	than	than	ADP
ajmsi-1283	33	26	in	in	ADP
ajmsi-1283	33	27	areas	area	NOUN
ajmsi-1283	33	28	with	with	ADP
ajmsi-1283	33	29	a	a	DET
ajmsi-1283	33	30	low	low	ADJ
ajmsi-1283	33	31	prevalence	prevalence	NOUN
ajmsi-1283	33	32	(	(	PUNCT
ajmsi-1283	33	33	iarc	iarc	NOUN
ajmsi-1283	33	34	,	,	PUNCT
ajmsi-1283	33	35	2012	2012	NUM
ajmsi-1283	33	36	)	)	PUNCT
ajmsi-1283	33	37	.	.	PUNCT
ajmsi-1283	34	1	another	another	DET
ajmsi-1283	34	2	study	study	NOUN
ajmsi-1283	34	3	on	on	ADP
ajmsi-1283	34	4	the	the	DET
ajmsi-1283	34	5	incidence	incidence	NOUN
ajmsi-1283	34	6	of	of	ADP
ajmsi-1283	34	7	different	different	ADJ
ajmsi-1283	34	8	histological	histological	ADJ
ajmsi-1283	34	9	types	type	NOUN
ajmsi-1283	34	10	of	of	ADP
ajmsi-1283	34	11	bladder	bladder	NOUN
ajmsi-1283	34	12	cancer	cancer	NOUN
ajmsi-1283	34	13	in	in	ADP
ajmsi-1283	34	14	various	various	ADJ
ajmsi-1283	34	15	racial	racial	ADJ
ajmsi-1283	34	16	groups	group	NOUN
ajmsi-1283	34	17	living	live	VERB
ajmsi-1283	34	18	within	within	ADP
ajmsi-1283	34	19	the	the	DET
ajmsi-1283	34	20	same	same	ADJ
ajmsi-1283	34	21	geographic	geographic	ADJ
ajmsi-1283	34	22	area	area	NOUN
ajmsi-1283	34	23	of	of	ADP
ajmsi-1283	34	24	kwazulu	kwazulu	PROPN
ajmsi-1283	34	25	-	-	PUNCT
ajmsi-1283	34	26	natal	natal	ADJ
ajmsi-1283	34	27	,	,	PUNCT
ajmsi-1283	34	28	south	south	PROPN
ajmsi-1283	34	29	africa	africa	PROPN
ajmsi-1283	34	30	,	,	PUNCT
ajmsi-1283	34	31	reported	report	VERB
ajmsi-1283	34	32	similar	similar	ADJ
ajmsi-1283	34	33	results	result	NOUN
ajmsi-1283	34	34	:	:	PUNCT
ajmsi-1283	34	35	squamous	squamous	ADJ
ajmsi-1283	34	36	cell	cell	NOUN
ajmsi-1283	34	37	carcinoma	carcinoma	NOUN
ajmsi-1283	34	38	occurred	occur	VERB
ajmsi-1283	34	39	in	in	ADP
ajmsi-1283	34	40	53	53	NUM
ajmsi-1283	34	41	%	%	NOUN
ajmsi-1283	34	42	of	of	ADP
ajmsi-1283	34	43	the	the	DET
ajmsi-1283	34	44	african	african	ADJ
ajmsi-1283	34	45	patients	patient	NOUN
ajmsi-1283	34	46	(	(	PUNCT
ajmsi-1283	34	47	who	who	PRON
ajmsi-1283	34	48	have	have	VERB
ajmsi-1283	34	49	a	a	DET
ajmsi-1283	34	50	much	much	ADV
ajmsi-1283	34	51	higher	high	ADJ
ajmsi-1283	34	52	risk	risk	NOUN
ajmsi-1283	34	53	of	of	ADP
ajmsi-1283	34	54	exposure	exposure	NOUN
ajmsi-1283	34	55	and	and	CCONJ
ajmsi-1283	34	56	infestation	infestation	NOUN
ajmsi-1283	34	57	to	to	ADP
ajmsi-1283	34	58	s.	s.	PROPN
ajmsi-1283	34	59	haematobium	haematobium	PROPN
ajmsi-1283	34	60	due	due	ADP
ajmsi-1283	34	61	to	to	ADP
ajmsi-1283	34	62	socioeconomic	socioeconomic	ADJ
ajmsi-1283	34	63	,	,	PUNCT
ajmsi-1283	34	64	cultural	cultural	ADJ
ajmsi-1283	34	65	and	and	CCONJ
ajmsi-1283	34	66	educational	educational	ADJ
ajmsi-1283	34	67	factors	factor	NOUN
ajmsi-1283	34	68	)	)	PUNCT
ajmsi-1283	34	69	,	,	PUNCT
ajmsi-1283	34	70	and	and	CCONJ
ajmsi-1283	34	71	in	in	ADP
ajmsi-1283	34	72	2	2	NUM
ajmsi-1283	34	73	%	%	NOUN
ajmsi-1283	34	74	of	of	ADP
ajmsi-1283	34	75	the	the	DET
ajmsi-1283	34	76	caucasian	caucasian	ADJ
ajmsi-1283	34	77	patients	patient	NOUN
ajmsi-1283	34	78	(	(	PUNCT
ajmsi-1283	34	79	groeneveld	groeneveld	NOUN
ajmsi-1283	34	80	et	et	PROPN
ajmsi-1283	34	81	al	al	PROPN
ajmsi-1283	34	82	.	.	PROPN
ajmsi-1283	34	83	1996	1996	NUM
ajmsi-1283	34	84	)	)	PUNCT
ajmsi-1283	34	85	.	.	PUNCT
ajmsi-1283	35	1	also	also	ADV
ajmsi-1283	35	2	,	,	PUNCT
ajmsi-1283	35	3	groeneveld	groeneveld	NOUN
ajmsi-1283	35	4	et	et	PROPN
ajmsi-1283	35	5	al	al	PROPN
ajmsi-1283	35	6	.	.	PROPN
ajmsi-1283	36	1	(	(	PUNCT
ajmsi-1283	36	2	1996	1996	NUM
ajmsi-1283	36	3	)	)	PUNCT
ajmsi-1283	36	4	reported	report	VERB
ajmsi-1283	36	5	that	that	SCONJ
ajmsi-1283	36	6	eggs	egg	NOUN
ajmsi-1283	36	7	of	of	ADP
ajmsi-1283	36	8	s.	s.	PROPN
ajmsi-1283	36	9	haematobium	haematobium	PROPN
ajmsi-1283	36	10	were	be	AUX
ajmsi-1283	36	11	seen	see	VERB
ajmsi-1283	36	12	in	in	ADP
ajmsi-1283	36	13	microscopic	microscopic	ADJ
ajmsi-1283	36	14	sections	section	NOUN
ajmsi-1283	36	15	of	of	ADP
ajmsi-1283	36	16	the	the	DET
ajmsi-1283	36	17	bladder	bladder	NOUN
ajmsi-1283	36	18	tumour	tumour	NOUN
ajmsi-1283	36	19	in	in	ADP
ajmsi-1283	36	20	85	85	NUM
ajmsi-1283	36	21	%	%	NOUN
ajmsi-1283	36	22	of	of	ADP
ajmsi-1283	36	23	the	the	DET
ajmsi-1283	36	24	patients	patient	NOUN
ajmsi-1283	36	25	with	with	ADP
ajmsi-1283	36	26	squamous	squamous	ADJ
ajmsi-1283	36	27	cell	cell	NOUN
ajmsi-1283	36	28	carcinoma	carcinoma	NOUN
ajmsi-1283	36	29	,	,	PUNCT
ajmsi-1283	36	30	and	and	CCONJ
ajmsi-1283	36	31	in	in	ADP
ajmsi-1283	36	32	10	10	NUM
ajmsi-1283	36	33	%	%	NOUN
ajmsi-1283	36	34	of	of	ADP
ajmsi-1283	36	35	the	the	DET
ajmsi-1283	36	36	patients	patient	NOUN
ajmsi-1283	36	37	with	with	ADP
ajmsi-1283	36	38	transitional	transitional	ADJ
ajmsi-1283	36	39	cell	cell	NOUN
ajmsi-1283	36	40	carcinoma	carcinoma	NOUN
ajmsi-1283	36	41	with	with	ADP
ajmsi-1283	36	42	the	the	DET
ajmsi-1283	36	43	mean	mean	ADJ
ajmsi-1283	36	44	age	age	NOUN
ajmsi-1283	36	45	at	at	ADP
ajmsi-1283	36	46	presentation	presentation	NOUN
ajmsi-1283	36	47	of	of	ADP
ajmsi-1283	36	48	african	african	ADJ
ajmsi-1283	36	49	patients	patient	NOUN
ajmsi-1283	36	50	was	be	AUX
ajmsi-1283	36	51	at	at	ADV
ajmsi-1283	36	52	least	least	ADV
ajmsi-1283	36	53	20	20	NUM
ajmsi-1283	36	54	years	year	NOUN
ajmsi-1283	36	55	younger	young	ADJ
ajmsi-1283	36	56	than	than	ADP
ajmsi-1283	36	57	that	that	PRON
ajmsi-1283	36	58	of	of	ADP
ajmsi-1283	36	59	caucasian	caucasian	ADJ
ajmsi-1283	36	60	patients	patient	NOUN
ajmsi-1283	36	61	.	.	PUNCT
ajmsi-1283	37	1	adult	adult	NOUN
ajmsi-1283	37	2	schistosoma	schistosoma	ADJ
ajmsi-1283	37	3	haematobium	haematobium	NOUN
ajmsi-1283	37	4	worms	worm	NOUN
ajmsi-1283	37	5	do	do	AUX
ajmsi-1283	37	6	not	not	PART
ajmsi-1283	37	7	multiply	multiply	VERB
ajmsi-1283	37	8	in	in	ADP
ajmsi-1283	37	9	the	the	DET
ajmsi-1283	37	10	host	host	NOUN
ajmsi-1283	37	11	,	,	PUNCT
ajmsi-1283	37	12	but	but	CCONJ
ajmsi-1283	37	13	rather	rather	ADV
ajmsi-1283	37	14	produce	produce	VERB
ajmsi-1283	37	15	offspring	offspring	NOUN
ajmsi-1283	37	16	that	that	PRON
ajmsi-1283	37	17	must	must	AUX
ajmsi-1283	37	18	exit	exit	VERB
ajmsi-1283	37	19	the	the	DET
ajmsi-1283	37	20	host	host	NOUN
ajmsi-1283	37	21	to	to	PART
ajmsi-1283	37	22	continue	continue	VERB
ajmsi-1283	37	23	the	the	DET
ajmsi-1283	37	24	parasite	parasite	ADJ
ajmsi-1283	37	25	life	life	NOUN
ajmsi-1283	37	26	cycle	cycle	NOUN
ajmsi-1283	37	27	(	(	PUNCT
ajmsi-1283	37	28	klion	klion	NOUN
ajmsi-1283	37	29	and	and	CCONJ
ajmsi-1283	37	30	nutman	nutman	NOUN
ajmsi-1283	37	31	,	,	PUNCT
ajmsi-1283	37	32	2002	2002	NUM
ajmsi-1283	37	33	)	)	PUNCT
ajmsi-1283	37	34	.	.	PUNCT
ajmsi-1283	38	1	helminth	helminth	NOUN
ajmsi-1283	38	2	species	specie	NOUN
ajmsi-1283	38	3	such	such	ADJ
ajmsi-1283	38	4	as	as	ADP
ajmsi-1283	38	5	schistosoma	schistosoma	ADJ
ajmsi-1283	38	6	haematobium	haematobium	NOUN
ajmsi-1283	38	7	have	have	AUX
ajmsi-1283	38	8	developed	develop	VERB
ajmsi-1283	38	9	complex	complex	ADJ
ajmsi-1283	38	10	and	and	CCONJ
ajmsi-1283	38	11	redundant	redundant	ADJ
ajmsi-1283	38	12	mechanisms	mechanism	NOUN
ajmsi-1283	38	13	which	which	PRON
ajmsi-1283	38	14	help	help	VERB
ajmsi-1283	38	15	them	they	PRON
ajmsi-1283	38	16	to	to	PART
ajmsi-1283	38	17	maintain	maintain	VERB
ajmsi-1283	38	18	a	a	DET
ajmsi-1283	38	19	chronic	chronic	ADJ
ajmsi-1283	38	20	infection	infection	NOUN
ajmsi-1283	38	21	despite	despite	SCONJ
ajmsi-1283	38	22	immune	immune	ADJ
ajmsi-1283	38	23	recognition	recognition	NOUN
ajmsi-1283	38	24	by	by	ADP
ajmsi-1283	38	25	the	the	DET
ajmsi-1283	38	26	host	host	NOUN
ajmsi-1283	38	27	.	.	PUNCT
ajmsi-1283	39	1	these	these	DET
ajmsi-1283	39	2	parasite	parasite	NOUN
ajmsi-1283	39	3	are	be	AUX
ajmsi-1283	39	4	able	able	ADJ
ajmsi-1283	39	5	to	to	PART
ajmsi-1283	39	6	attain	attain	VERB
ajmsi-1283	39	7	the	the	DET
ajmsi-1283	39	8	chronic	chronic	ADJ
ajmsi-1283	39	9	infection	infection	NOUN
ajmsi-1283	39	10	by	by	ADP
ajmsi-1283	39	11	adoption	adoption	NOUN
ajmsi-1283	39	12	of	of	ADP
ajmsi-1283	39	13	certain	certain	ADJ
ajmsi-1283	39	14	strategies	strategy	NOUN
ajmsi-1283	39	15	which	which	PRON
ajmsi-1283	39	16	include	include	VERB
ajmsi-1283	39	17	residing	reside	VERB
ajmsi-1283	39	18	in	in	ADP
ajmsi-1283	39	19	anatomical	anatomical	ADJ
ajmsi-1283	39	20	locations	location	NOUN
ajmsi-1283	39	21	that	that	PRON
ajmsi-1283	39	22	are	be	AUX
ajmsi-1283	39	23	relatively	relatively	ADV
ajmsi-1283	39	24	free	free	ADJ
ajmsi-1283	39	25	to	to	ADP
ajmsi-1283	39	26	immune	immune	ADJ
ajmsi-1283	39	27	attack	attack	NOUN
ajmsi-1283	39	28	,	,	PUNCT
ajmsi-1283	39	29	molecular	molecular	ADJ
ajmsi-1283	39	30	mimicry	mimicry	NOUN
ajmsi-1283	39	31	,	,	PUNCT
ajmsi-1283	39	32	shedding	shed	VERB
ajmsi-1283	39	33	of	of	ADP
ajmsi-1283	39	34	antigenic	antigenic	ADJ
ajmsi-1283	39	35	surface	surface	NOUN
ajmsi-1283	39	36	proteins	protein	NOUN
ajmsi-1283	39	37	,	,	PUNCT
ajmsi-1283	39	38	and	and	CCONJ
ajmsi-1283	39	39	downregulation	downregulation	NOUN
ajmsi-1283	39	40	of	of	ADP
ajmsi-1283	39	41	the	the	DET
ajmsi-1283	39	42	host	host	NOUN
ajmsi-1283	39	43	immune	immune	ADJ
ajmsi-1283	39	44	response	response	NOUN
ajmsi-1283	39	45	to	to	ADP
ajmsi-1283	39	46	helminth	helminth	NOUN
ajmsi-1283	39	47	antigens	antigen	NOUN
ajmsi-1283	39	48	,	,	PUNCT
ajmsi-1283	39	49	thus	thus	ADV
ajmsi-1283	39	50	,	,	PUNCT
ajmsi-1283	39	51	producing	produce	VERB
ajmsi-1283	39	52	a	a	DET
ajmsi-1283	39	53	state	state	NOUN
ajmsi-1283	39	54	of	of	ADP
ajmsi-1283	39	55	parasite	parasite	NOUN
ajmsi-1283	39	56	-	-	PUNCT
ajmsi-1283	39	57	specific	specific	ADJ
ajmsi-1283	39	58	immune	immune	ADJ
ajmsi-1283	39	59	tolerance	tolerance	NOUN
ajmsi-1283	39	60	(	(	PUNCT
ajmsi-1283	39	61	brooks	brooks	PROPN
ajmsi-1283	39	62	et	et	PROPN
ajmsi-1283	39	63	al	al	PROPN
ajmsi-1283	39	64	.	.	PROPN
ajmsi-1283	39	65	,	,	PUNCT
ajmsi-1283	39	66	2010	2010	NUM
ajmsi-1283	39	67	)	)	PUNCT
ajmsi-1283	39	68	.	.	PUNCT
ajmsi-1283	40	1	when	when	SCONJ
ajmsi-1283	40	2	an	an	DET
ajmsi-1283	40	3	individual	individual	NOUN
ajmsi-1283	40	4	gets	get	AUX
ajmsi-1283	40	5	infected	infect	VERB
ajmsi-1283	40	6	with	with	ADP
ajmsi-1283	40	7	a	a	DET
ajmsi-1283	40	8	parasite	parasite	NOUN
ajmsi-1283	40	9	or	or	CCONJ
ajmsi-1283	40	10	any	any	DET
ajmsi-1283	40	11	foreign	foreign	ADJ
ajmsi-1283	40	12	material	material	NOUN
ajmsi-1283	40	13	,	,	PUNCT
ajmsi-1283	40	14	the	the	DET
ajmsi-1283	40	15	immune	immune	ADJ
ajmsi-1283	40	16	system	system	NOUN
ajmsi-1283	40	17	activates	activate	VERB
ajmsi-1283	40	18	the	the	DET
ajmsi-1283	40	19	humoral	humoral	ADJ
ajmsi-1283	40	20	and	and	CCONJ
ajmsi-1283	40	21	cell	cell	NOUN
ajmsi-1283	40	22	mediated	mediate	VERB
ajmsi-1283	40	23	immune	immune	ADJ
ajmsi-1283	40	24	response	response	NOUN
ajmsi-1283	40	25	(	(	PUNCT
ajmsi-1283	40	26	thomas	thomas	PROPN
ajmsi-1283	40	27	and	and	CCONJ
ajmsi-1283	40	28	harn	harn	PROPN
ajmsi-1283	40	29	,	,	PUNCT
ajmsi-1283	40	30	2004	2004	NUM
ajmsi-1283	40	31	;	;	PUNCT
ajmsi-1283	40	32	hokke	hokke	PROPN
ajmsi-1283	40	33	and	and	CCONJ
ajmsi-1283	40	34	yazdanbakhsh	yazdanbakhsh	NOUN
ajmsi-1283	40	35	,	,	PUNCT
ajmsi-1283	40	36	2005	2005	NUM
ajmsi-1283	40	37	;	;	PUNCT
ajmsi-1283	40	38	van	van	PROPN
ajmsi-1283	40	39	die	die	NOUN
ajmsi-1283	40	40	and	and	CCONJ
ajmsi-1283	40	41	cummings	cummings	PROPN
ajmsi-1283	40	42	,	,	PUNCT
ajmsi-1283	40	43	2006	2006	NUM
ajmsi-1283	40	44	;	;	PUNCT
ajmsi-1283	40	45	hokke	hokke	PROPN
ajmsi-1283	40	46	et	et	PROPN
ajmsi-1283	40	47	al	al	PROPN
ajmsi-1283	40	48	.	.	PROPN
ajmsi-1283	40	49	,	,	PUNCT
ajmsi-1283	40	50	2007	2007	NUM
ajmsi-1283	40	51	;	;	PUNCT
ajmsi-1283	40	52	mickum	mickum	NOUN
ajmsi-1283	40	53	et	et	PROPN
ajmsi-1283	40	54	al	al	PROPN
ajmsi-1283	40	55	.	.	PROPN
ajmsi-1283	40	56	,	,	PUNCT
ajmsi-1283	40	57	2014	2014	NUM
ajmsi-1283	40	58	)	)	PUNCT
ajmsi-1283	40	59	,	,	PUNCT
ajmsi-1283	40	60	this	this	DET
ajmsi-1283	40	61	immune	immune	ADJ
ajmsi-1283	40	62	response	response	NOUN
ajmsi-1283	40	63	can	can	AUX
ajmsi-1283	40	64	also	also	ADV
ajmsi-1283	40	65	be	be	AUX
ajmsi-1283	40	66	found	find	VERB
ajmsi-1283	40	67	in	in	ADP
ajmsi-1283	40	68	infection	infection	NOUN
ajmsi-1283	40	69	with	with	ADP
ajmsi-1283	40	70	schistosomes	schistosome	NOUN
ajmsi-1283	40	71	.	.	PUNCT
ajmsi-1283	41	1	schistosomes	schistosome	NOUN
ajmsi-1283	41	2	are	be	AUX
ajmsi-1283	41	3	parasites	parasite	NOUN
ajmsi-1283	41	4	that	that	PRON
ajmsi-1283	41	5	might	might	AUX
ajmsi-1283	41	6	not	not	PART
ajmsi-1283	41	7	be	be	AUX
ajmsi-1283	41	8	cleared	clear	VERB
ajmsi-1283	41	9	through	through	ADP
ajmsi-1283	41	10	the	the	DET
ajmsi-1283	41	11	process	process	NOUN
ajmsi-1283	41	12	of	of	ADP
ajmsi-1283	41	13	phagocytosis	phagocytosis	NOUN
ajmsi-1283	41	14	by	by	ADP
ajmsi-1283	41	15	host	host	NOUN
ajmsi-1283	41	16	immune	immune	ADJ
ajmsi-1283	41	17	responses	response	NOUN
ajmsi-1283	41	18	;	;	PUNCT
ajmsi-1283	41	19	therefore	therefore	ADV
ajmsi-1283	41	20	,	,	PUNCT
ajmsi-1283	41	21	in	in	ADP
ajmsi-1283	41	22	most	most	ADJ
ajmsi-1283	41	23	cases	case	NOUN
ajmsi-1283	41	24	the	the	DET
ajmsi-1283	41	25	host	host	NOUN
ajmsi-1283	41	26	immune	immune	ADJ
ajmsi-1283	41	27	system	system	NOUN
ajmsi-1283	41	28	responds	respond	VERB
ajmsi-1283	41	29	through	through	ADP
ajmsi-1283	41	30	inflammation	inflammation	NOUN
ajmsi-1283	41	31	and	and	CCONJ
ajmsi-1283	41	32	hypersensitivity	hypersensitivity	NOUN
ajmsi-1283	41	33	.	.	PUNCT
ajmsi-1283	42	1	immunoglobulin	immunoglobulin	NOUN
ajmsi-1283	42	2	g	g	PROPN
ajmsi-1283	42	3	(	(	PUNCT
ajmsi-1283	42	4	igg	igg	PROPN
ajmsi-1283	42	5	)	)	PUNCT
ajmsi-1283	42	6	,	,	PUNCT
ajmsi-1283	42	7	eosinophils	eosinophil	NOUN
ajmsi-1283	42	8	and	and	CCONJ
ajmsi-1283	42	9	immunoglobulin	immunoglobulin	NOUN
ajmsi-1283	42	10	e	e	PROPN
ajmsi-1283	42	11	(	(	PUNCT
ajmsi-1283	42	12	ige	ige	PROPN
ajmsi-1283	42	13	)	)	PUNCT
ajmsi-1283	42	14	are	be	AUX
ajmsi-1283	42	15	activated	activate	VERB
ajmsi-1283	42	16	to	to	PART
ajmsi-1283	42	17	initiate	initiate	VERB
ajmsi-1283	42	18	inflammatory	inflammatory	ADJ
ajmsi-1283	42	19	response	response	NOUN
ajmsi-1283	42	20	in	in	ADP
ajmsi-1283	42	21	the	the	DET
ajmsi-1283	42	22	site	site	NOUN
ajmsi-1283	42	23	where	where	SCONJ
ajmsi-1283	42	24	the	the	DET
ajmsi-1283	42	25	parasite	parasite	NOUN
ajmsi-1283	42	26	is	be	AUX
ajmsi-1283	42	27	found	find	VERB
ajmsi-1283	42	28	.	.	PUNCT
ajmsi-1283	43	1	infection	infection	NOUN
ajmsi-1283	43	2	with	with	ADP
ajmsi-1283	43	3	schistosomes	schistosome	NOUN
ajmsi-1283	43	4	has	have	AUX
ajmsi-1283	43	5	been	be	AUX
ajmsi-1283	43	6	shown	show	VERB
ajmsi-1283	43	7	to	to	PART
ajmsi-1283	43	8	elicit	elicit	VERB
ajmsi-1283	43	9	various	various	ADJ
ajmsi-1283	43	10	immune	immune	ADJ
ajmsi-1283	43	11	responses	response	NOUN
ajmsi-1283	43	12	such	such	ADJ
ajmsi-1283	43	13	as	as	ADP
ajmsi-1283	43	14	the	the	DET
ajmsi-1283	43	15	induced	induced	ADJ
ajmsi-1283	43	16	release	release	NOUN
ajmsi-1283	43	17	of	of	ADP
ajmsi-1283	43	18	il6	il6	PROPN
ajmsi-1283	43	19	,	,	PUNCT
ajmsi-1283	43	20	tnf	tnf	PROPN
ajmsi-1283	43	21	,	,	PUNCT
ajmsi-1283	43	22	and	and	CCONJ
ajmsi-1283	43	23	il1	il1	PROPN
ajmsi-1283	43	24	-	-	PROPN
ajmsi-1283	43	25	b	b	NOUN
ajmsi-1283	43	26	from	from	ADP
ajmsi-1283	43	27	monocytes	monocyte	NOUN
ajmsi-1283	43	28	(	(	PUNCT
ajmsi-1283	43	29	tevelde	tevelde	PROPN
ajmsi-1283	43	30	et	et	PROPN
ajmsi-1283	43	31	al	al	PROPN
ajmsi-1283	43	32	.	.	PROPN
ajmsi-1283	43	33	,	,	PUNCT
ajmsi-1283	43	34	1990	1990	NUM
ajmsi-1283	43	35	)	)	PUNCT
ajmsi-1283	43	36	,	,	PUNCT
ajmsi-1283	43	37	inhibition	inhibition	NOUN
ajmsi-1283	43	38	of	of	ADP
ajmsi-1283	43	39	th17	th17	PROPN
ajmsi-1283	43	40	-	-	PUNCT
ajmsi-1283	43	41	development	development	NOUN
ajmsi-1283	43	42	(	(	PUNCT
ajmsi-1283	43	43	park	park	NOUN
ajmsi-1283	43	44	et	et	PROPN
ajmsi-1283	43	45	al	al	PROPN
ajmsi-1283	43	46	.	.	PROPN
ajmsi-1283	43	47	,	,	PUNCT
ajmsi-1283	43	48	2005	2005	NUM
ajmsi-1283	43	49	)	)	PUNCT
ajmsi-1283	43	50	and	and	CCONJ
ajmsi-1283	43	51	trigger	trigger	VERB
ajmsi-1283	43	52	the	the	DET
ajmsi-1283	43	53	alternative	alternative	ADJ
ajmsi-1283	43	54	activation	activation	NOUN
ajmsi-1283	43	55	of	of	ADP
ajmsi-1283	43	56	macrophages	macrophage	NOUN
ajmsi-1283	43	57	with	with	ADP
ajmsi-1283	43	58	the	the	DET
ajmsi-1283	43	59	help	help	NOUN
ajmsi-1283	43	60	of	of	ADP
ajmsi-1283	43	61	il-13	il-13	PUNCT
ajmsi-1283	43	62	(	(	PUNCT
ajmsi-1283	43	63	gea	gea	NOUN
ajmsi-1283	43	64	-	-	PUNCT
ajmsi-1283	43	65	sorlí	sorlí	NOUN
ajmsi-1283	43	66	and	and	CCONJ
ajmsi-1283	43	67	closa	closa	NOUN
ajmsi-1283	43	68	,	,	PUNCT
ajmsi-1283	43	69	2009	2009	NUM
ajmsi-1283	43	70	)	)	PUNCT
ajmsi-1283	43	71	.	.	PUNCT
ajmsi-1283	44	1	also	also	ADV
ajmsi-1283	44	2	,	,	PUNCT
ajmsi-1283	44	3	there	there	PRON
ajmsi-1283	44	4	is	be	VERB
ajmsi-1283	44	5	the	the	DET
ajmsi-1283	44	6	suggestion	suggestion	NOUN
ajmsi-1283	44	7	that	that	SCONJ
ajmsi-1283	44	8	70	70	NUM
ajmsi-1283	44	9	%	%	NOUN
ajmsi-1283	44	10	of	of	ADP
ajmsi-1283	44	11	bladder	bladder	NOUN
ajmsi-1283	44	12	cancers	cancer	NOUN
ajmsi-1283	44	13	involve	involve	VERB
ajmsi-1283	44	14	a	a	DET
ajmsi-1283	44	15	specific	specific	ADJ
ajmsi-1283	44	16	mutation	mutation	NOUN
ajmsi-1283	44	17	in	in	ADP
ajmsi-1283	44	18	a	a	DET
ajmsi-1283	44	19	particular	particular	ADJ
ajmsi-1283	44	20	gene	gene	NOUN
ajmsi-1283	44	21	called	call	VERB
ajmsi-1283	44	22	the	the	DET
ajmsi-1283	44	23	telomerase	telomerase	NOUN
ajmsi-1283	44	24	reverse	reverse	NOUN
ajmsi-1283	44	25	transcriptase	transcriptase	NOUN
ajmsi-1283	44	26	(	(	PUNCT
ajmsi-1283	44	27	tert	tert	NOUN
ajmsi-1283	44	28	)	)	PUNCT
ajmsi-1283	44	29	gene	gene	NOUN
ajmsi-1283	44	30	(	(	PUNCT
ajmsi-1283	44	31	zhang	zhang	PROPN
ajmsi-1283	44	32	and	and	CCONJ
ajmsi-1283	44	33	zhang	zhang	PROPN
ajmsi-1283	44	34	,	,	PUNCT
ajmsi-1283	44	35	2015	2015	NUM
ajmsi-1283	44	36	)	)	PUNCT
ajmsi-1283	44	37	.	.	PUNCT
ajmsi-1283	45	1	the	the	DET
ajmsi-1283	45	2	tert	tert	NOUN
ajmsi-1283	45	3	gene	gene	NOUN
ajmsi-1283	45	4	is	be	AUX
ajmsi-1283	45	5	involved	involve	VERB
ajmsi-1283	45	6	in	in	ADP
ajmsi-1283	45	7	dna	dna	PROPN
ajmsi-1283	45	8	protection	protection	NOUN
ajmsi-1283	45	9	,	,	PUNCT
ajmsi-1283	45	10	cellular	cellular	ADJ
ajmsi-1283	45	11	aging	age	VERB
ajmsi-1283	45	12	processes	process	NOUN
ajmsi-1283	45	13	,	,	PUNCT
ajmsi-1283	45	14	and	and	CCONJ
ajmsi-1283	45	15	cancer	cancer	NOUN
ajmsi-1283	45	16	.	.	PUNCT
ajmsi-1283	46	1	there	there	PRON
ajmsi-1283	46	2	could	could	AUX
ajmsi-1283	46	3	be	be	AUX
ajmsi-1283	46	4	genetic	genetic	ADJ
ajmsi-1283	46	5	mutations	mutation	NOUN
ajmsi-1283	46	6	in	in	ADP
ajmsi-1283	46	7	some	some	DET
ajmsi-1283	46	8	chromosomal	chromosomal	ADJ
ajmsi-1283	46	9	genes	gene	NOUN
ajmsi-1283	46	10	,	,	PUNCT
ajmsi-1283	46	11	such	such	ADJ
ajmsi-1283	46	12	as	as	ADP
ajmsi-1283	46	13	fgfr3	fgfr3	PROPN
ajmsi-1283	46	14	,	,	PUNCT
ajmsi-1283	46	15	rb1	rb1	PROPN
ajmsi-1283	46	16	,	,	PUNCT
ajmsi-1283	46	17	hras	hra	NOUN
ajmsi-1283	46	18	,	,	PUNCT
ajmsi-1283	46	19	tp53	tp53	PROPN
ajmsi-1283	46	20	,	,	PUNCT
ajmsi-1283	46	21	tsc1	tsc1	PROPN
ajmsi-1283	46	22	,	,	PUNCT
ajmsi-1283	46	23	and	and	CCONJ
ajmsi-1283	46	24	others	other	NOUN
ajmsi-1283	46	25	which	which	PRON
ajmsi-1283	46	26	may	may	AUX
ajmsi-1283	46	27	play	play	VERB
ajmsi-1283	46	28	certain	certain	ADJ
ajmsi-1283	46	29	roles	role	NOUN
ajmsi-1283	46	30	in	in	ADP
ajmsi-1283	46	31	the	the	DET
ajmsi-1283	46	32	formation	formation	NOUN
ajmsi-1283	46	33	of	of	ADP
ajmsi-1283	46	34	tumors	tumor	NOUN
ajmsi-1283	46	35	in	in	ADP
ajmsi-1283	46	36	the	the	DET
ajmsi-1283	46	37	urinary	urinary	ADJ
ajmsi-1283	46	38	bladder	bladder	NOUN
ajmsi-1283	46	39	(	(	PUNCT
ajmsi-1283	46	40	zhang	zhang	PROPN
ajmsi-1283	46	41	and	and	CCONJ
ajmsi-1283	46	42	zhang	zhang	PROPN
ajmsi-1283	46	43	,	,	PUNCT
ajmsi-1283	46	44	2015	2015	NUM
ajmsi-1283	46	45	)	)	PUNCT
ajmsi-1283	46	46	.	.	PUNCT
ajmsi-1283	47	1	these	these	DET
ajmsi-1283	47	2	genes	gene	NOUN
ajmsi-1283	47	3	play	play	VERB
ajmsi-1283	47	4	an	an	DET
ajmsi-1283	47	5	important	important	ADJ
ajmsi-1283	47	6	role	role	NOUN
ajmsi-1283	47	7	in	in	ADP
ajmsi-1283	47	8	the	the	DET
ajmsi-1283	47	9	regulation	regulation	NOUN
ajmsi-1283	47	10	of	of	ADP
ajmsi-1283	47	11	gene	gene	NOUN
ajmsi-1283	47	12	mutations	mutation	NOUN
ajmsi-1283	47	13	on	on	ADP
ajmsi-1283	47	14	p53	p53	NOUN
ajmsi-1283	47	15	suppressor	suppressor	NOUN
ajmsi-1283	47	16	gene	gene	NOUN
ajmsi-1283	47	17	as	as	SCONJ
ajmsi-1283	47	18	was	be	AUX
ajmsi-1283	47	19	shown	show	VERB
ajmsi-1283	47	20	in	in	ADP
ajmsi-1283	47	21	a	a	DET
ajmsi-1283	47	22	study	study	NOUN
ajmsi-1283	47	23	which	which	PRON
ajmsi-1283	47	24	evaluated	evaluate	VERB
ajmsi-1283	47	25	18	18	NUM
ajmsi-1283	47	26	different	different	ADJ
ajmsi-1283	47	27	bladder	bladder	NOUN
ajmsi-1283	47	28	tumors	tumor	NOUN
ajmsi-1283	47	29	of	of	ADP
ajmsi-1283	47	30	which	which	PRON
ajmsi-1283	47	31	11	11	NUM
ajmsi-1283	47	32	(	(	PUNCT
ajmsi-1283	47	33	61	61	NUM
ajmsi-1283	47	34	%	%	NOUN
ajmsi-1283	47	35	)	)	PUNCT
ajmsi-1283	47	36	had	have	VERB
ajmsi-1283	47	37	genetic	genetic	ADJ
ajmsi-1283	47	38	mutations	mutation	NOUN
ajmsi-1283	47	39	of	of	ADP
ajmsi-1283	47	40	p53	p53	NOUN
ajmsi-1283	47	41	gene	gene	NOUN
ajmsi-1283	47	42	(	(	PUNCT
ajmsi-1283	47	43	zhang	zhang	PROPN
ajmsi-1283	47	44	and	and	CCONJ
ajmsi-1283	47	45	zhang	zhang	PROPN
ajmsi-1283	47	46	,	,	PUNCT
ajmsi-1283	47	47	2015	2015	NUM
ajmsi-1283	47	48	)	)	PUNCT
ajmsi-1283	47	49	.	.	PUNCT
ajmsi-1283	48	1	the	the	DET
ajmsi-1283	48	2	p53	p53	NOUN
ajmsi-1283	48	3	marker	marker	NOUN
ajmsi-1283	48	4	has	have	AUX
ajmsi-1283	48	5	also	also	ADV
ajmsi-1283	48	6	been	be	AUX
ajmsi-1283	48	7	associated	associate	VERB
ajmsi-1283	48	8	with	with	ADP
ajmsi-1283	48	9	the	the	DET
ajmsi-1283	48	10	most	most	ADV
ajmsi-1283	48	11	aggressive	aggressive	ADJ
ajmsi-1283	48	12	t1g3	t1g3	NOUN
ajmsi-1283	48	13	cancers	cancer	NOUN
ajmsi-1283	48	14	(	(	PUNCT
ajmsi-1283	48	15	soria	soria	PROPN
ajmsi-1283	48	16	et	et	PROPN
ajmsi-1283	48	17	al	al	PROPN
ajmsi-1283	48	18	.	.	PROPN
ajmsi-1283	48	19	,	,	PUNCT
ajmsi-1283	48	20	2019	2019	NUM
ajmsi-1283	48	21	)	)	PUNCT
ajmsi-1283	48	22	.	.	PUNCT
ajmsi-1283	49	1	hras	hra	NOUN
ajmsi-1283	49	2	is	be	AUX
ajmsi-1283	49	3	a	a	DET
ajmsi-1283	49	4	proto	proto	NOUN
ajmsi-1283	49	5	-	-	PUNCT
ajmsi-1283	49	6	oncogene	oncogene	NOUN
ajmsi-1283	49	7	and	and	CCONJ
ajmsi-1283	49	8	has	have	VERB
ajmsi-1283	49	9	potential	potential	NOUN
ajmsi-1283	49	10	to	to	PART
ajmsi-1283	49	11	cause	cause	VERB
ajmsi-1283	49	12	cancer	cancer	NOUN
ajmsi-1283	49	13	in	in	ADP
ajmsi-1283	49	14	several	several	ADJ
ajmsi-1283	49	15	organs	organ	NOUN
ajmsi-1283	49	16	including	include	VERB
ajmsi-1283	49	17	the	the	DET
ajmsi-1283	49	18	bladder	bladder	NOUN
ajmsi-1283	49	19	.	.	PUNCT
ajmsi-1283	50	1	the	the	DET
ajmsi-1283	50	2	tsc1	tsc1	PROPN
ajmsi-1283	50	3	c.	c.	PROPN
ajmsi-1283	50	4	1907	1907	NUM
ajmsi-1283	50	5	1908	1908	NUM
ajmsi-1283	50	6	del	del	PROPN
ajmsi-1283	50	7	(	(	PUNCT
ajmsi-1283	50	8	e636fs	e636fs	NOUN
ajmsi-1283	50	9	)	)	PUNCT
ajmsi-1283	50	10	mutation	mutation	NOUN
ajmsi-1283	50	11	in	in	ADP
ajmsi-1283	50	12	bladder	bladder	NOUN
ajmsi-1283	50	13	cancer	cancer	NOUN
ajmsi-1283	50	14	suggests	suggest	VERB
ajmsi-1283	50	15	that	that	SCONJ
ajmsi-1283	50	16	the	the	DET
ajmsi-1283	50	17	location	location	NOUN
ajmsi-1283	50	18	of	of	ADP
ajmsi-1283	50	19	the	the	DET
ajmsi-1283	50	20	mutation	mutation	NOUN
ajmsi-1283	50	21	is	be	AUX
ajmsi-1283	50	22	exon	exon	ADJ
ajmsi-1283	50	23	15	15	NUM
ajmsi-1283	50	24	with	with	ADP
ajmsi-1283	50	25	frequency	frequency	NOUN
ajmsi-1283	50	26	of	of	ADP
ajmsi-1283	50	27	tsc1	tsc1	PROPN
ajmsi-1283	50	28	mutation	mutation	NOUN
ajmsi-1283	50	29	of	of	ADP
ajmsi-1283	50	30	11.7	11.7	NUM
ajmsi-1283	50	31	%	%	NOUN
ajmsi-1283	50	32	.	.	PUNCT
ajmsi-1283	51	1	the	the	DET
ajmsi-1283	51	2	bap1	bap1	PROPN
ajmsi-1283	51	3	mutations	mutation	NOUN
ajmsi-1283	51	4	have	have	AUX
ajmsi-1283	51	5	shown	show	VERB
ajmsi-1283	51	6	that	that	SCONJ
ajmsi-1283	51	7	it	it	PRON
ajmsi-1283	51	8	contributes	contribute	VERB
ajmsi-1283	51	9	to	to	ADP
ajmsi-1283	51	10	brca	brca	PROPN
ajmsi-1283	51	11	pathway	pathway	NOUN
ajmsi-1283	51	12	alterations	alteration	NOUN
ajmsi-1283	51	13	in	in	ADP
ajmsi-1283	51	14	bladder	bladder	NOUN
ajmsi-1283	51	15	cancer	cancer	NOUN
ajmsi-1283	51	16	.	.	PUNCT
ajmsi-1283	52	1	the	the	DET
ajmsi-1283	52	2	discoveries	discovery	NOUN
ajmsi-1283	52	3	of	of	ADP
ajmsi-1283	52	4	more	more	ADJ
ajmsi-1283	52	5	gene	gene	NOUN
ajmsi-1283	52	6	mutations	mutation	NOUN
ajmsi-1283	52	7	and	and	CCONJ
ajmsi-1283	52	8	new	new	ADJ
ajmsi-1283	52	9	biomarkers	biomarker	NOUN
ajmsi-1283	52	10	and	and	CCONJ
ajmsi-1283	52	11	polymerase	polymerase	NOUN
ajmsi-1283	52	12	chain	chain	NOUN
ajmsi-1283	52	13	reaction	reaction	NOUN
ajmsi-1283	52	14	bioassays	bioassay	VERB
ajmsi-1283	52	15	for	for	ADP
ajmsi-1283	52	16	gene	gene	NOUN
ajmsi-1283	52	17	mutations	mutation	NOUN
ajmsi-1283	52	18	in	in	ADP
ajmsi-1283	52	19	bladder	bladder	NOUN
ajmsi-1283	52	20	cancer	cancer	NOUN
ajmsi-1283	52	21	need	need	VERB
ajmsi-1283	52	22	further	further	ADJ
ajmsi-1283	52	23	research	research	NOUN
ajmsi-1283	52	24	(	(	PUNCT
ajmsi-1283	52	25	zhang	zhang	PROPN
ajmsi-1283	52	26	and	and	CCONJ
ajmsi-1283	52	27	zhang	zhang	PROPN
ajmsi-1283	52	28	,	,	PUNCT
ajmsi-1283	52	29	2015	2015	NUM
ajmsi-1283	52	30	)	)	PUNCT
ajmsi-1283	52	31	.	.	PUNCT
ajmsi-1283	53	1	the	the	DET
ajmsi-1283	53	2	regulation	regulation	NOUN
ajmsi-1283	53	3	of	of	ADP
ajmsi-1283	53	4	the	the	DET
ajmsi-1283	53	5	immune	immune	ADJ
ajmsi-1283	53	6	response	response	NOUN
ajmsi-1283	53	7	in	in	ADP
ajmsi-1283	53	8	human	human	ADJ
ajmsi-1283	53	9	schistosome	schistosome	NOUN
ajmsi-1283	53	10	infection	infection	NOUN
ajmsi-1283	53	11	determines	determine	VERB
ajmsi-1283	53	12	the	the	DET
ajmsi-1283	53	13	pathogenic	pathogenic	ADJ
ajmsi-1283	53	14	response	response	NOUN
ajmsi-1283	53	15	of	of	ADP
ajmsi-1283	53	16	the	the	DET
ajmsi-1283	53	17	host	host	NOUN
ajmsi-1283	53	18	.	.	PUNCT
ajmsi-1283	54	1	also	also	ADV
ajmsi-1283	54	2	,	,	PUNCT
ajmsi-1283	54	3	an	an	DET
ajmsi-1283	54	4	individual	individual	NOUN
ajmsi-1283	54	5	’s	’s	PART
ajmsi-1283	54	6	genetic	genetic	ADJ
ajmsi-1283	54	7	makeup	makeup	NOUN
ajmsi-1283	54	8	is	be	AUX
ajmsi-1283	54	9	the	the	DET
ajmsi-1283	54	10	template	template	NOUN
ajmsi-1283	54	11	on	on	ADP
ajmsi-1283	54	12	which	which	PRON
ajmsi-1283	54	13	every	every	PRON
ajmsi-1283	54	14	of	of	ADP
ajmsi-1283	54	15	the	the	DET
ajmsi-1283	54	16	organism	organism	NOUN
ajmsi-1283	54	17	’s	’s	PART
ajmsi-1283	54	18	profile	profile	NOUN
ajmsi-1283	54	19	is	be	AUX
ajmsi-1283	54	20	written	write	VERB
ajmsi-1283	54	21	including	include	VERB
ajmsi-1283	54	22	the	the	DET
ajmsi-1283	54	23	individual	individual	NOUN
ajmsi-1283	54	24	’s	’s	PART
ajmsi-1283	54	25	response	response	NOUN
ajmsi-1283	54	26	to	to	ADP
ajmsi-1283	54	27	diseases	disease	NOUN
ajmsi-1283	54	28	such	such	ADJ
ajmsi-1283	54	29	as	as	ADP
ajmsi-1283	54	30	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	54	31	.	.	PUNCT
ajmsi-1283	55	1	chronic	chronic	ADJ
ajmsi-1283	55	2	schistosoma	schistosoma	ADJ
ajmsi-1283	55	3	infections	infection	NOUN
ajmsi-1283	55	4	are	be	AUX
ajmsi-1283	55	5	usually	usually	ADV
ajmsi-1283	55	6	seen	see	VERB
ajmsi-1283	55	7	to	to	PART
ajmsi-1283	55	8	be	be	AUX
ajmsi-1283	55	9	established	establish	VERB
ajmsi-1283	55	10	through	through	ADP
ajmsi-1283	55	11	the	the	DET
ajmsi-1283	55	12	modulation	modulation	NOUN
ajmsi-1283	55	13	of	of	ADP
ajmsi-1283	55	14	the	the	DET
ajmsi-1283	55	15	host	host	NOUN
ajmsi-1283	55	16	immune	immune	ADJ
ajmsi-1283	55	17	system	system	NOUN
ajmsi-1283	55	18	(	(	PUNCT
ajmsi-1283	55	19	waknine	waknine	NOUN
ajmsi-1283	55	20	-	-	PUNCT
ajmsi-1283	55	21	grinberg	grinberg	PROPN
ajmsi-1283	55	22	et	et	PROPN
ajmsi-1283	55	23	al	al	PROPN
ajmsi-1283	55	24	.	.	PROPN
ajmsi-1283	55	25	,	,	PUNCT
ajmsi-1283	55	26	2010	2010	NUM
ajmsi-1283	55	27	)	)	PUNCT
ajmsi-1283	55	28	.	.	PUNCT
ajmsi-1283	56	1	one	one	NUM
ajmsi-1283	56	2	of	of	ADP
ajmsi-1283	56	3	the	the	DET
ajmsi-1283	56	4	complications	complication	NOUN
ajmsi-1283	56	5	of	of	ADP
ajmsi-1283	56	6	urogenital	urogenital	ADJ
ajmsi-1283	56	7	shistosomiasis	shistosomiasis	NOUN
ajmsi-1283	56	8	is	be	AUX
ajmsi-1283	56	9	the	the	DET
ajmsi-1283	56	10	formation	formation	NOUN
ajmsi-1283	56	11	of	of	ADP
ajmsi-1283	56	12	granuloma	granuloma	NOUN
ajmsi-1283	56	13	on	on	ADP
ajmsi-1283	56	14	the	the	DET
ajmsi-1283	56	15	bladder	bladder	NOUN
ajmsi-1283	56	16	walls	wall	NOUN
ajmsi-1283	56	17	,	,	PUNCT
ajmsi-1283	56	18	which	which	PRON
ajmsi-1283	56	19	is	be	AUX
ajmsi-1283	56	20	the	the	DET
ajmsi-1283	56	21	main	main	ADJ
ajmsi-1283	56	22	lesion	lesion	NOUN
ajmsi-1283	56	23	found	find	VERB
ajmsi-1283	56	24	in	in	ADP
ajmsi-1283	56	25	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	56	26	(	(	PUNCT
ajmsi-1283	56	27	ekwunife	ekwunife	NOUN
ajmsi-1283	56	28	et	et	PROPN
ajmsi-1283	56	29	al	al	PROPN
ajmsi-1283	56	30	.	.	PROPN
ajmsi-1283	56	31	,	,	PUNCT
ajmsi-1283	56	32	2009	2009	NUM
ajmsi-1283	56	33	)	)	PUNCT
ajmsi-1283	56	34	and	and	CCONJ
ajmsi-1283	56	35	is	be	AUX
ajmsi-1283	56	36	also	also	ADV
ajmsi-1283	56	37	a	a	DET
ajmsi-1283	56	38	predisposing	predispose	VERB
ajmsi-1283	56	39	factor	factor	NOUN
ajmsi-1283	56	40	to	to	ADP
ajmsi-1283	56	41	the	the	DET
ajmsi-1283	56	42	development	development	NOUN
ajmsi-1283	56	43	of	of	ADP
ajmsi-1283	56	44	bladder	bladder	NOUN
ajmsi-1283	56	45	cancer	cancer	NOUN
ajmsi-1283	56	46	(	(	PUNCT
ajmsi-1283	56	47	ishida	ishida	PROPN
ajmsi-1283	56	48	and	and	CCONJ
ajmsi-1283	56	49	hsieh	hsieh	PROPN
ajmsi-1283	56	50	,	,	PUNCT
ajmsi-1283	56	51	2018	2018	NUM
ajmsi-1283	56	52	)	)	PUNCT
ajmsi-1283	56	53	.	.	PUNCT
ajmsi-1283	57	1	this	this	DET
ajmsi-1283	57	2	bladder	bladder	NOUN
ajmsi-1283	57	3	cancer	cancer	NOUN
ajmsi-1283	57	4	is	be	AUX
ajmsi-1283	57	5	the	the	DET
ajmsi-1283	57	6	worldwide	worldwide	ADJ
ajmsi-1283	57	7	9th	9th	ADJ
ajmsi-1283	57	8	most	most	ADV
ajmsi-1283	57	9	common	common	ADJ
ajmsi-1283	57	10	cancer	cancer	NOUN
ajmsi-1283	57	11	(	(	PUNCT
ajmsi-1283	57	12	siegel	siegel	PROPN
ajmsi-1283	57	13	et	et	PROPN
ajmsi-1283	57	14	al	al	PROPN
ajmsi-1283	57	15	.	.	PROPN
ajmsi-1283	57	16	,	,	PUNCT
ajmsi-1283	57	17	2015	2015	NUM
ajmsi-1283	57	18	)	)	PUNCT
ajmsi-1283	57	19	.	.	PUNCT
ajmsi-1283	58	1	other	other	ADJ
ajmsi-1283	58	2	pathologic	pathologic	ADJ
ajmsi-1283	58	3	effects	effect	NOUN
ajmsi-1283	58	4	due	due	ADJ
ajmsi-1283	58	5	to	to	ADP
ajmsi-1283	58	6	s.	s.	PROPN
ajmsi-1283	58	7	haematobium	haematobium	PROPN
ajmsi-1283	58	8	include	include	VERB
ajmsi-1283	58	9	:	:	PUNCT
ajmsi-1283	58	10	irregularity	irregularity	NOUN
ajmsi-1283	58	11	of	of	ADP
ajmsi-1283	58	12	bladder	bladder	NOUN
ajmsi-1283	58	13	wall	wall	NOUN
ajmsi-1283	58	14	,	,	PUNCT
ajmsi-1283	58	15	thickening	thickening	NOUN
ajmsi-1283	58	16	of	of	ADP
ajmsi-1283	58	17	the	the	DET
ajmsi-1283	58	18	bladder	bladder	NOUN
ajmsi-1283	58	19	wall	wall	NOUN
ajmsi-1283	58	20	,	,	PUNCT
ajmsi-1283	58	21	massing	massing	NOUN
ajmsi-1283	58	22	of	of	ADP
ajmsi-1283	58	23	bladder	bladder	NOUN
ajmsi-1283	58	24	wall	wall	NOUN
ajmsi-1283	58	25	,	,	PUNCT
ajmsi-1283	58	26	dilated	dilate	VERB
ajmsi-1283	58	27	kidney	kidney	NOUN
ajmsi-1283	58	28	and	and	CCONJ
ajmsi-1283	58	29	bladder	bladder	NOUN
ajmsi-1283	58	30	wall	wall	NOUN
ajmsi-1283	58	31	lesions	lesion	NOUN
ajmsi-1283	58	32	(	(	PUNCT
ajmsi-1283	58	33	ekwunife	ekwunife	NOUN
ajmsi-1283	58	34	et	et	PROPN
ajmsi-1283	58	35	al	al	PROPN
ajmsi-1283	58	36	.	.	PROPN
ajmsi-1283	58	37	,	,	PUNCT
ajmsi-1283	58	38	2009	2009	NUM
ajmsi-1283	58	39	)	)	PUNCT
ajmsi-1283	58	40	.	.	PUNCT
ajmsi-1283	59	1	in	in	ADP
ajmsi-1283	59	2	non	non	ADJ
ajmsi-1283	59	3	-	-	ADJ
ajmsi-1283	59	4	invasive	invasive	ADJ
ajmsi-1283	59	5	tumors	tumor	NOUN
ajmsi-1283	59	6	,	,	PUNCT
ajmsi-1283	59	7	mutations	mutation	NOUN
ajmsi-1283	59	8	had	have	AUX
ajmsi-1283	59	9	been	be	AUX
ajmsi-1283	59	10	found	find	VERB
ajmsi-1283	59	11	in	in	ADP
ajmsi-1283	59	12	the	the	DET
ajmsi-1283	59	13	fibroblasts	fibroblast	NOUN
ajmsi-1283	59	14	growth	growth	NOUN
ajmsi-1283	59	15	factor	factor	NOUN
ajmsi-1283	59	16	receptor	receptor	NOUN
ajmsi-1283	59	17	3	3	NUM
ajmsi-1283	59	18	(	(	PUNCT
ajmsi-1283	59	19	fgfr3	fgfr3	PROPN
ajmsi-1283	59	20	)	)	PUNCT
ajmsi-1283	59	21	where	where	SCONJ
ajmsi-1283	59	22	the	the	DET
ajmsi-1283	59	23	presence	presence	NOUN
ajmsi-1283	59	24	of	of	ADP
ajmsi-1283	59	25	the	the	DET
ajmsi-1283	59	26	fgfr3	fgfr3	NOUN
ajmsi-1283	59	27	mutation	mutation	NOUN
ajmsi-1283	59	28	in	in	ADP
ajmsi-1283	59	29	urine	urine	NOUN
ajmsi-1283	59	30	is	be	AUX
ajmsi-1283	59	31	observed	observe	VERB
ajmsi-1283	59	32	for	for	ADP
ajmsi-1283	59	33	low	low	ADJ
ajmsi-1283	59	34	-	-	PUNCT
ajmsi-1283	59	35	grade	grade	NOUN
ajmsi-1283	59	36	tumors	tumor	NOUN
ajmsi-1283	59	37	and	and	CCONJ
ajmsi-1283	59	38	are	be	AUX
ajmsi-1283	59	39	proposed	propose	VERB
ajmsi-1283	59	40	to	to	PART
ajmsi-1283	59	41	be	be	AUX
ajmsi-1283	59	42	associated	associate	VERB
ajmsi-1283	59	43	with	with	ADP
ajmsi-1283	59	44	concomitant	concomitant	ADJ
ajmsi-1283	59	45	or	or	CCONJ
ajmsi-1283	59	46	future	future	ADJ
ajmsi-1283	59	47	recurrence	recurrence	NOUN
ajmsi-1283	59	48	(	(	PUNCT
ajmsi-1283	59	49	frantzi	frantzi	VERB
ajmsi-1283	59	50	et	et	PROPN
ajmsi-1283	59	51	al	al	PROPN
ajmsi-1283	59	52	.	.	PROPN
ajmsi-1283	59	53	,	,	PUNCT
ajmsi-1283	59	54	2012	2012	NUM
ajmsi-1283	59	55	;	;	PUNCT
ajmsi-1283	59	56	critelli	critelli	PROPN
ajmsi-1283	59	57	et	et	PROPN
ajmsi-1283	59	58	al	al	PROPN
ajmsi-1283	59	59	.	.	PROPN
ajmsi-1283	59	60	,	,	PUNCT
ajmsi-1283	59	61	2016	2016	NUM
ajmsi-1283	59	62	)	)	PUNCT
ajmsi-1283	59	63	.	.	PUNCT
ajmsi-1283	60	1	fgfr3	fgfr3	NOUN
ajmsi-1283	60	2	is	be	AUX
ajmsi-1283	60	3	a	a	DET
ajmsi-1283	60	4	genetic	genetic	ADJ
ajmsi-1283	60	5	marker	marker	NOUN
ajmsi-1283	60	6	that	that	PRON
ajmsi-1283	60	7	has	have	AUX
ajmsi-1283	60	8	been	be	AUX
ajmsi-1283	60	9	implicated	implicate	VERB
ajmsi-1283	60	10	in	in	ADP
ajmsi-1283	60	11	bladder	bladder	NOUN
ajmsi-1283	60	12	cancer	cancer	NOUN
ajmsi-1283	60	13	where	where	SCONJ
ajmsi-1283	60	14	some	some	DET
ajmsi-1283	60	15	cases	case	NOUN
ajmsi-1283	60	16	of	of	ADP
ajmsi-1283	60	17	multiple	multiple	ADJ
ajmsi-1283	60	18	myeloma	myeloma	NOUN
ajmsi-1283	60	19	are	be	AUX
ajmsi-1283	60	20	seen	see	VERB
ajmsi-1283	60	21	to	to	PART
ajmsi-1283	60	22	express	express	VERB
ajmsi-1283	60	23	both	both	DET
ajmsi-1283	60	24	mutation	mutation	NOUN
ajmsi-1283	60	25	and	and	CCONJ
ajmsi-1283	60	26	over	over	ADP
ajmsi-1283	60	27	-	-	PUNCT
ajmsi-1283	60	28	expression	expression	NOUN
ajmsi-1283	60	29	of	of	ADP
ajmsi-1283	60	30	fgfr3	fgfr3	PROPN
ajmsi-1283	60	31	(	(	PUNCT
ajmsi-1283	60	32	akanksha	akanksha	PROPN
ajmsi-1283	60	33	and	and	CCONJ
ajmsi-1283	60	34	sandhya	sandhya	PROPN
ajmsi-1283	60	35	,	,	PUNCT
ajmsi-1283	60	36	2019	2019	NUM
ajmsi-1283	60	37	)	)	PUNCT
ajmsi-1283	60	38	.	.	PUNCT
ajmsi-1283	61	1	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	61	2	pa	pa	PROPN
ajmsi-1283	61	3	ge	ge	PROPN
ajmsi-1283	61	4	28	28	NUM
ajmsi-1283	61	5	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	61	6	am	be	AUX
ajmsi-1283	61	7	.	.	PUNCT
ajmsi-1283	62	1	j.	j.	PROPN
ajmsi-1283	62	2	med	med	PROPN
ajmsi-1283	62	3	.	.	PUNCT
ajmsi-1283	63	1	sci	sci	PROPN
ajmsi-1283	63	2	.	.	PUNCT
ajmsi-1283	63	3	innov	innov	PROPN
ajmsi-1283	63	4	.	.	PUNCT
ajmsi-1283	64	1	2(1	2(1	NUM
ajmsi-1283	64	2	)	)	PUNCT
ajmsi-1283	64	3	26	26	NUM
ajmsi-1283	64	4	-	-	SYM
ajmsi-1283	64	5	31	31	NUM
ajmsi-1283	64	6	,	,	PUNCT
ajmsi-1283	64	7	2023	2023	NUM
ajmsi-1283	64	8	furthermore	furthermore	ADV
ajmsi-1283	64	9	,	,	PUNCT
ajmsi-1283	64	10	there	there	PRON
ajmsi-1283	64	11	are	be	VERB
ajmsi-1283	64	12	also	also	ADV
ajmsi-1283	64	13	studies	study	NOUN
ajmsi-1283	64	14	that	that	PRON
ajmsi-1283	64	15	has	have	AUX
ajmsi-1283	64	16	shown	show	VERB
ajmsi-1283	64	17	that	that	SCONJ
ajmsi-1283	64	18	there	there	PRON
ajmsi-1283	64	19	could	could	AUX
ajmsi-1283	64	20	be	be	AUX
ajmsi-1283	64	21	increased	increase	VERB
ajmsi-1283	64	22	glyceraldehyde-3	glyceraldehyde-3	NUM
ajmsi-1283	64	23	-	-	ADJ
ajmsi-1283	64	24	phosphate	phosphate	ADJ
ajmsi-1283	64	25	dehydrogenase	dehydrogenase	NOUN
ajmsi-1283	64	26	(	(	PUNCT
ajmsi-1283	64	27	gapdh	gapdh	NOUN
ajmsi-1283	64	28	)	)	PUNCT
ajmsi-1283	64	29	levels	level	NOUN
ajmsi-1283	64	30	in	in	ADP
ajmsi-1283	64	31	many	many	ADJ
ajmsi-1283	64	32	human	human	ADJ
ajmsi-1283	64	33	cancer	cancer	NOUN
ajmsi-1283	64	34	types	type	NOUN
ajmsi-1283	64	35	which	which	PRON
ajmsi-1283	64	36	has	have	AUX
ajmsi-1283	64	37	been	be	AUX
ajmsi-1283	64	38	correlated	correlate	VERB
ajmsi-1283	64	39	with	with	ADP
ajmsi-1283	64	40	possible	possible	ADJ
ajmsi-1283	64	41	reduction	reduction	NOUN
ajmsi-1283	64	42	in	in	ADP
ajmsi-1283	64	43	survival	survival	NOUN
ajmsi-1283	64	44	(	(	PUNCT
ajmsi-1283	64	45	altenberg	altenberg	PROPN
ajmsi-1283	64	46	and	and	CCONJ
ajmsi-1283	64	47	greulich	greulich	PROPN
ajmsi-1283	64	48	,	,	PUNCT
ajmsi-1283	64	49	2004	2004	NUM
ajmsi-1283	64	50	;	;	PUNCT
ajmsi-1283	64	51	guo	guo	PROPN
ajmsi-1283	64	52	et	et	PROPN
ajmsi-1283	64	53	al	al	PROPN
ajmsi-1283	64	54	.	.	PROPN
ajmsi-1283	64	55	,	,	PUNCT
ajmsi-1283	64	56	2013	2013	NUM
ajmsi-1283	64	57	)	)	PUNCT
ajmsi-1283	64	58	.	.	PUNCT
ajmsi-1283	65	1	there	there	PRON
ajmsi-1283	65	2	had	have	AUX
ajmsi-1283	65	3	also	also	ADV
ajmsi-1283	65	4	been	be	AUX
ajmsi-1283	65	5	report	report	NOUN
ajmsi-1283	65	6	of	of	ADP
ajmsi-1283	65	7	deregulation	deregulation	NOUN
ajmsi-1283	65	8	of	of	ADP
ajmsi-1283	65	9	gapdh	gapdh	NOUN
ajmsi-1283	65	10	in	in	ADP
ajmsi-1283	65	11	bladder	bladder	NOUN
ajmsi-1283	65	12	cancer	cancer	NOUN
ajmsi-1283	65	13	cases	case	NOUN
ajmsi-1283	65	14	(	(	PUNCT
ajmsi-1283	65	15	colell	colell	VERB
ajmsi-1283	65	16	et	et	PROPN
ajmsi-1283	65	17	al	al	PROPN
ajmsi-1283	65	18	.	.	PROPN
ajmsi-1283	65	19	,	,	PUNCT
ajmsi-1283	65	20	2009	2009	NUM
ajmsi-1283	65	21	;	;	PUNCT
ajmsi-1283	65	22	guo	guo	PROPN
ajmsi-1283	65	23	et	et	PROPN
ajmsi-1283	65	24	al	al	PROPN
ajmsi-1283	65	25	.	.	PROPN
ajmsi-1283	65	26	,	,	PUNCT
ajmsi-1283	65	27	2013	2013	NUM
ajmsi-1283	65	28	)	)	PUNCT
ajmsi-1283	65	29	.	.	PUNCT
ajmsi-1283	66	1	gapdh	gapdh	NOUN
ajmsi-1283	66	2	has	have	AUX
ajmsi-1283	66	3	been	be	AUX
ajmsi-1283	66	4	implicated	implicate	VERB
ajmsi-1283	66	5	to	to	PART
ajmsi-1283	66	6	play	play	VERB
ajmsi-1283	66	7	certain	certain	ADJ
ajmsi-1283	66	8	roles	role	NOUN
ajmsi-1283	66	9	in	in	ADP
ajmsi-1283	66	10	apoptosis	apoptosis	NOUN
ajmsi-1283	66	11	(	(	PUNCT
ajmsi-1283	66	12	colell	colell	NOUN
ajmsi-1283	66	13	et	et	PROPN
ajmsi-1283	66	14	al	al	PROPN
ajmsi-1283	66	15	.	.	PROPN
ajmsi-1283	66	16	,	,	PUNCT
ajmsi-1283	66	17	2009	2009	NUM
ajmsi-1283	66	18	)	)	PUNCT
ajmsi-1283	66	19	and	and	CCONJ
ajmsi-1283	66	20	there	there	PRON
ajmsi-1283	66	21	are	be	VERB
ajmsi-1283	66	22	suggestion	suggestion	NOUN
ajmsi-1283	66	23	that	that	SCONJ
ajmsi-1283	66	24	gapdh	gapdh	NOUN
ajmsi-1283	66	25	participates	participate	VERB
ajmsi-1283	66	26	in	in	ADP
ajmsi-1283	66	27	tumor	tumor	NOUN
ajmsi-1283	66	28	progression	progression	NOUN
ajmsi-1283	66	29	and	and	CCONJ
ajmsi-1283	66	30	could	could	AUX
ajmsi-1283	66	31	serve	serve	VERB
ajmsi-1283	66	32	as	as	ADP
ajmsi-1283	66	33	a	a	DET
ajmsi-1283	66	34	new	new	ADJ
ajmsi-1283	66	35	therapeutic	therapeutic	ADJ
ajmsi-1283	66	36	target	target	NOUN
ajmsi-1283	66	37	(	(	PUNCT
ajmsi-1283	66	38	zhang	zhang	X
ajmsi-1283	66	39	et	et	PROPN
ajmsi-1283	66	40	al	al	PROPN
ajmsi-1283	66	41	.	.	PROPN
ajmsi-1283	66	42	,	,	PUNCT
ajmsi-1283	66	43	2015	2015	NUM
ajmsi-1283	66	44	)	)	PUNCT
ajmsi-1283	66	45	.	.	PUNCT
ajmsi-1283	67	1	materials	material	NOUN
ajmsi-1283	67	2	and	and	CCONJ
ajmsi-1283	67	3	methods	method	NOUN
ajmsi-1283	67	4	ethical	ethical	ADJ
ajmsi-1283	67	5	approval	approval	NOUN
ajmsi-1283	67	6	:	:	PUNCT
ajmsi-1283	67	7	ethical	ethical	ADJ
ajmsi-1283	67	8	approval	approval	NOUN
ajmsi-1283	67	9	was	be	AUX
ajmsi-1283	67	10	obtained	obtain	VERB
ajmsi-1283	67	11	from	from	ADP
ajmsi-1283	67	12	ethics	ethic	NOUN
ajmsi-1283	67	13	board	board	PROPN
ajmsi-1283	67	14	of	of	ADP
ajmsi-1283	67	15	nnamdi	nnamdi	PROPN
ajmsi-1283	67	16	azikiwe	azikiwe	PROPN
ajmsi-1283	67	17	university	university	PROPN
ajmsi-1283	67	18	teaching	teaching	NOUN
ajmsi-1283	67	19	hospital	hospital	NOUN
ajmsi-1283	67	20	(	(	PUNCT
ajmsi-1283	67	21	nauth	nauth	NOUN
ajmsi-1283	67	22	)	)	PUNCT
ajmsi-1283	67	23	(	(	PUNCT
ajmsi-1283	67	24	nauth	nauth	ADJ
ajmsi-1283	67	25	/	/	SYM
ajmsi-1283	67	26	cs/66	cs/66	PROPN
ajmsi-1283	67	27	/	/	SYM
ajmsi-1283	67	28	vol.13	vol.13	NOUN
ajmsi-1283	67	29	/	/	SYM
ajmsi-1283	67	30	ver	ver	NOUN
ajmsi-1283	67	31	iii/10/2020/07	iii/10/2020/07	PROPN
ajmsi-1283	67	32	)	)	PUNCT
ajmsi-1283	67	33	.	.	PUNCT
ajmsi-1283	68	1	study	study	NOUN
ajmsi-1283	68	2	site	site	NOUN
ajmsi-1283	68	3	and	and	CCONJ
ajmsi-1283	68	4	sample	sample	NOUN
ajmsi-1283	68	5	collection	collection	NOUN
ajmsi-1283	68	6	:	:	PUNCT
ajmsi-1283	68	7	a	a	DET
ajmsi-1283	68	8	cross	cross	ADJ
ajmsi-1283	68	9	-	-	ADJ
ajmsi-1283	68	10	sectional	sectional	ADJ
ajmsi-1283	68	11	study	study	NOUN
ajmsi-1283	68	12	was	be	AUX
ajmsi-1283	68	13	earlier	early	ADV
ajmsi-1283	68	14	carried	carry	VERB
ajmsi-1283	68	15	out	out	ADP
ajmsi-1283	68	16	in	in	ADP
ajmsi-1283	68	17	anambra	anambra	PROPN
ajmsi-1283	68	18	north	north	PROPN
ajmsi-1283	68	19	senatorial	senatorial	ADJ
ajmsi-1283	68	20	district	district	NOUN
ajmsi-1283	68	21	of	of	ADP
ajmsi-1283	68	22	anambra	anambra	PROPN
ajmsi-1283	68	23	state	state	PROPN
ajmsi-1283	68	24	for	for	ADP
ajmsi-1283	68	25	presence	presence	NOUN
ajmsi-1283	68	26	of	of	ADP
ajmsi-1283	68	27	urogenital	urogenital	ADJ
ajmsi-1283	68	28	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	68	29	(	(	PUNCT
ajmsi-1283	68	30	the	the	DET
ajmsi-1283	68	31	manuscript	manuscript	NOUN
ajmsi-1283	68	32	on	on	ADP
ajmsi-1283	68	33	the	the	DET
ajmsi-1283	68	34	prevalence	prevalence	NOUN
ajmsi-1283	68	35	is	be	AUX
ajmsi-1283	68	36	presently	presently	ADV
ajmsi-1283	68	37	under	under	ADP
ajmsi-1283	68	38	review	review	NOUN
ajmsi-1283	68	39	in	in	ADP
ajmsi-1283	68	40	the	the	DET
ajmsi-1283	68	41	nigerian	nigerian	ADJ
ajmsi-1283	68	42	journal	journal	NOUN
ajmsi-1283	68	43	of	of	ADP
ajmsi-1283	68	44	parasitology	parasitology	NOUN
ajmsi-1283	68	45	)	)	PUNCT
ajmsi-1283	68	46	.	.	PUNCT
ajmsi-1283	69	1	anambra	anambra	PROPN
ajmsi-1283	69	2	north	north	PROPN
ajmsi-1283	69	3	senatorial	senatorial	ADJ
ajmsi-1283	69	4	district	district	NOUN
ajmsi-1283	69	5	is	be	AUX
ajmsi-1283	69	6	made	make	VERB
ajmsi-1283	69	7	up	up	ADP
ajmsi-1283	69	8	of	of	ADP
ajmsi-1283	69	9	7	7	NUM
ajmsi-1283	69	10	local	local	ADJ
ajmsi-1283	69	11	government	government	NOUN
ajmsi-1283	69	12	(	(	PUNCT
ajmsi-1283	69	13	lga	lga	ADJ
ajmsi-1283	69	14	)	)	PUNCT
ajmsi-1283	69	15	areas	area	NOUN
ajmsi-1283	69	16	which	which	PRON
ajmsi-1283	69	17	are	be	AUX
ajmsi-1283	69	18	:	:	PUNCT
ajmsi-1283	69	19	anambra	anambra	PROPN
ajmsi-1283	69	20	east	east	PROPN
ajmsi-1283	69	21	lga	lga	PROPN
ajmsi-1283	69	22	,	,	PUNCT
ajmsi-1283	69	23	anambra	anambra	PROPN
ajmsi-1283	69	24	west	west	PROPN
ajmsi-1283	69	25	lga	lga	PROPN
ajmsi-1283	69	26	,	,	PUNCT
ajmsi-1283	69	27	ayamelum	ayamelum	VERB
ajmsi-1283	69	28	lga	lga	ADJ
ajmsi-1283	69	29	,	,	PUNCT
ajmsi-1283	69	30	ogbaru	ogbaru	NOUN
ajmsi-1283	69	31	lga	lga	NOUN
ajmsi-1283	69	32	,	,	PUNCT
ajmsi-1283	69	33	onitsha	onitsha	ADP
ajmsi-1283	69	34	north	north	PROPN
ajmsi-1283	69	35	lga	lga	NOUN
ajmsi-1283	69	36	,	,	PUNCT
ajmsi-1283	69	37	onitsha	onitsha	ADP
ajmsi-1283	69	38	south	south	ADJ
ajmsi-1283	69	39	lga	lga	PROPN
ajmsi-1283	69	40	and	and	CCONJ
ajmsi-1283	69	41	oyi	oyi	PROPN
ajmsi-1283	69	42	lga	lga	PROPN
ajmsi-1283	69	43	(	(	PUNCT
ajmsi-1283	69	44	mictu	mictu	ADJ
ajmsi-1283	69	45	/	/	SYM
ajmsi-1283	69	46	unizik	unizik	NOUN
ajmsi-1283	69	47	,	,	PUNCT
ajmsi-1283	69	48	2019	2019	NUM
ajmsi-1283	69	49	)	)	PUNCT
ajmsi-1283	69	50	.	.	PUNCT
ajmsi-1283	70	1	three	three	NUM
ajmsi-1283	70	2	lgas	lgas	NOUN
ajmsi-1283	70	3	were	be	AUX
ajmsi-1283	70	4	randomly	randomly	ADV
ajmsi-1283	70	5	selected	select	VERB
ajmsi-1283	70	6	.	.	PUNCT
ajmsi-1283	71	1	informed	inform	VERB
ajmsi-1283	71	2	consent	consent	NOUN
ajmsi-1283	71	3	from	from	ADP
ajmsi-1283	71	4	community	community	NOUN
ajmsi-1283	71	5	heads	head	NOUN
ajmsi-1283	71	6	,	,	PUNCT
ajmsi-1283	71	7	head	head	NOUN
ajmsi-1283	71	8	teachers	teacher	NOUN
ajmsi-1283	71	9	and	and	CCONJ
ajmsi-1283	71	10	parents	parent	NOUN
ajmsi-1283	71	11	were	be	AUX
ajmsi-1283	71	12	obtained	obtain	VERB
ajmsi-1283	71	13	before	before	ADP
ajmsi-1283	71	14	sample	sample	NOUN
ajmsi-1283	71	15	collection	collection	NOUN
ajmsi-1283	71	16	.	.	PUNCT
ajmsi-1283	72	1	blood	blood	NOUN
ajmsi-1283	72	2	samples	sample	NOUN
ajmsi-1283	72	3	(	(	PUNCT
ajmsi-1283	72	4	2mls	2mls	NOUN
ajmsi-1283	72	5	)	)	PUNCT
ajmsi-1283	72	6	were	be	AUX
ajmsi-1283	72	7	collected	collect	VERB
ajmsi-1283	72	8	in	in	ADP
ajmsi-1283	72	9	edta	edta	NOUN
ajmsi-1283	72	10	bottles	bottle	NOUN
ajmsi-1283	72	11	for	for	ADP
ajmsi-1283	72	12	further	further	ADJ
ajmsi-1283	72	13	immunological	immunological	ADJ
ajmsi-1283	72	14	studies	study	NOUN
ajmsi-1283	72	15	.	.	PUNCT
ajmsi-1283	73	1	a	a	DET
ajmsi-1283	73	2	subset	subset	NOUN
ajmsi-1283	73	3	of	of	ADP
ajmsi-1283	73	4	the	the	DET
ajmsi-1283	73	5	general	general	ADJ
ajmsi-1283	73	6	study	study	NOUN
ajmsi-1283	73	7	population	population	NOUN
ajmsi-1283	73	8	was	be	AUX
ajmsi-1283	73	9	used	use	VERB
ajmsi-1283	73	10	for	for	ADP
ajmsi-1283	73	11	serology	serology	NOUN
ajmsi-1283	73	12	.	.	PUNCT
ajmsi-1283	74	1	two	two	NUM
ajmsi-1283	74	2	plates	plate	NOUN
ajmsi-1283	74	3	of	of	ADP
ajmsi-1283	74	4	96	96	NUM
ajmsi-1283	74	5	wells	well	NOUN
ajmsi-1283	74	6	was	be	AUX
ajmsi-1283	74	7	used	use	VERB
ajmsi-1283	74	8	for	for	ADP
ajmsi-1283	74	9	the	the	DET
ajmsi-1283	74	10	assay	assay	NOUN
ajmsi-1283	74	11	.	.	PUNCT
ajmsi-1283	75	1	the	the	DET
ajmsi-1283	75	2	blood	blood	NOUN
ajmsi-1283	75	3	samples	sample	NOUN
ajmsi-1283	75	4	collected	collect	VERB
ajmsi-1283	75	5	in	in	ADP
ajmsi-1283	75	6	the	the	DET
ajmsi-1283	75	7	edta	edta	NOUN
ajmsi-1283	75	8	bottles	bottle	NOUN
ajmsi-1283	75	9	were	be	AUX
ajmsi-1283	75	10	spurned	spurn	VERB
ajmsi-1283	75	11	at	at	ADP
ajmsi-1283	75	12	3000	3000	NUM
ajmsi-1283	75	13	revolution	revolution	NOUN
ajmsi-1283	75	14	per	per	ADP
ajmsi-1283	75	15	minute	minute	NOUN
ajmsi-1283	75	16	for	for	ADP
ajmsi-1283	75	17	five	five	NUM
ajmsi-1283	75	18	minutes	minute	NOUN
ajmsi-1283	75	19	.	.	PUNCT
ajmsi-1283	76	1	the	the	DET
ajmsi-1283	76	2	plasma	plasma	NOUN
ajmsi-1283	76	3	was	be	AUX
ajmsi-1283	76	4	separated	separate	VERB
ajmsi-1283	76	5	from	from	ADP
ajmsi-1283	76	6	the	the	DET
ajmsi-1283	76	7	edta	edta	NOUN
ajmsi-1283	76	8	container	container	NOUN
ajmsi-1283	76	9	into	into	ADP
ajmsi-1283	76	10	cryogenic	cryogenic	ADJ
ajmsi-1283	76	11	vials	vial	NOUN
ajmsi-1283	76	12	.	.	PUNCT
ajmsi-1283	77	1	the	the	DET
ajmsi-1283	77	2	separated	separate	VERB
ajmsi-1283	77	3	plasma	plasma	NOUN
ajmsi-1283	77	4	was	be	AUX
ajmsi-1283	77	5	stored	store	VERB
ajmsi-1283	77	6	in	in	ADP
ajmsi-1283	77	7	cryogenic	cryogenic	NOUN
ajmsi-1283	77	8	vials	vial	NOUN
ajmsi-1283	77	9	for	for	ADP
ajmsi-1283	77	10	serology	serology	NOUN
ajmsi-1283	77	11	.	.	PUNCT
ajmsi-1283	78	1	serology	serology	NOUN
ajmsi-1283	78	2	was	be	AUX
ajmsi-1283	78	3	done	do	VERB
ajmsi-1283	78	4	using	use	VERB
ajmsi-1283	78	5	enzyme	enzyme	NOUN
ajmsi-1283	78	6	linked	link	VERB
ajmsi-1283	78	7	immunosorbent	immunosorbent	ADJ
ajmsi-1283	78	8	assay	assay	PROPN
ajmsi-1283	78	9	(	(	PUNCT
ajmsi-1283	78	10	elisa	elisa	NOUN
ajmsi-1283	78	11	)	)	PUNCT
ajmsi-1283	78	12	.	.	PUNCT
ajmsi-1283	79	1	this	this	DET
ajmsi-1283	79	2	assay	assay	NOUN
ajmsi-1283	79	3	was	be	AUX
ajmsi-1283	79	4	done	do	VERB
ajmsi-1283	79	5	for	for	ADP
ajmsi-1283	79	6	both	both	CCONJ
ajmsi-1283	79	7	positive	positive	ADJ
ajmsi-1283	79	8	and	and	CCONJ
ajmsi-1283	79	9	negative	negative	ADJ
ajmsi-1283	79	10	samples	sample	NOUN
ajmsi-1283	79	11	.	.	PUNCT
ajmsi-1283	80	1	immunogens	immunogen	NOUN
ajmsi-1283	80	2	tested	test	VERB
ajmsi-1283	80	3	for	for	ADP
ajmsi-1283	80	4	,	,	PUNCT
ajmsi-1283	80	5	included	include	VERB
ajmsi-1283	80	6	glyceraldehyde-3phosphate	glyceraldehyde-3phosphate	NOUN
ajmsi-1283	80	7	dehydrogenase	dehydrogenase	NOUN
ajmsi-1283	80	8	(	(	PUNCT
ajmsi-1283	80	9	gapdh	gapdh	NOUN
ajmsi-1283	80	10	)	)	PUNCT
ajmsi-1283	80	11	and	and	CCONJ
ajmsi-1283	80	12	fibroblast	fibroblast	ADJ
ajmsi-1283	80	13	growth	growth	NOUN
ajmsi-1283	80	14	factor	factor	NOUN
ajmsi-1283	80	15	receptor	receptor	NOUN
ajmsi-1283	80	16	(	(	PUNCT
ajmsi-1283	80	17	fgfr3	fgfr3	PROPN
ajmsi-1283	80	18	)	)	PUNCT
ajmsi-1283	80	19	.	.	PUNCT
ajmsi-1283	81	1	age	age	NOUN
ajmsi-1283	81	2	range	range	NOUN
ajmsi-1283	81	3	of	of	ADP
ajmsi-1283	81	4	individuals	individual	NOUN
ajmsi-1283	81	5	tested	test	VERB
ajmsi-1283	81	6	was	be	AUX
ajmsi-1283	81	7	6	6	NUM
ajmsi-1283	81	8	-	-	SYM
ajmsi-1283	81	9	18	18	NUM
ajmsi-1283	81	10	years	year	NOUN
ajmsi-1283	81	11	.	.	PUNCT
ajmsi-1283	82	1	the	the	DET
ajmsi-1283	82	2	human	human	PROPN
ajmsi-1283	82	3	fgfr3	fgfr3	PROPN
ajmsi-1283	82	4	elisa	elisa	PROPN
ajmsi-1283	82	5	kit	kit	NOUN
ajmsi-1283	82	6	and	and	CCONJ
ajmsi-1283	82	7	the	the	DET
ajmsi-1283	82	8	anti	anti	ADJ
ajmsi-1283	82	9	-	-	ADJ
ajmsi-1283	82	10	gapdh	gapdh	ADJ
ajmsi-1283	82	11	monoclonal	monoclonal	NOUN
ajmsi-1283	82	12	antibody	antibody	NOUN
ajmsi-1283	82	13	by	by	ADP
ajmsi-1283	82	14	mybiosource.com	mybiosource.com	X
ajmsi-1283	82	15	was	be	AUX
ajmsi-1283	82	16	used	use	VERB
ajmsi-1283	82	17	for	for	ADP
ajmsi-1283	82	18	this	this	DET
ajmsi-1283	82	19	study	study	NOUN
ajmsi-1283	82	20	.	.	PUNCT
ajmsi-1283	83	1	the	the	DET
ajmsi-1283	83	2	assay	assay	NOUN
ajmsi-1283	83	3	procedures	procedure	NOUN
ajmsi-1283	83	4	were	be	AUX
ajmsi-1283	83	5	carried	carry	VERB
ajmsi-1283	83	6	out	out	ADP
ajmsi-1283	83	7	following	follow	VERB
ajmsi-1283	83	8	manufacturer	manufacturer	NOUN
ajmsi-1283	83	9	’s	’s	PART
ajmsi-1283	83	10	instructions	instruction	NOUN
ajmsi-1283	83	11	.	.	PUNCT
ajmsi-1283	84	1	procedure	procedure	NOUN
ajmsi-1283	84	2	for	for	ADP
ajmsi-1283	84	3	the	the	DET
ajmsi-1283	84	4	coating	coating	NOUN
ajmsi-1283	84	5	of	of	ADP
ajmsi-1283	84	6	plate	plate	NOUN
ajmsi-1283	84	7	for	for	ADP
ajmsi-1283	84	8	the	the	DET
ajmsi-1283	84	9	fgfr3	fgfr3	NOUN
ajmsi-1283	84	10	and	and	CCONJ
ajmsi-1283	84	11	anti	anti	ADJ
ajmsi-1283	84	12	-	-	ADJ
ajmsi-1283	84	13	gapdh	gapdh	ADJ
ajmsi-1283	84	14	monoclonal	monoclonal	NOUN
ajmsi-1283	84	15	antibody	antibody	NOUN
ajmsi-1283	84	16	was	be	AUX
ajmsi-1283	84	17	done	do	VERB
ajmsi-1283	84	18	following	follow	VERB
ajmsi-1283	84	19	the	the	DET
ajmsi-1283	84	20	protocol	protocol	NOUN
ajmsi-1283	84	21	by	by	ADP
ajmsi-1283	84	22	thermo	thermo	NOUN
ajmsi-1283	84	23	fisher	fisher	PROPN
ajmsi-1283	84	24	scientific	scientific	PROPN
ajmsi-1283	84	25	inc	inc	PROPN
ajmsi-1283	84	26	.	.	PROPN
ajmsi-1283	84	27	(	(	PUNCT
ajmsi-1283	84	28	2010	2010	NUM
ajmsi-1283	84	29	)	)	PUNCT
ajmsi-1283	84	30	.	.	PUNCT
ajmsi-1283	85	1	optical	optical	ADJ
ajmsi-1283	85	2	density	density	NOUN
ajmsi-1283	85	3	(	(	PUNCT
ajmsi-1283	85	4	od	od	NOUN
ajmsi-1283	85	5	)	)	PUNCT
ajmsi-1283	85	6	of	of	ADP
ajmsi-1283	85	7	plate	plate	NOUN
ajmsi-1283	85	8	was	be	AUX
ajmsi-1283	85	9	read	read	VERB
ajmsi-1283	85	10	at	at	ADP
ajmsi-1283	85	11	450	450	NUM
ajmsi-1283	85	12	nm	nm	NOUN
ajmsi-1283	85	13	using	use	VERB
ajmsi-1283	85	14	an	an	DET
ajmsi-1283	85	15	elisa	elisa	NOUN
ajmsi-1283	85	16	plate	plate	NOUN
ajmsi-1283	85	17	reader	reader	NOUN
ajmsi-1283	85	18	.	.	PUNCT
ajmsi-1283	86	1	wash	wash	NOUN
ajmsi-1283	86	2	buffer	buffer	NOUN
ajmsi-1283	86	3	was	be	AUX
ajmsi-1283	86	4	prepared	prepare	VERB
ajmsi-1283	86	5	using	use	VERB
ajmsi-1283	86	6	0.05	0.05	NUM
ajmsi-1283	86	7	%	%	NOUN
ajmsi-1283	86	8	tween	tween	NOUN
ajmsi-1283	86	9	20	20	NUM
ajmsi-1283	86	10	and	and	CCONJ
ajmsi-1283	86	11	phosphate	phosphate	ADJ
ajmsi-1283	86	12	buffer	buffer	NOUN
ajmsi-1283	86	13	saline	saline	NOUN
ajmsi-1283	86	14	(	(	PUNCT
ajmsi-1283	86	15	pbs	pbs	PROPN
ajmsi-1283	86	16	)	)	PUNCT
ajmsi-1283	86	17	.	.	PUNCT
ajmsi-1283	87	1	the	the	DET
ajmsi-1283	87	2	markers	marker	NOUN
ajmsi-1283	87	3	,	,	PUNCT
ajmsi-1283	87	4	hrp	hrp	NOUN
ajmsi-1283	87	5	conjugated	conjugate	VERB
ajmsi-1283	87	6	anti	anti	ADJ
ajmsi-1283	87	7	-	-	ADJ
ajmsi-1283	87	8	rabbit	rabbit	ADJ
ajmsi-1283	87	9	antigen	antigen	NOUN
ajmsi-1283	87	10	,	,	PUNCT
ajmsi-1283	87	11	blocking	block	VERB
ajmsi-1283	87	12	buffer	buffer	NOUN
ajmsi-1283	87	13	,	,	PUNCT
ajmsi-1283	87	14	substrate	substrate	NOUN
ajmsi-1283	87	15	and	and	CCONJ
ajmsi-1283	87	16	stop	stop	VERB
ajmsi-1283	87	17	solution	solution	NOUN
ajmsi-1283	87	18	were	be	AUX
ajmsi-1283	87	19	all	all	PRON
ajmsi-1283	87	20	provided	provide	VERB
ajmsi-1283	87	21	by	by	ADP
ajmsi-1283	87	22	the	the	DET
ajmsi-1283	87	23	manufacturer	manufacturer	NOUN
ajmsi-1283	87	24	.	.	PUNCT
ajmsi-1283	88	1	data	datum	NOUN
ajmsi-1283	88	2	was	be	AUX
ajmsi-1283	88	3	entered	enter	VERB
ajmsi-1283	88	4	and	and	CCONJ
ajmsi-1283	88	5	cleaned	clean	VERB
ajmsi-1283	88	6	in	in	ADP
ajmsi-1283	88	7	microsoft	microsoft	PROPN
ajmsi-1283	88	8	excel	excel	PROPN
ajmsi-1283	88	9	.	.	PUNCT
ajmsi-1283	89	1	data	datum	NOUN
ajmsi-1283	89	2	was	be	AUX
ajmsi-1283	89	3	analyzed	analyze	VERB
ajmsi-1283	89	4	using	use	VERB
ajmsi-1283	89	5	microsoft	microsoft	PROPN
ajmsi-1283	89	6	excel	excel	PROPN
ajmsi-1283	89	7	and	and	CCONJ
ajmsi-1283	89	8	ibm	ibm	PROPN
ajmsi-1283	89	9	spss	spss	PROPN
ajmsi-1283	89	10	20	20	NUM
ajmsi-1283	89	11	software	software	NOUN
ajmsi-1283	89	12	.	.	PUNCT
ajmsi-1283	90	1	mcnemar	mcnemar	PROPN
ajmsi-1283	90	2	’s	’s	PART
ajmsi-1283	90	3	test	test	NOUN
ajmsi-1283	90	4	and	and	CCONJ
ajmsi-1283	90	5	inter	inter	PROPN
ajmsi-1283	90	6	rater	rater	NOUN
ajmsi-1283	90	7	reliability	reliability	NOUN
ajmsi-1283	90	8	tests	test	NOUN
ajmsi-1283	90	9	were	be	AUX
ajmsi-1283	90	10	tested	test	VERB
ajmsi-1283	90	11	for	for	ADP
ajmsi-1283	90	12	all	all	DET
ajmsi-1283	90	13	elisa	elisa	NOUN
ajmsi-1283	90	14	tests	test	NOUN
ajmsi-1283	90	15	.	.	PUNCT
ajmsi-1283	91	1	the	the	DET
ajmsi-1283	91	2	fisher	fisher	PROPN
ajmsi-1283	91	3	exact	exact	ADJ
ajmsi-1283	91	4	tests	test	NOUN
ajmsi-1283	91	5	and	and	CCONJ
ajmsi-1283	91	6	chi	chi	NOUN
ajmsi-1283	91	7	-	-	PUNCT
ajmsi-1283	91	8	square	square	NOUN
ajmsi-1283	91	9	were	be	AUX
ajmsi-1283	91	10	used	use	VERB
ajmsi-1283	91	11	to	to	PART
ajmsi-1283	91	12	compare	compare	VERB
ajmsi-1283	91	13	s.	s.	PROPN
ajmsi-1283	91	14	haematobium	haematobium	PROPN
ajmsi-1283	91	15	infection	infection	NOUN
ajmsi-1283	91	16	rates	rate	NOUN
ajmsi-1283	91	17	between	between	ADP
ajmsi-1283	91	18	age	age	NOUN
ajmsi-1283	91	19	and	and	CCONJ
ajmsi-1283	91	20	sex	sex	NOUN
ajmsi-1283	91	21	.	.	PUNCT
ajmsi-1283	92	1	the	the	DET
ajmsi-1283	92	2	spearman	spearman	NOUN
ajmsi-1283	92	3	’s	’s	PART
ajmsi-1283	92	4	and	and	CCONJ
ajmsi-1283	92	5	pearson	pearson	PROPN
ajmsi-1283	92	6	correlation	correlation	NOUN
ajmsi-1283	92	7	coefficient	coefficient	NOUN
ajmsi-1283	92	8	was	be	AUX
ajmsi-1283	92	9	used	use	VERB
ajmsi-1283	92	10	to	to	PART
ajmsi-1283	92	11	determine	determine	VERB
ajmsi-1283	92	12	relationships	relationship	NOUN
ajmsi-1283	92	13	.	.	PUNCT
ajmsi-1283	93	1	results	result	NOUN
ajmsi-1283	93	2	and	and	CCONJ
ajmsi-1283	93	3	discussion	discussion	NOUN
ajmsi-1283	93	4	in	in	ADP
ajmsi-1283	93	5	the	the	DET
ajmsi-1283	93	6	said	say	VERB
ajmsi-1283	93	7	study	study	NOUN
ajmsi-1283	93	8	,	,	PUNCT
ajmsi-1283	93	9	a	a	DET
ajmsi-1283	93	10	total	total	NOUN
ajmsi-1283	93	11	of	of	ADP
ajmsi-1283	93	12	396	396	NUM
ajmsi-1283	93	13	children	child	NOUN
ajmsi-1283	93	14	were	be	AUX
ajmsi-1283	93	15	sampled	sample	VERB
ajmsi-1283	93	16	and	and	CCONJ
ajmsi-1283	93	17	urine	urine	NOUN
ajmsi-1283	93	18	microscopy	microscopy	NOUN
ajmsi-1283	93	19	done	do	VERB
ajmsi-1283	93	20	for	for	ADP
ajmsi-1283	93	21	schistosoma	schistosoma	ADJ
ajmsi-1283	93	22	haematobium	haematobium	NOUN
ajmsi-1283	93	23	detection	detection	NOUN
ajmsi-1283	93	24	.	.	PUNCT
ajmsi-1283	94	1	from	from	ADP
ajmsi-1283	94	2	this	this	PRON
ajmsi-1283	94	3	,	,	PUNCT
ajmsi-1283	94	4	36	36	NUM
ajmsi-1283	94	5	children	child	NOUN
ajmsi-1283	94	6	were	be	AUX
ajmsi-1283	94	7	positive	positive	ADJ
ajmsi-1283	94	8	for	for	ADP
ajmsi-1283	94	9	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	94	10	.	.	PUNCT
ajmsi-1283	95	1	all	all	DET
ajmsi-1283	95	2	36	36	NUM
ajmsi-1283	95	3	s.	s.	PROPN
ajmsi-1283	95	4	haematobium	haematobium	PROPN
ajmsi-1283	95	5	positive	positive	ADJ
ajmsi-1283	95	6	consisting	consisting	NOUN
ajmsi-1283	95	7	of	of	ADP
ajmsi-1283	95	8	26	26	NUM
ajmsi-1283	95	9	females	female	NOUN
ajmsi-1283	95	10	and	and	CCONJ
ajmsi-1283	95	11	10	10	NUM
ajmsi-1283	95	12	males	male	NOUN
ajmsi-1283	95	13	and	and	CCONJ
ajmsi-1283	95	14	randomly	randomly	ADV
ajmsi-1283	95	15	selected	select	VERB
ajmsi-1283	95	16	156	156	NUM
ajmsi-1283	95	17	negative	negative	ADJ
ajmsi-1283	95	18	samples	sample	NOUN
ajmsi-1283	95	19	were	be	AUX
ajmsi-1283	95	20	used	use	VERB
ajmsi-1283	95	21	for	for	ADP
ajmsi-1283	95	22	the	the	DET
ajmsi-1283	95	23	study	study	NOUN
ajmsi-1283	95	24	.	.	PUNCT
ajmsi-1283	96	1	the	the	DET
ajmsi-1283	96	2	study	study	NOUN
ajmsi-1283	96	3	subset	subset	NOUN
ajmsi-1283	96	4	included	include	VERB
ajmsi-1283	96	5	a	a	DET
ajmsi-1283	96	6	total	total	NOUN
ajmsi-1283	96	7	of	of	ADP
ajmsi-1283	96	8	192	192	NUM
ajmsi-1283	96	9	samples	sample	NOUN
ajmsi-1283	96	10	,	,	PUNCT
ajmsi-1283	96	11	108	108	NUM
ajmsi-1283	96	12	females	female	NOUN
ajmsi-1283	96	13	and	and	CCONJ
ajmsi-1283	96	14	84	84	NUM
ajmsi-1283	96	15	males	male	NOUN
ajmsi-1283	96	16	.	.	PUNCT
ajmsi-1283	97	1	absorbance	absorbance	NOUN
ajmsi-1283	97	2	cutoff	cutoff	NOUN
ajmsi-1283	97	3	points	point	NOUN
ajmsi-1283	97	4	were	be	AUX
ajmsi-1283	97	5	determined	determine	VERB
ajmsi-1283	97	6	as	as	ADP
ajmsi-1283	97	7	1.0	1.0	NUM
ajmsi-1283	97	8	and	and	CCONJ
ajmsi-1283	97	9	1.1	1.1	NUM
ajmsi-1283	97	10	for	for	ADP
ajmsi-1283	97	11	gapdh	gapdh	NOUN
ajmsi-1283	97	12	and	and	CCONJ
ajmsi-1283	97	13	fgfr3	fgfr3	NOUN
ajmsi-1283	97	14	respectively	respectively	ADV
ajmsi-1283	97	15	(	(	PUNCT
ajmsi-1283	97	16	figure	figure	NOUN
ajmsi-1283	97	17	1	1	NUM
ajmsi-1283	97	18	,	,	PUNCT
ajmsi-1283	97	19	figure	figure	NOUN
ajmsi-1283	97	20	2	2	NUM
ajmsi-1283	97	21	)	)	PUNCT
ajmsi-1283	97	22	.	.	PUNCT
ajmsi-1283	98	1	mean	mean	VERB
ajmsi-1283	98	2	optical	optical	ADJ
ajmsi-1283	98	3	density	density	NOUN
ajmsi-1283	98	4	was	be	AUX
ajmsi-1283	98	5	0.73	0.73	NUM
ajmsi-1283	98	6	and	and	CCONJ
ajmsi-1283	98	7	0.79	0.79	NUM
ajmsi-1283	98	8	for	for	ADP
ajmsi-1283	98	9	gapdh	gapdh	NOUN
ajmsi-1283	98	10	and	and	CCONJ
ajmsi-1283	98	11	fgfr3	fgfr3	NOUN
ajmsi-1283	98	12	respectively	respectively	ADV
ajmsi-1283	98	13	.	.	PUNCT
ajmsi-1283	99	1	the	the	DET
ajmsi-1283	99	2	result	result	NOUN
ajmsi-1283	99	3	from	from	ADP
ajmsi-1283	99	4	the	the	DET
ajmsi-1283	99	5	s.	s.	PROPN
ajmsi-1283	99	6	haematobium	haematobium	PROPN
ajmsi-1283	99	7	36	36	NUM
ajmsi-1283	99	8	positive	positive	ADJ
ajmsi-1283	99	9	cases	case	NOUN
ajmsi-1283	99	10	showed	show	VERB
ajmsi-1283	99	11	a	a	DET
ajmsi-1283	99	12	mean	mean	NOUN
ajmsi-1283	99	13	od	od	NOUN
ajmsi-1283	99	14	for	for	ADP
ajmsi-1283	99	15	gapdh	gapdh	NOUN
ajmsi-1283	99	16	as	as	ADP
ajmsi-1283	99	17	0.938	0.938	NUM
ajmsi-1283	99	18	,	,	PUNCT
ajmsi-1283	99	19	minimum	minimum	ADJ
ajmsi-1283	99	20	value	value	NOUN
ajmsi-1283	99	21	was	be	AUX
ajmsi-1283	99	22	0.119	0.119	NUM
ajmsi-1283	99	23	while	while	SCONJ
ajmsi-1283	99	24	maximum	maximum	ADJ
ajmsi-1283	99	25	value	value	NOUN
ajmsi-1283	99	26	was	be	AUX
ajmsi-1283	99	27	4.507	4.507	NUM
ajmsi-1283	99	28	.	.	PUNCT
ajmsi-1283	100	1	for	for	ADP
ajmsi-1283	100	2	fgfr3	fgfr3	PROPN
ajmsi-1283	100	3	mean	mean	NOUN
ajmsi-1283	100	4	od	od	PROPN
ajmsi-1283	100	5	was	be	AUX
ajmsi-1283	100	6	0.896	0.896	NUM
ajmsi-1283	100	7	,	,	PUNCT
ajmsi-1283	100	8	maximum	maximum	ADJ
ajmsi-1283	100	9	2.882	2.882	NUM
ajmsi-1283	100	10	and	and	CCONJ
ajmsi-1283	100	11	minimum	minimum	NOUN
ajmsi-1283	100	12	0.28	0.28	NUM
ajmsi-1283	100	13	,	,	PUNCT
ajmsi-1283	100	14	while	while	SCONJ
ajmsi-1283	100	15	females	female	NOUN
ajmsi-1283	100	16	showed	show	VERB
ajmsi-1283	100	17	higher	high	ADJ
ajmsi-1283	100	18	gapdh	gapdh	NOUN
ajmsi-1283	100	19	od	od	NOUN
ajmsi-1283	100	20	(	(	PUNCT
ajmsi-1283	100	21	table	table	NOUN
ajmsi-1283	100	22	1	1	NUM
ajmsi-1283	100	23	)	)	PUNCT
ajmsi-1283	100	24	.	.	PUNCT
ajmsi-1283	101	1	this	this	DET
ajmsi-1283	101	2	study	study	NOUN
ajmsi-1283	101	3	identified	identify	VERB
ajmsi-1283	101	4	that	that	SCONJ
ajmsi-1283	101	5	there	there	PRON
ajmsi-1283	101	6	are	be	VERB
ajmsi-1283	101	7	some	some	DET
ajmsi-1283	101	8	school	school	NOUN
ajmsi-1283	101	9	children	child	NOUN
ajmsi-1283	101	10	that	that	PRON
ajmsi-1283	101	11	are	be	AUX
ajmsi-1283	101	12	positive	positive	ADJ
ajmsi-1283	101	13	for	for	ADP
ajmsi-1283	101	14	the	the	DET
ajmsi-1283	101	15	cancer	cancer	NOUN
ajmsi-1283	101	16	genetic	genetic	ADJ
ajmsi-1283	101	17	markers	marker	NOUN
ajmsi-1283	101	18	gapdh	gapdh	NOUN
ajmsi-1283	101	19	and	and	CCONJ
ajmsi-1283	101	20	fgfr3	fgfr3	NOUN
ajmsi-1283	101	21	in	in	ADP
ajmsi-1283	101	22	the	the	DET
ajmsi-1283	101	23	study	study	NOUN
ajmsi-1283	101	24	area	area	NOUN
ajmsi-1283	101	25	.	.	PUNCT
ajmsi-1283	102	1	also	also	ADV
ajmsi-1283	102	2	,	,	PUNCT
ajmsi-1283	102	3	in	in	ADP
ajmsi-1283	102	4	the	the	DET
ajmsi-1283	102	5	case	case	NOUN
ajmsi-1283	102	6	of	of	ADP
ajmsi-1283	102	7	individuals	individual	NOUN
ajmsi-1283	102	8	that	that	PRON
ajmsi-1283	102	9	are	be	AUX
ajmsi-1283	102	10	positive	positive	ADJ
ajmsi-1283	102	11	for	for	ADP
ajmsi-1283	102	12	s.	s.	PROPN
ajmsi-1283	102	13	haematobium	haematobium	PROPN
ajmsi-1283	102	14	eggs	egg	NOUN
ajmsi-1283	102	15	,	,	PUNCT
ajmsi-1283	102	16	it	it	PRON
ajmsi-1283	102	17	was	be	AUX
ajmsi-1283	102	18	also	also	ADV
ajmsi-1283	102	19	noted	note	VERB
ajmsi-1283	102	20	that	that	SCONJ
ajmsi-1283	102	21	some	some	PRON
ajmsi-1283	102	22	of	of	ADP
ajmsi-1283	102	23	the	the	DET
ajmsi-1283	102	24	participants	participant	NOUN
ajmsi-1283	102	25	are	be	AUX
ajmsi-1283	102	26	positive	positive	ADJ
ajmsi-1283	102	27	for	for	ADP
ajmsi-1283	102	28	the	the	DET
ajmsi-1283	102	29	cancer	cancer	NOUN
ajmsi-1283	102	30	genetic	genetic	ADJ
ajmsi-1283	102	31	markers	marker	NOUN
ajmsi-1283	102	32	.	.	PUNCT
ajmsi-1283	103	1	more	more	ADJ
ajmsi-1283	103	2	positivity	positivity	NOUN
ajmsi-1283	103	3	rate	rate	NOUN
ajmsi-1283	103	4	was	be	AUX
ajmsi-1283	103	5	noted	note	VERB
ajmsi-1283	103	6	for	for	ADP
ajmsi-1283	103	7	fgfr3	fgfr3	NOUN
ajmsi-1283	103	8	than	than	ADP
ajmsi-1283	103	9	gapdh	gapdh	NOUN
ajmsi-1283	103	10	.	.	PUNCT
ajmsi-1283	104	1	a	a	DET
ajmsi-1283	104	2	study	study	NOUN
ajmsi-1283	104	3	on	on	ADP
ajmsi-1283	104	4	s.	s.	PROPN
ajmsi-1283	104	5	mansoni	mansoni	PROPN
ajmsi-1283	104	6	has	have	AUX
ajmsi-1283	104	7	sown	sow	VERB
ajmsi-1283	104	8	that	that	SCONJ
ajmsi-1283	104	9	there	there	PRON
ajmsi-1283	104	10	is	be	VERB
ajmsi-1283	104	11	an	an	DET
ajmsi-1283	104	12	indication	indication	NOUN
ajmsi-1283	104	13	that	that	SCONJ
ajmsi-1283	104	14	the	the	DET
ajmsi-1283	104	15	expression	expression	NOUN
ajmsi-1283	104	16	of	of	ADP
ajmsi-1283	104	17	the	the	DET
ajmsi-1283	104	18	glycolytic	glycolytic	ADJ
ajmsi-1283	104	19	enzyme	enzyme	NOUN
ajmsi-1283	104	20	gapdh	gapdh	NOUN
ajmsi-1283	104	21	is	be	AUX
ajmsi-1283	104	22	as	as	ADP
ajmsi-1283	104	23	a	a	DET
ajmsi-1283	104	24	result	result	NOUN
ajmsi-1283	104	25	of	of	ADP
ajmsi-1283	104	26	the	the	DET
ajmsi-1283	104	27	parasite	parasite	NOUN
ajmsi-1283	104	28	activity	activity	NOUN
ajmsi-1283	104	29	(	(	PUNCT
ajmsi-1283	104	30	pirovich	pirovich	NOUN
ajmsi-1283	104	31	et	et	PROPN
ajmsi-1283	104	32	al	al	PROPN
ajmsi-1283	104	33	.	.	PROPN
ajmsi-1283	104	34	,	,	PUNCT
ajmsi-1283	104	35	2020	2020	NUM
ajmsi-1283	104	36	)	)	PUNCT
ajmsi-1283	104	37	.	.	PUNCT
ajmsi-1283	105	1	gapdh	gapdh	NOUN
ajmsi-1283	105	2	has	have	AUX
ajmsi-1283	105	3	been	be	AUX
ajmsi-1283	105	4	implicated	implicate	VERB
ajmsi-1283	105	5	as	as	ADP
ajmsi-1283	105	6	an	an	DET
ajmsi-1283	105	7	immune	immune	ADJ
ajmsi-1283	105	8	marker	marker	NOUN
ajmsi-1283	105	9	that	that	PRON
ajmsi-1283	105	10	is	be	AUX
ajmsi-1283	105	11	essential	essential	ADJ
ajmsi-1283	105	12	for	for	ADP
ajmsi-1283	105	13	cancer	cancer	NOUN
ajmsi-1283	105	14	cells	cell	NOUN
ajmsi-1283	105	15	by	by	ADP
ajmsi-1283	105	16	influencing	influence	VERB
ajmsi-1283	105	17	cancer	cancer	NOUN
ajmsi-1283	105	18	cell	cell	NOUN
ajmsi-1283	105	19	fate	fate	NOUN
ajmsi-1283	105	20	and	and	CCONJ
ajmsi-1283	105	21	may	may	AUX
ajmsi-1283	105	22	be	be	AUX
ajmsi-1283	105	23	a	a	DET
ajmsi-1283	105	24	critical	critical	ADJ
ajmsi-1283	105	25	regulator	regulator	NOUN
ajmsi-1283	105	26	of	of	ADP
ajmsi-1283	105	27	cancer	cancer	NOUN
ajmsi-1283	105	28	cell	cell	NOUN
ajmsi-1283	105	29	functions	function	NOUN
ajmsi-1283	105	30	and	and	CCONJ
ajmsi-1283	105	31	hence	hence	ADV
ajmsi-1283	105	32	a	a	DET
ajmsi-1283	105	33	marker	marker	NOUN
ajmsi-1283	105	34	of	of	ADP
ajmsi-1283	105	35	cancer	cancer	NOUN
ajmsi-1283	105	36	cell	cell	NOUN
ajmsi-1283	105	37	progression	progression	NOUN
ajmsi-1283	105	38	and	and	CCONJ
ajmsi-1283	105	39	prognosis	prognosis	NOUN
ajmsi-1283	105	40	(	(	PUNCT
ajmsi-1283	105	41	zhang	zhang	X
ajmsi-1283	105	42	et	et	PROPN
ajmsi-1283	105	43	al	al	PROPN
ajmsi-1283	105	44	.	.	PROPN
ajmsi-1283	105	45	,	,	PUNCT
ajmsi-1283	105	46	2015	2015	NUM
ajmsi-1283	105	47	)	)	PUNCT
ajmsi-1283	105	48	.	.	PUNCT
ajmsi-1283	106	1	fgfr3	fgfr3	PROPN
ajmsi-1283	106	2	has	have	AUX
ajmsi-1283	106	3	also	also	ADV
ajmsi-1283	106	4	been	be	AUX
ajmsi-1283	106	5	implicated	implicate	VERB
ajmsi-1283	106	6	in	in	ADP
ajmsi-1283	106	7	the	the	DET
ajmsi-1283	106	8	development	development	NOUN
ajmsi-1283	106	9	of	of	ADP
ajmsi-1283	106	10	different	different	ADJ
ajmsi-1283	106	11	forms	form	NOUN
ajmsi-1283	106	12	of	of	ADP
ajmsi-1283	106	13	cancer	cancer	NOUN
ajmsi-1283	106	14	and	and	CCONJ
ajmsi-1283	106	15	could	could	AUX
ajmsi-1283	106	16	also	also	ADV
ajmsi-1283	106	17	serve	serve	VERB
ajmsi-1283	106	18	as	as	ADP
ajmsi-1283	106	19	cancer	cancer	NOUN
ajmsi-1283	106	20	prognostic	prognostic	ADJ
ajmsi-1283	106	21	marker	marker	NOUN
ajmsi-1283	106	22	(	(	PUNCT
ajmsi-1283	106	23	akanksha	akanksha	PROPN
ajmsi-1283	106	24	and	and	CCONJ
ajmsi-1283	106	25	sandhya	sandhya	PROPN
ajmsi-1283	106	26	,	,	PUNCT
ajmsi-1283	106	27	2019	2019	NUM
ajmsi-1283	106	28	)	)	PUNCT
ajmsi-1283	106	29	.	.	PUNCT
ajmsi-1283	107	1	this	this	PRON
ajmsi-1283	107	2	basically	basically	ADV
ajmsi-1283	107	3	implies	imply	VERB
ajmsi-1283	107	4	that	that	SCONJ
ajmsi-1283	107	5	among	among	ADP
ajmsi-1283	107	6	this	this	DET
ajmsi-1283	107	7	study	study	NOUN
ajmsi-1283	107	8	group	group	NOUN
ajmsi-1283	107	9	,	,	PUNCT
ajmsi-1283	107	10	there	there	PRON
ajmsi-1283	107	11	is	be	VERB
ajmsi-1283	107	12	a	a	DET
ajmsi-1283	107	13	risk	risk	NOUN
ajmsi-1283	107	14	of	of	ADP
ajmsi-1283	107	15	possible	possible	ADJ
ajmsi-1283	107	16	progression	progression	NOUN
ajmsi-1283	107	17	of	of	ADP
ajmsi-1283	107	18	bladder	bladder	NOUN
ajmsi-1283	107	19	cancer	cancer	NOUN
ajmsi-1283	107	20	development	development	NOUN
ajmsi-1283	107	21	if	if	SCONJ
ajmsi-1283	107	22	infection	infection	NOUN
ajmsi-1283	107	23	with	with	ADP
ajmsi-1283	107	24	urogenital	urogenital	ADJ
ajmsi-1283	107	25	schistosomiais	schistosomiais	NOUN
ajmsi-1283	107	26	is	be	AUX
ajmsi-1283	107	27	not	not	PART
ajmsi-1283	107	28	well	well	ADV
ajmsi-1283	107	29	managed	manage	VERB
ajmsi-1283	107	30	.	.	PUNCT
ajmsi-1283	108	1	this	this	PRON
ajmsi-1283	108	2	should	should	AUX
ajmsi-1283	108	3	be	be	AUX
ajmsi-1283	108	4	an	an	DET
ajmsi-1283	108	5	issue	issue	NOUN
ajmsi-1283	108	6	of	of	ADP
ajmsi-1283	108	7	public	public	ADJ
ajmsi-1283	108	8	health	health	NOUN
ajmsi-1283	108	9	importance	importance	NOUN
ajmsi-1283	108	10	since	since	SCONJ
ajmsi-1283	108	11	this	this	PRON
ajmsi-1283	108	12	implies	imply	VERB
ajmsi-1283	108	13	potential	potential	ADJ
ajmsi-1283	108	14	risk	risk	NOUN
ajmsi-1283	108	15	of	of	ADP
ajmsi-1283	108	16	bladder	bladder	NOUN
ajmsi-1283	108	17	cancer	cancer	NOUN
ajmsi-1283	108	18	development	development	NOUN
ajmsi-1283	108	19	because	because	SCONJ
ajmsi-1283	108	20	,	,	PUNCT
ajmsi-1283	108	21	the	the	DET
ajmsi-1283	108	22	positivity	positivity	NOUN
ajmsi-1283	108	23	for	for	ADP
ajmsi-1283	108	24	these	these	DET
ajmsi-1283	108	25	markers	marker	NOUN
ajmsi-1283	108	26	identifies	identify	VERB
ajmsi-1283	108	27	that	that	SCONJ
ajmsi-1283	108	28	there	there	PRON
ajmsi-1283	108	29	is	be	VERB
ajmsi-1283	108	30	a	a	DET
ajmsi-1283	108	31	potential	potential	ADJ
ajmsi-1283	108	32	risk	risk	NOUN
ajmsi-1283	108	33	of	of	ADP
ajmsi-1283	108	34	them	they	PRON
ajmsi-1283	108	35	developing	develop	VERB
ajmsi-1283	108	36	bladder	bladder	NOUN
ajmsi-1283	108	37	cancer	cancer	NOUN
ajmsi-1283	108	38	in	in	ADP
ajmsi-1283	108	39	the	the	DET
ajmsi-1283	108	40	future	future	NOUN
ajmsi-1283	108	41	because	because	SCONJ
ajmsi-1283	108	42	,	,	PUNCT
ajmsi-1283	108	43	these	these	DET
ajmsi-1283	108	44	markers	marker	NOUN
ajmsi-1283	108	45	could	could	AUX
ajmsi-1283	108	46	serve	serve	VERB
ajmsi-1283	108	47	as	as	ADP
ajmsi-1283	108	48	cancer	cancer	NOUN
ajmsi-1283	108	49	prognostic	prognostic	ADJ
ajmsi-1283	108	50	markers	marker	NOUN
ajmsi-1283	108	51	(	(	PUNCT
ajmsi-1283	108	52	akanksha	akanksha	PROPN
ajmsi-1283	108	53	and	and	CCONJ
ajmsi-1283	108	54	sandhya	sandhya	PROPN
ajmsi-1283	108	55	,	,	PUNCT
ajmsi-1283	108	56	2019	2019	NUM
ajmsi-1283	108	57	;	;	PUNCT
ajmsi-1283	109	1	zhang	zhang	PROPN
ajmsi-1283	109	2	et	et	PROPN
ajmsi-1283	109	3	al	al	PROPN
ajmsi-1283	109	4	.	.	PROPN
ajmsi-1283	109	5	,	,	PUNCT
ajmsi-1283	109	6	2015	2015	NUM
ajmsi-1283	109	7	)	)	PUNCT
ajmsi-1283	109	8	.	.	PUNCT
ajmsi-1283	110	1	a	a	DET
ajmsi-1283	110	2	total	total	NOUN
ajmsi-1283	110	3	of	of	ADP
ajmsi-1283	110	4	21	21	NUM
ajmsi-1283	110	5	(	(	PUNCT
ajmsi-1283	110	6	10.94	10.94	NUM
ajmsi-1283	110	7	%	%	NOUN
ajmsi-1283	110	8	)	)	PUNCT
ajmsi-1283	110	9	participants	participant	NOUN
ajmsi-1283	110	10	were	be	AUX
ajmsi-1283	110	11	positive	positive	ADJ
ajmsi-1283	110	12	for	for	ADP
ajmsi-1283	110	13	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	110	14	pa	pa	PROPN
ajmsi-1283	110	15	ge	ge	PROPN
ajmsi-1283	110	16	29	29	NUM
ajmsi-1283	110	17	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	110	18	am	be	AUX
ajmsi-1283	110	19	.	.	PUNCT
ajmsi-1283	111	1	j.	j.	PROPN
ajmsi-1283	111	2	med	med	PROPN
ajmsi-1283	111	3	.	.	PUNCT
ajmsi-1283	112	1	sci	sci	PROPN
ajmsi-1283	112	2	.	.	PUNCT
ajmsi-1283	112	3	innov	innov	PROPN
ajmsi-1283	112	4	.	.	PUNCT
ajmsi-1283	113	1	2(1	2(1	NUM
ajmsi-1283	113	2	)	)	PUNCT
ajmsi-1283	113	3	26	26	NUM
ajmsi-1283	113	4	-	-	SYM
ajmsi-1283	113	5	31	31	NUM
ajmsi-1283	113	6	,	,	PUNCT
ajmsi-1283	113	7	2023	2023	NUM
ajmsi-1283	113	8	figure	figure	NOUN
ajmsi-1283	113	9	1	1	NUM
ajmsi-1283	113	10	:	:	PUNCT
ajmsi-1283	113	11	scatter	scatter	NOUN
ajmsi-1283	113	12	plot	plot	NOUN
ajmsi-1283	113	13	of	of	ADP
ajmsi-1283	113	14	gapdh	gapdh	NOUN
ajmsi-1283	113	15	elisa	elisa	NOUN
ajmsi-1283	113	16	detection	detection	NOUN
ajmsi-1283	113	17	results	result	NOUN
ajmsi-1283	113	18	.	.	PUNCT
ajmsi-1283	114	1	figure	figure	VERB
ajmsi-1283	114	2	2	2	NUM
ajmsi-1283	114	3	:	:	PUNCT
ajmsi-1283	114	4	scatter	scatter	NOUN
ajmsi-1283	114	5	plot	plot	NOUN
ajmsi-1283	114	6	of	of	ADP
ajmsi-1283	114	7	fgfr3	fgfr3	PROPN
ajmsi-1283	114	8	elisa	elisa	NOUN
ajmsi-1283	114	9	detection	detection	NOUN
ajmsi-1283	114	10	results	result	NOUN
ajmsi-1283	114	11	.	.	PUNCT
ajmsi-1283	115	1	table	table	NOUN
ajmsi-1283	115	2	1	1	NUM
ajmsi-1283	115	3	:	:	PUNCT
ajmsi-1283	115	4	od	od	NUM
ajmsi-1283	115	5	and	and	CCONJ
ajmsi-1283	115	6	prevalence	prevalence	NOUN
ajmsi-1283	115	7	of	of	ADP
ajmsi-1283	115	8	gapdh	gapdh	NOUN
ajmsi-1283	115	9	and	and	CCONJ
ajmsi-1283	115	10	fgfr3	fgfr3	NOUN
ajmsi-1283	115	11	by	by	ADP
ajmsi-1283	115	12	sex	sex	NOUN
ajmsi-1283	115	13	gapdh	gapdh	NOUN
ajmsi-1283	115	14	fgfr3	fgfr3	NOUN
ajmsi-1283	115	15	female	female	ADJ
ajmsi-1283	115	16	male	male	ADJ
ajmsi-1283	115	17	female	female	ADJ
ajmsi-1283	115	18	male	male	NOUN
ajmsi-1283	115	19	mean	mean	NOUN
ajmsi-1283	115	20	od	od	ADV
ajmsi-1283	115	21	0.876	0.876	NUM
ajmsi-1283	115	22	0.557	0.557	NUM
ajmsi-1283	115	23	0.822	0.822	NUM
ajmsi-1283	115	24	0.733	0.733	NUM
ajmsi-1283	115	25	max	max	PROPN
ajmsi-1283	115	26	od	od	ADP
ajmsi-1283	115	27	4.448	4.448	NUM
ajmsi-1283	115	28	4.507	4.507	NUM
ajmsi-1283	115	29	2.26	2.26	NUM
ajmsi-1283	115	30	2.882	2.882	NUM
ajmsi-1283	115	31	min	min	NOUN
ajmsi-1283	115	32	od	od	ADP
ajmsi-1283	115	33	0.14	0.14	NUM
ajmsi-1283	115	34	0.119	0.119	NUM
ajmsi-1283	115	35	0.248	0.248	NUM
ajmsi-1283	115	36	0.225	0.225	NUM
ajmsi-1283	115	37	no	no	NOUN
ajmsi-1283	115	38	.	.	PUNCT
ajmsi-1283	116	1	negative	negative	ADJ
ajmsi-1283	116	2	(	(	PUNCT
ajmsi-1283	116	3	%	%	NOUN
ajmsi-1283	116	4	)	)	PUNCT
ajmsi-1283	116	5	92	92	NUM
ajmsi-1283	116	6	(	(	PUNCT
ajmsi-1283	116	7	85.2	85.2	NUM
ajmsi-1283	116	8	)	)	PUNCT
ajmsi-1283	116	9	79	79	NUM
ajmsi-1283	116	10	(	(	PUNCT
ajmsi-1283	116	11	94	94	NUM
ajmsi-1283	116	12	)	)	PUNCT
ajmsi-1283	116	13	82	82	NUM
ajmsi-1283	116	14	(	(	PUNCT
ajmsi-1283	116	15	75.9	75.9	NUM
ajmsi-1283	116	16	)	)	PUNCT
ajmsi-1283	116	17	60	60	NUM
ajmsi-1283	116	18	(	(	PUNCT
ajmsi-1283	116	19	71.4	71.4	NUM
ajmsi-1283	116	20	)	)	PUNCT
ajmsi-1283	117	1	no	no	NOUN
ajmsi-1283	117	2	.	.	PUNCT
ajmsi-1283	118	1	positive	positive	ADJ
ajmsi-1283	118	2	(	(	PUNCT
ajmsi-1283	118	3	%	%	NOUN
ajmsi-1283	118	4	)	)	PUNCT
ajmsi-1283	118	5	16	16	NUM
ajmsi-1283	118	6	(	(	PUNCT
ajmsi-1283	118	7	14.8	14.8	NUM
ajmsi-1283	118	8	)	)	PUNCT
ajmsi-1283	118	9	5	5	NUM
ajmsi-1283	118	10	(	(	PUNCT
ajmsi-1283	118	11	6.0	6.0	NUM
ajmsi-1283	118	12	)	)	PUNCT
ajmsi-1283	118	13	26	26	NUM
ajmsi-1283	118	14	(	(	PUNCT
ajmsi-1283	118	15	24.1	24.1	NUM
ajmsi-1283	118	16	)	)	PUNCT
ajmsi-1283	118	17	24	24	NUM
ajmsi-1283	118	18	(	(	PUNCT
ajmsi-1283	118	19	28.6	28.6	NUM
ajmsi-1283	118	20	)	)	PUNCT
ajmsi-1283	118	21	total	total	NOUN
ajmsi-1283	118	22	108	108	NUM
ajmsi-1283	118	23	84	84	NUM
ajmsi-1283	118	24	108	108	NUM
ajmsi-1283	118	25	84	84	NUM
ajmsi-1283	118	26	p>0.05	p>0.05	PROPN
ajmsi-1283	118	27	gapdh	gapdh	NOUN
ajmsi-1283	118	28	while	while	SCONJ
ajmsi-1283	118	29	50	50	NUM
ajmsi-1283	118	30	(	(	PUNCT
ajmsi-1283	118	31	26.04	26.04	NUM
ajmsi-1283	118	32	%	%	NOUN
ajmsi-1283	118	33	)	)	PUNCT
ajmsi-1283	118	34	participants	participant	NOUN
ajmsi-1283	118	35	were	be	AUX
ajmsi-1283	118	36	positive	positive	ADJ
ajmsi-1283	118	37	for	for	ADP
ajmsi-1283	118	38	fgfr3	fgfr3	NOUN
ajmsi-1283	118	39	via	via	ADP
ajmsi-1283	118	40	elisa	elisa	PROPN
ajmsi-1283	118	41	cutoff	cutoff	NOUN
ajmsi-1283	118	42	(	(	PUNCT
ajmsi-1283	118	43	table	table	NOUN
ajmsi-1283	118	44	2	2	NUM
ajmsi-1283	118	45	)	)	PUNCT
ajmsi-1283	118	46	.	.	PUNCT
ajmsi-1283	119	1	age	age	NOUN
ajmsi-1283	119	2	range	range	NOUN
ajmsi-1283	119	3	of	of	ADP
ajmsi-1283	119	4	individuals	individual	NOUN
ajmsi-1283	119	5	tested	test	VERB
ajmsi-1283	119	6	was	be	AUX
ajmsi-1283	119	7	6	6	NUM
ajmsi-1283	119	8	-	-	SYM
ajmsi-1283	119	9	18	18	NUM
ajmsi-1283	119	10	years	year	NOUN
ajmsi-1283	119	11	.	.	PUNCT
ajmsi-1283	120	1	there	there	PRON
ajmsi-1283	120	2	was	be	VERB
ajmsi-1283	120	3	a	a	DET
ajmsi-1283	120	4	slight	slight	ADJ
ajmsi-1283	120	5	positive	positive	ADJ
ajmsi-1283	120	6	correlation	correlation	NOUN
ajmsi-1283	120	7	between	between	ADP
ajmsi-1283	120	8	age	age	NOUN
ajmsi-1283	120	9	and	and	CCONJ
ajmsi-1283	120	10	gapdh	gapdh	NOUN
ajmsi-1283	120	11	though	though	SCONJ
ajmsi-1283	120	12	this	this	PRON
ajmsi-1283	120	13	was	be	AUX
ajmsi-1283	120	14	not	not	PART
ajmsi-1283	120	15	statistically	statistically	ADV
ajmsi-1283	120	16	significant	significant	ADJ
ajmsi-1283	120	17	(	(	PUNCT
ajmsi-1283	120	18	r=	r=	ADJ
ajmsi-1283	120	19	0.27	0.27	NUM
ajmsi-1283	120	20	,	,	PUNCT
ajmsi-1283	120	21	p>0.005	p>0.005	PROPN
ajmsi-1283	120	22	)	)	PUNCT
ajmsi-1283	120	23	.	.	PUNCT
ajmsi-1283	121	1	there	there	PRON
ajmsi-1283	121	2	was	be	VERB
ajmsi-1283	121	3	also	also	ADV
ajmsi-1283	121	4	a	a	DET
ajmsi-1283	121	5	slight	slight	ADJ
ajmsi-1283	121	6	positive	positive	ADJ
ajmsi-1283	121	7	correlation	correlation	NOUN
ajmsi-1283	121	8	between	between	ADP
ajmsi-1283	121	9	age	age	NOUN
ajmsi-1283	121	10	and	and	CCONJ
ajmsi-1283	121	11	fgfr3	fgfr3	PROPN
ajmsi-1283	121	12	(	(	PUNCT
ajmsi-1283	121	13	r=	r=	ADJ
ajmsi-1283	121	14	0.27	0.27	NUM
ajmsi-1283	121	15	,	,	PUNCT
ajmsi-1283	121	16	p>0.005	p>0.005	PROPN
ajmsi-1283	121	17	)	)	PUNCT
ajmsi-1283	121	18	.	.	PUNCT
ajmsi-1283	122	1	s.	s.	PROPN
ajmsi-1283	122	2	haematobium	haematobium	PROPN
ajmsi-1283	122	3	positive	positive	ADJ
ajmsi-1283	122	4	individuals	individual	NOUN
ajmsi-1283	122	5	in	in	ADP
ajmsi-1283	122	6	the	the	DET
ajmsi-1283	122	7	age	age	NOUN
ajmsi-1283	122	8	group	group	NOUN
ajmsi-1283	122	9	11	11	NUM
ajmsi-1283	122	10	-	-	SYM
ajmsi-1283	122	11	15	15	NUM
ajmsi-1283	122	12	years	year	NOUN
ajmsi-1283	122	13	were	be	AUX
ajmsi-1283	122	14	the	the	DET
ajmsi-1283	122	15	only	only	ADJ
ajmsi-1283	122	16	group	group	NOUN
ajmsi-1283	122	17	positive	positive	ADJ
ajmsi-1283	122	18	for	for	ADP
ajmsi-1283	122	19	gapdh	gapdh	NOUN
ajmsi-1283	122	20	while	while	SCONJ
ajmsi-1283	122	21	for	for	ADP
ajmsi-1283	122	22	fgfr3	fgfr3	NOUN
ajmsi-1283	122	23	positivity	positivity	NOUN
ajmsi-1283	122	24	was	be	AUX
ajmsi-1283	122	25	noticed	notice	VERB
ajmsi-1283	122	26	across	across	ADP
ajmsi-1283	122	27	all	all	DET
ajmsi-1283	122	28	age	age	NOUN
ajmsi-1283	122	29	groups	group	NOUN
ajmsi-1283	122	30	(	(	PUNCT
ajmsi-1283	122	31	table	table	NOUN
ajmsi-1283	122	32	3	3	NUM
ajmsi-1283	122	33	)	)	PUNCT
ajmsi-1283	122	34	.	.	PUNCT
ajmsi-1283	123	1	this	this	DET
ajmsi-1283	123	2	study	study	NOUN
ajmsi-1283	123	3	was	be	AUX
ajmsi-1283	123	4	also	also	ADV
ajmsi-1283	123	5	able	able	ADJ
ajmsi-1283	123	6	to	to	PART
ajmsi-1283	123	7	show	show	VERB
ajmsi-1283	123	8	that	that	SCONJ
ajmsi-1283	123	9	there	there	PRON
ajmsi-1283	123	10	was	be	VERB
ajmsi-1283	123	11	a	a	DET
ajmsi-1283	123	12	weak	weak	ADJ
ajmsi-1283	123	13	positive	positive	ADJ
ajmsi-1283	123	14	correlation	correlation	NOUN
ajmsi-1283	123	15	between	between	ADP
ajmsi-1283	123	16	age	age	NOUN
ajmsi-1283	123	17	and	and	CCONJ
ajmsi-1283	123	18	gapdh	gapdh	NOUN
ajmsi-1283	123	19	and	and	CCONJ
ajmsi-1283	123	20	age	age	NOUN
ajmsi-1283	123	21	and	and	CCONJ
ajmsi-1283	123	22	fgfr3	fgfr3	NOUN
ajmsi-1283	123	23	for	for	ADP
ajmsi-1283	123	24	the	the	DET
ajmsi-1283	123	25	general	general	ADJ
ajmsi-1283	123	26	assayed	assayed	ADJ
ajmsi-1283	123	27	population	population	NOUN
ajmsi-1283	123	28	though	though	SCONJ
ajmsi-1283	123	29	this	this	PRON
ajmsi-1283	123	30	was	be	AUX
ajmsi-1283	123	31	not	not	PART
ajmsi-1283	123	32	statistically	statistically	ADV
ajmsi-1283	123	33	significant	significant	ADJ
ajmsi-1283	123	34	.	.	PUNCT
ajmsi-1283	124	1	individuals	individual	NOUN
ajmsi-1283	124	2	from	from	ADP
ajmsi-1283	124	3	the	the	DET
ajmsi-1283	124	4	assayed	assayed	ADJ
ajmsi-1283	124	5	samples	sample	NOUN
ajmsi-1283	124	6	in	in	ADP
ajmsi-1283	124	7	the	the	DET
ajmsi-1283	124	8	age	age	NOUN
ajmsi-1283	124	9	group	group	NOUN
ajmsi-1283	124	10	1115	1115	NUM
ajmsi-1283	124	11	years	year	NOUN
ajmsi-1283	124	12	had	have	VERB
ajmsi-1283	124	13	a	a	DET
ajmsi-1283	124	14	slightly	slightly	ADV
ajmsi-1283	124	15	higher	high	ADJ
ajmsi-1283	124	16	gapdh	gapdh	NOUN
ajmsi-1283	124	17	od	od	ADV
ajmsi-1283	124	18	though	though	SCONJ
ajmsi-1283	124	19	those	those	PRON
ajmsi-1283	124	20	in	in	ADP
ajmsi-1283	124	21	the	the	DET
ajmsi-1283	124	22	age	age	NOUN
ajmsi-1283	124	23	group	group	NOUN
ajmsi-1283	124	24	6	6	NUM
ajmsi-1283	124	25	-	-	SYM
ajmsi-1283	124	26	10	10	NUM
ajmsi-1283	124	27	years	year	NOUN
ajmsi-1283	124	28	had	have	VERB
ajmsi-1283	124	29	more	more	ADV
ajmsi-1283	124	30	positive	positive	ADJ
ajmsi-1283	124	31	individuals	individual	NOUN
ajmsi-1283	124	32	for	for	ADP
ajmsi-1283	124	33	the	the	DET
ajmsi-1283	124	34	assayed	assayed	ADJ
ajmsi-1283	124	35	marker	marker	NOUN
ajmsi-1283	124	36	.	.	PUNCT
ajmsi-1283	125	1	on	on	ADP
ajmsi-1283	125	2	the	the	DET
ajmsi-1283	125	3	other	other	ADJ
ajmsi-1283	125	4	hand	hand	NOUN
ajmsi-1283	125	5	,	,	PUNCT
ajmsi-1283	125	6	individuals	individual	NOUN
ajmsi-1283	125	7	assayed	assayed	ADJ
ajmsi-1283	125	8	for	for	ADP
ajmsi-1283	125	9	fgfr3	fgfr3	NOUN
ajmsi-1283	125	10	had	have	VERB
ajmsi-1283	125	11	more	more	ADV
ajmsi-1283	125	12	positive	positive	ADJ
ajmsi-1283	125	13	cases	case	NOUN
ajmsi-1283	125	14	for	for	ADP
ajmsi-1283	125	15	those	those	PRON
ajmsi-1283	125	16	in	in	ADP
ajmsi-1283	125	17	age	age	NOUN
ajmsi-1283	125	18	group	group	NOUN
ajmsi-1283	125	19	11	11	NUM
ajmsi-1283	125	20	-	-	SYM
ajmsi-1283	125	21	15	15	NUM
ajmsi-1283	125	22	years	year	NOUN
ajmsi-1283	125	23	.	.	PUNCT
ajmsi-1283	126	1	furthermore	furthermore	ADV
ajmsi-1283	126	2	,	,	PUNCT
ajmsi-1283	126	3	in	in	ADP
ajmsi-1283	126	4	individuals	individual	NOUN
ajmsi-1283	126	5	that	that	PRON
ajmsi-1283	126	6	are	be	AUX
ajmsi-1283	126	7	positive	positive	ADJ
ajmsi-1283	126	8	for	for	ADP
ajmsi-1283	126	9	s.	s.	PROPN
ajmsi-1283	126	10	haematobium	haematobium	PROPN
ajmsi-1283	126	11	there	there	PRON
ajmsi-1283	126	12	was	be	VERB
ajmsi-1283	126	13	no	no	DET
ajmsi-1283	126	14	relationship	relationship	NOUN
ajmsi-1283	126	15	between	between	ADP
ajmsi-1283	126	16	age	age	NOUN
ajmsi-1283	126	17	and	and	CCONJ
ajmsi-1283	126	18	the	the	DET
ajmsi-1283	126	19	presence	presence	NOUN
ajmsi-1283	126	20	of	of	ADP
ajmsi-1283	126	21	the	the	DET
ajmsi-1283	126	22	markers	marker	NOUN
ajmsi-1283	126	23	.	.	PUNCT
ajmsi-1283	127	1	though	though	SCONJ
ajmsi-1283	127	2	it	it	PRON
ajmsi-1283	127	3	was	be	AUX
ajmsi-1283	127	4	noted	note	VERB
ajmsi-1283	127	5	that	that	SCONJ
ajmsi-1283	127	6	six	six	NUM
ajmsi-1283	127	7	(	(	PUNCT
ajmsi-1283	127	8	6	6	NUM
ajmsi-1283	127	9	)	)	PUNCT
ajmsi-1283	127	10	individuals	individual	NOUN
ajmsi-1283	127	11	in	in	ADP
ajmsi-1283	127	12	the	the	DET
ajmsi-1283	127	13	age	age	NOUN
ajmsi-1283	127	14	group	group	NOUN
ajmsi-1283	127	15	11	11	NUM
ajmsi-1283	127	16	-	-	SYM
ajmsi-1283	127	17	15	15	NUM
ajmsi-1283	127	18	years	year	NOUN
ajmsi-1283	127	19	who	who	PRON
ajmsi-1283	127	20	were	be	AUX
ajmsi-1283	127	21	positive	positive	ADJ
ajmsi-1283	127	22	for	for	ADP
ajmsi-1283	127	23	s.	s.	PROPN
ajmsi-1283	127	24	haematobium	haematobium	PROPN
ajmsi-1283	127	25	eggs	egg	NOUN
ajmsi-1283	127	26	were	be	AUX
ajmsi-1283	127	27	also	also	ADV
ajmsi-1283	127	28	positive	positive	ADJ
ajmsi-1283	127	29	for	for	ADP
ajmsi-1283	127	30	gapdh	gapdh	NOUN
ajmsi-1283	127	31	while	while	SCONJ
ajmsi-1283	127	32	for	for	ADP
ajmsi-1283	127	33	fgfr3	fgfr3	NOUN
ajmsi-1283	127	34	there	there	PRON
ajmsi-1283	127	35	were	be	VERB
ajmsi-1283	127	36	positive	positive	ADJ
ajmsi-1283	127	37	cases	case	NOUN
ajmsi-1283	127	38	across	across	ADP
ajmsi-1283	127	39	the	the	DET
ajmsi-1283	127	40	different	different	ADJ
ajmsi-1283	127	41	age	age	NOUN
ajmsi-1283	127	42	group	group	NOUN
ajmsi-1283	127	43	represented	represent	VERB
ajmsi-1283	127	44	in	in	ADP
ajmsi-1283	127	45	the	the	DET
ajmsi-1283	127	46	study	study	NOUN
ajmsi-1283	127	47	.	.	PUNCT
ajmsi-1283	128	1	this	this	PRON
ajmsi-1283	128	2	may	may	AUX
ajmsi-1283	128	3	imply	imply	VERB
ajmsi-1283	128	4	that	that	SCONJ
ajmsi-1283	128	5	the	the	DET
ajmsi-1283	128	6	risk	risk	NOUN
ajmsi-1283	128	7	of	of	ADP
ajmsi-1283	128	8	the	the	DET
ajmsi-1283	128	9	development	development	NOUN
ajmsi-1283	128	10	of	of	ADP
ajmsi-1283	128	11	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	128	12	pa	pa	PROPN
ajmsi-1283	128	13	ge	ge	PROPN
ajmsi-1283	128	14	30	30	NUM
ajmsi-1283	128	15	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	128	16	am	be	AUX
ajmsi-1283	128	17	.	.	PUNCT
ajmsi-1283	129	1	j.	j.	PROPN
ajmsi-1283	129	2	med	med	PROPN
ajmsi-1283	129	3	.	.	PUNCT
ajmsi-1283	130	1	sci	sci	PROPN
ajmsi-1283	130	2	.	.	PUNCT
ajmsi-1283	130	3	innov	innov	PROPN
ajmsi-1283	130	4	.	.	PUNCT
ajmsi-1283	131	1	2(1	2(1	NUM
ajmsi-1283	131	2	)	)	PUNCT
ajmsi-1283	131	3	26	26	NUM
ajmsi-1283	131	4	-	-	SYM
ajmsi-1283	131	5	31	31	NUM
ajmsi-1283	131	6	,	,	PUNCT
ajmsi-1283	131	7	2023	2023	NUM
ajmsi-1283	131	8	urogenital	urogenital	ADJ
ajmsi-1283	131	9	cancer	cancer	NOUN
ajmsi-1283	131	10	increases	increase	VERB
ajmsi-1283	131	11	with	with	ADP
ajmsi-1283	131	12	age	age	NOUN
ajmsi-1283	131	13	as	as	SCONJ
ajmsi-1283	131	14	it	it	PRON
ajmsi-1283	131	15	had	have	AUX
ajmsi-1283	131	16	been	be	AUX
ajmsi-1283	131	17	noted	note	VERB
ajmsi-1283	131	18	that	that	SCONJ
ajmsi-1283	131	19	age	age	NOUN
ajmsi-1283	131	20	is	be	AUX
ajmsi-1283	131	21	the	the	DET
ajmsi-1283	131	22	greatest	great	ADJ
ajmsi-1283	131	23	single	single	ADJ
ajmsi-1283	131	24	risk	risk	NOUN
ajmsi-1283	131	25	factor	factor	NOUN
ajmsi-1283	131	26	for	for	ADP
ajmsi-1283	131	27	developing	develop	VERB
ajmsi-1283	131	28	urogenital	urogenital	ADJ
ajmsi-1283	131	29	cancer	cancer	NOUN
ajmsi-1283	131	30	(	(	PUNCT
ajmsi-1283	131	31	shariat	shariat	PROPN
ajmsi-1283	131	32	et	et	PROPN
ajmsi-1283	131	33	al	al	PROPN
ajmsi-1283	131	34	.	.	PROPN
ajmsi-1283	131	35	,	,	PUNCT
ajmsi-1283	131	36	2019	2019	NUM
ajmsi-1283	131	37	)	)	PUNCT
ajmsi-1283	131	38	.	.	PUNCT
ajmsi-1283	132	1	this	this	PRON
ajmsi-1283	132	2	could	could	AUX
ajmsi-1283	132	3	also	also	ADV
ajmsi-1283	132	4	be	be	AUX
ajmsi-1283	132	5	an	an	DET
ajmsi-1283	132	6	indication	indication	NOUN
ajmsi-1283	132	7	that	that	SCONJ
ajmsi-1283	132	8	the	the	DET
ajmsi-1283	132	9	expression	expression	NOUN
ajmsi-1283	132	10	of	of	ADP
ajmsi-1283	132	11	these	these	DET
ajmsi-1283	132	12	markers	marker	NOUN
ajmsi-1283	132	13	is	be	AUX
ajmsi-1283	132	14	more	more	ADV
ajmsi-1283	132	15	represented	represent	VERB
ajmsi-1283	132	16	with	with	ADP
ajmsi-1283	132	17	an	an	DET
ajmsi-1283	132	18	increase	increase	NOUN
ajmsi-1283	132	19	in	in	ADP
ajmsi-1283	132	20	years	year	NOUN
ajmsi-1283	132	21	of	of	ADP
ajmsi-1283	132	22	school	school	NOUN
ajmsi-1283	132	23	children	child	NOUN
ajmsi-1283	132	24	in	in	ADP
ajmsi-1283	132	25	the	the	DET
ajmsi-1283	132	26	sampled	sample	VERB
ajmsi-1283	132	27	communities	community	NOUN
ajmsi-1283	132	28	.	.	PUNCT
ajmsi-1283	133	1	a	a	DET
ajmsi-1283	133	2	study	study	NOUN
ajmsi-1283	133	3	by	by	ADP
ajmsi-1283	133	4	ahmad	ahmad	PROPN
ajmsi-1283	133	5	et	et	PROPN
ajmsi-1283	133	6	al	al	PROPN
ajmsi-1283	133	7	(	(	PUNCT
ajmsi-1283	133	8	2018	2018	NUM
ajmsi-1283	133	9	)	)	PUNCT
ajmsi-1283	133	10	identified	identify	VERB
ajmsi-1283	133	11	that	that	SCONJ
ajmsi-1283	133	12	older	old	ADJ
ajmsi-1283	133	13	age	age	NOUN
ajmsi-1283	133	14	patients	patient	NOUN
ajmsi-1283	133	15	tend	tend	VERB
ajmsi-1283	133	16	to	to	PART
ajmsi-1283	133	17	show	show	VERB
ajmsi-1283	133	18	increased	increase	VERB
ajmsi-1283	133	19	frequency	frequency	NOUN
ajmsi-1283	133	20	of	of	ADP
ajmsi-1283	133	21	fgfr3	fgfr3	NOUN
ajmsi-1283	133	22	mutations	mutation	NOUN
ajmsi-1283	133	23	.	.	PUNCT
ajmsi-1283	134	1	mean	mean	VERB
ajmsi-1283	134	2	fgfr3	fgfr3	NOUN
ajmsi-1283	134	3	and	and	CCONJ
ajmsi-1283	134	4	gapdh	gapdh	NOUN
ajmsi-1283	134	5	od	od	PROPN
ajmsi-1283	134	6	was	be	AUX
ajmsi-1283	134	7	higher	high	ADJ
ajmsi-1283	134	8	in	in	ADP
ajmsi-1283	134	9	females	female	NOUN
ajmsi-1283	134	10	than	than	ADP
ajmsi-1283	134	11	males	male	NOUN
ajmsi-1283	134	12	.	.	PUNCT
ajmsi-1283	135	1	gapdh	gapdh	NOUN
ajmsi-1283	135	2	mean	mean	VERB
ajmsi-1283	135	3	od	od	PROPN
ajmsi-1283	135	4	for	for	ADP
ajmsi-1283	135	5	females	female	NOUN
ajmsi-1283	135	6	was	be	AUX
ajmsi-1283	135	7	0.876	0.876	NUM
ajmsi-1283	135	8	table	table	NOUN
ajmsi-1283	135	9	2	2	NUM
ajmsi-1283	135	10	:	:	PUNCT
ajmsi-1283	135	11	prevalence	prevalence	NOUN
ajmsi-1283	135	12	of	of	ADP
ajmsi-1283	135	13	gapdh	gapdh	NOUN
ajmsi-1283	135	14	and	and	CCONJ
ajmsi-1283	135	15	fgfr3	fgfr3	NOUN
ajmsi-1283	135	16	in	in	ADP
ajmsi-1283	135	17	various	various	ADJ
ajmsi-1283	135	18	age	age	NOUN
ajmsi-1283	135	19	group	group	NOUN
ajmsi-1283	135	20	gapdh	gapdh	NOUN
ajmsi-1283	135	21	fgfr3	fgfr3	PROPN
ajmsi-1283	135	22	age	age	NOUN
ajmsi-1283	135	23	(	(	PUNCT
ajmsi-1283	135	24	years	year	NOUN
ajmsi-1283	135	25	)	)	PUNCT
ajmsi-1283	135	26	total	total	ADJ
ajmsi-1283	135	27	positive	positive	ADJ
ajmsi-1283	135	28	prevalence	prevalence	NOUN
ajmsi-1283	135	29	(	(	PUNCT
ajmsi-1283	135	30	%	%	INTJ
ajmsi-1283	135	31	)	)	PUNCT
ajmsi-1283	135	32	positive	positive	ADJ
ajmsi-1283	135	33	prevalence	prevalence	NOUN
ajmsi-1283	135	34	(	(	PUNCT
ajmsi-1283	135	35	%	%	NOUN
ajmsi-1283	135	36	)	)	PUNCT
ajmsi-1283	135	37	0	0	NUM
ajmsi-1283	135	38	-	-	SYM
ajmsi-1283	135	39	5	5	NUM
ajmsi-1283	135	40	0	0	NUM
ajmsi-1283	135	41	0	0	NUM
ajmsi-1283	135	42	0	0	NUM
ajmsi-1283	135	43	0	0	NUM
ajmsi-1283	135	44	0	0	NUM
ajmsi-1283	135	45	6	6	NUM
ajmsi-1283	135	46	-	-	SYM
ajmsi-1283	135	47	10	10	NUM
ajmsi-1283	135	48	72	72	NUM
ajmsi-1283	135	49	12	12	NUM
ajmsi-1283	135	50	16.67	16.67	NUM
ajmsi-1283	135	51	16	16	NUM
ajmsi-1283	135	52	22.22	22.22	NUM
ajmsi-1283	135	53	11	11	NUM
ajmsi-1283	135	54	-	-	SYM
ajmsi-1283	135	55	15	15	NUM
ajmsi-1283	135	56	83	83	NUM
ajmsi-1283	135	57	6	6	NUM
ajmsi-1283	135	58	7.32	7.32	NUM
ajmsi-1283	135	59	24	24	NUM
ajmsi-1283	135	60	29.27	29.27	NUM
ajmsi-1283	135	61	16	16	NUM
ajmsi-1283	135	62	-	-	SYM
ajmsi-1283	135	63	20	20	NUM
ajmsi-1283	135	64	38	38	NUM
ajmsi-1283	135	65	3	3	NUM
ajmsi-1283	135	66	7.89	7.89	NUM
ajmsi-1283	135	67	10	10	NUM
ajmsi-1283	135	68	26.32	26.32	NUM
ajmsi-1283	135	69	total	total	NOUN
ajmsi-1283	135	70	192	192	NUM
ajmsi-1283	135	71	21	21	NUM
ajmsi-1283	135	72	10.94	10.94	NUM
ajmsi-1283	135	73	50	50	NUM
ajmsi-1283	135	74	26.04	26.04	NUM
ajmsi-1283	135	75	p>0.05	p>0.05	PROPN
ajmsi-1283	135	76	table	table	NOUN
ajmsi-1283	135	77	3	3	NUM
ajmsi-1283	135	78	:	:	PUNCT
ajmsi-1283	135	79	gapdh	gapdh	NOUN
ajmsi-1283	135	80	and	and	CCONJ
ajmsi-1283	135	81	fgfr3	fgfr3	NOUN
ajmsi-1283	135	82	prevalence	prevalence	NOUN
ajmsi-1283	135	83	for	for	ADP
ajmsi-1283	135	84	individuals	individual	NOUN
ajmsi-1283	135	85	positive	positive	ADJ
ajmsi-1283	135	86	for	for	ADP
ajmsi-1283	135	87	s.	s.	PROPN
ajmsi-1283	135	88	haematobium	haematobium	PROPN
ajmsi-1283	135	89	in	in	ADP
ajmsi-1283	135	90	various	various	ADJ
ajmsi-1283	135	91	age	age	NOUN
ajmsi-1283	135	92	group	group	NOUN
ajmsi-1283	135	93	gapdh	gapdh	NOUN
ajmsi-1283	135	94	fgfr3	fgfr3	PROPN
ajmsi-1283	135	95	age	age	NOUN
ajmsi-1283	135	96	(	(	PUNCT
ajmsi-1283	135	97	years	year	NOUN
ajmsi-1283	135	98	)	)	PUNCT
ajmsi-1283	135	99	total	total	ADJ
ajmsi-1283	135	100	positive	positive	ADJ
ajmsi-1283	135	101	prevalence	prevalence	NOUN
ajmsi-1283	135	102	(	(	PUNCT
ajmsi-1283	135	103	%	%	INTJ
ajmsi-1283	135	104	)	)	PUNCT
ajmsi-1283	135	105	positive	positive	ADJ
ajmsi-1283	135	106	prevalence	prevalence	NOUN
ajmsi-1283	135	107	(	(	PUNCT
ajmsi-1283	135	108	%	%	NOUN
ajmsi-1283	135	109	)	)	PUNCT
ajmsi-1283	135	110	0	0	NUM
ajmsi-1283	135	111	-	-	SYM
ajmsi-1283	135	112	5	5	NUM
ajmsi-1283	135	113	0	0	NUM
ajmsi-1283	135	114	0	0	NUM
ajmsi-1283	135	115	0	0	NUM
ajmsi-1283	135	116	0	0	NUM
ajmsi-1283	135	117	0.00	0.00	NUM
ajmsi-1283	135	118	6	6	NUM
ajmsi-1283	135	119	-	-	SYM
ajmsi-1283	135	120	10	10	NUM
ajmsi-1283	135	121	9	9	NUM
ajmsi-1283	135	122	0	0	NUM
ajmsi-1283	135	123	0	0	NUM
ajmsi-1283	135	124	5	5	NUM
ajmsi-1283	135	125	13.89	13.89	NUM
ajmsi-1283	135	126	11	11	NUM
ajmsi-1283	135	127	-	-	SYM
ajmsi-1283	135	128	15	15	NUM
ajmsi-1283	135	129	18	18	NUM
ajmsi-1283	135	130	6	6	NUM
ajmsi-1283	135	131	16.67	16.67	NUM
ajmsi-1283	135	132	5	5	NUM
ajmsi-1283	135	133	13.89	13.89	NUM
ajmsi-1283	135	134	16	16	NUM
ajmsi-1283	135	135	-	-	SYM
ajmsi-1283	135	136	20	20	NUM
ajmsi-1283	135	137	9	9	NUM
ajmsi-1283	135	138	0	0	NUM
ajmsi-1283	135	139	0	0	NUM
ajmsi-1283	135	140	3	3	NUM
ajmsi-1283	135	141	8.33	8.33	NUM
ajmsi-1283	135	142	total	total	NOUN
ajmsi-1283	135	143	36	36	NUM
ajmsi-1283	135	144	6	6	NUM
ajmsi-1283	135	145	16.67	16.67	NUM
ajmsi-1283	135	146	13	13	NUM
ajmsi-1283	135	147	36.11	36.11	NUM
ajmsi-1283	135	148	while	while	SCONJ
ajmsi-1283	135	149	male	male	ADJ
ajmsi-1283	135	150	was	be	AUX
ajmsi-1283	135	151	0.557	0.557	NUM
ajmsi-1283	135	152	.	.	PUNCT
ajmsi-1283	136	1	fgfr3	fgfr3	NOUN
ajmsi-1283	136	2	mean	mean	PROPN
ajmsi-1283	136	3	od	od	PROPN
ajmsi-1283	136	4	for	for	ADP
ajmsi-1283	136	5	females	female	NOUN
ajmsi-1283	136	6	was	be	AUX
ajmsi-1283	136	7	0.866	0.866	NUM
ajmsi-1283	136	8	and	and	CCONJ
ajmsi-1283	136	9	males	male	NOUN
ajmsi-1283	136	10	was	be	AUX
ajmsi-1283	136	11	0.733	0.733	NUM
ajmsi-1283	136	12	.	.	PUNCT
ajmsi-1283	137	1	prevalence	prevalence	NOUN
ajmsi-1283	137	2	of	of	ADP
ajmsi-1283	137	3	gapdh	gapdh	NOUN
ajmsi-1283	137	4	showed	show	VERB
ajmsi-1283	137	5	that	that	SCONJ
ajmsi-1283	137	6	16	16	NUM
ajmsi-1283	137	7	(	(	PUNCT
ajmsi-1283	137	8	14.8	14.8	NUM
ajmsi-1283	137	9	%	%	NOUN
ajmsi-1283	137	10	)	)	PUNCT
ajmsi-1283	137	11	of	of	ADP
ajmsi-1283	137	12	the	the	DET
ajmsi-1283	137	13	108	108	NUM
ajmsi-1283	137	14	females	female	NOUN
ajmsi-1283	137	15	were	be	AUX
ajmsi-1283	137	16	positive	positive	ADJ
ajmsi-1283	137	17	while	while	SCONJ
ajmsi-1283	137	18	5	5	NUM
ajmsi-1283	137	19	(	(	PUNCT
ajmsi-1283	137	20	6.0	6.0	NUM
ajmsi-1283	137	21	%	%	NOUN
ajmsi-1283	137	22	)	)	PUNCT
ajmsi-1283	137	23	of	of	ADP
ajmsi-1283	137	24	84	84	NUM
ajmsi-1283	137	25	males	male	NOUN
ajmsi-1283	137	26	were	be	AUX
ajmsi-1283	137	27	positive	positive	ADJ
ajmsi-1283	137	28	for	for	ADP
ajmsi-1283	137	29	the	the	DET
ajmsi-1283	137	30	marker	marker	NOUN
ajmsi-1283	137	31	.	.	PUNCT
ajmsi-1283	138	1	also	also	ADV
ajmsi-1283	138	2	,	,	PUNCT
ajmsi-1283	138	3	26	26	NUM
ajmsi-1283	138	4	(	(	PUNCT
ajmsi-1283	138	5	24.1	24.1	NUM
ajmsi-1283	138	6	%	%	NOUN
ajmsi-1283	138	7	)	)	PUNCT
ajmsi-1283	138	8	females	female	NOUN
ajmsi-1283	138	9	and	and	CCONJ
ajmsi-1283	138	10	24	24	NUM
ajmsi-1283	138	11	(	(	PUNCT
ajmsi-1283	138	12	28.6	28.6	NUM
ajmsi-1283	138	13	%	%	NOUN
ajmsi-1283	138	14	)	)	PUNCT
ajmsi-1283	138	15	males	male	NOUN
ajmsi-1283	138	16	were	be	AUX
ajmsi-1283	138	17	positive	positive	ADJ
ajmsi-1283	138	18	for	for	ADP
ajmsi-1283	138	19	fgfr3	fgfr3	NOUN
ajmsi-1283	138	20	(	(	PUNCT
ajmsi-1283	138	21	table	table	NOUN
ajmsi-1283	138	22	1	1	NUM
ajmsi-1283	138	23	)	)	PUNCT
ajmsi-1283	138	24	.	.	PUNCT
ajmsi-1283	139	1	more	more	ADJ
ajmsi-1283	139	2	females	female	NOUN
ajmsi-1283	139	3	positive	positive	ADJ
ajmsi-1283	139	4	for	for	ADP
ajmsi-1283	139	5	s.	s.	PROPN
ajmsi-1283	139	6	haematobium	haematobium	PROPN
ajmsi-1283	139	7	were	be	AUX
ajmsi-1283	139	8	also	also	ADV
ajmsi-1283	139	9	positive	positive	ADJ
ajmsi-1283	139	10	for	for	ADP
ajmsi-1283	139	11	gapdh	gapdh	NOUN
ajmsi-1283	139	12	(	(	PUNCT
ajmsi-1283	139	13	11.1	11.1	NUM
ajmsi-1283	139	14	%	%	NOUN
ajmsi-1283	139	15	)	)	PUNCT
ajmsi-1283	139	16	and	and	CCONJ
ajmsi-1283	139	17	fgfr3	fgfr3	NOUN
ajmsi-1283	139	18	(	(	PUNCT
ajmsi-1283	139	19	25	25	NUM
ajmsi-1283	139	20	%	%	NOUN
ajmsi-1283	139	21	)	)	PUNCT
ajmsi-1283	139	22	(	(	PUNCT
ajmsi-1283	139	23	table	table	NOUN
ajmsi-1283	139	24	4	4	NUM
ajmsi-1283	139	25	)	)	PUNCT
ajmsi-1283	139	26	.	.	PUNCT
ajmsi-1283	140	1	fgfr3	fgfr3	NOUN
ajmsi-1283	140	2	and	and	CCONJ
ajmsi-1283	140	3	gapdh	gapdh	NOUN
ajmsi-1283	140	4	marker	marker	NOUN
ajmsi-1283	140	5	prevalence	prevalence	NOUN
ajmsi-1283	140	6	for	for	ADP
ajmsi-1283	140	7	individuals	individual	NOUN
ajmsi-1283	140	8	positive	positive	ADJ
ajmsi-1283	140	9	for	for	ADP
ajmsi-1283	140	10	s.	s.	PROPN
ajmsi-1283	140	11	haematobium	haematobium	PROPN
ajmsi-1283	140	12	is	be	AUX
ajmsi-1283	140	13	25	25	NUM
ajmsi-1283	140	14	%	%	NOUN
ajmsi-1283	140	15	and	and	CCONJ
ajmsi-1283	140	16	16.7	16.7	NUM
ajmsi-1283	140	17	%	%	NOUN
ajmsi-1283	140	18	respectively	respectively	ADV
ajmsi-1283	140	19	.	.	PUNCT
ajmsi-1283	141	1	in	in	ADP
ajmsi-1283	141	2	this	this	DET
ajmsi-1283	141	3	study	study	NOUN
ajmsi-1283	141	4	,	,	PUNCT
ajmsi-1283	141	5	female	female	ADJ
ajmsi-1283	141	6	participants	participant	NOUN
ajmsi-1283	141	7	showed	show	VERB
ajmsi-1283	141	8	higher	high	ADJ
ajmsi-1283	141	9	mean	mean	ADJ
ajmsi-1283	141	10	gapdh	gapdh	NOUN
ajmsi-1283	141	11	and	and	CCONJ
ajmsi-1283	141	12	fgfr3	fgfr3	PROPN
ajmsi-1283	141	13	od	od	INTJ
ajmsi-1283	141	14	than	than	ADP
ajmsi-1283	141	15	male	male	ADJ
ajmsi-1283	141	16	participants	participant	NOUN
ajmsi-1283	141	17	.	.	PUNCT
ajmsi-1283	142	1	also	also	ADV
ajmsi-1283	142	2	,	,	PUNCT
ajmsi-1283	142	3	for	for	ADP
ajmsi-1283	142	4	those	those	PRON
ajmsi-1283	142	5	positive	positive	ADJ
ajmsi-1283	142	6	for	for	ADP
ajmsi-1283	142	7	s.	s.	PROPN
ajmsi-1283	142	8	haematobium	haematobium	PROPN
ajmsi-1283	142	9	there	there	PRON
ajmsi-1283	142	10	were	be	VERB
ajmsi-1283	142	11	more	more	ADJ
ajmsi-1283	142	12	females	female	NOUN
ajmsi-1283	142	13	positive	positive	ADJ
ajmsi-1283	142	14	for	for	ADP
ajmsi-1283	142	15	the	the	DET
ajmsi-1283	142	16	marker	marker	NOUN
ajmsi-1283	142	17	than	than	ADP
ajmsi-1283	142	18	males	male	NOUN
ajmsi-1283	142	19	.	.	PUNCT
ajmsi-1283	143	1	this	this	DET
ajmsi-1283	143	2	occurrence	occurrence	NOUN
ajmsi-1283	143	3	may	may	AUX
ajmsi-1283	143	4	be	be	AUX
ajmsi-1283	143	5	attributed	attribute	VERB
ajmsi-1283	143	6	to	to	ADP
ajmsi-1283	143	7	the	the	DET
ajmsi-1283	143	8	fact	fact	NOUN
ajmsi-1283	143	9	that	that	SCONJ
ajmsi-1283	143	10	they	they	PRON
ajmsi-1283	143	11	are	be	AUX
ajmsi-1283	143	12	the	the	DET
ajmsi-1283	143	13	most	most	ADV
ajmsi-1283	143	14	exposed	expose	VERB
ajmsi-1283	143	15	group	group	NOUN
ajmsi-1283	143	16	since	since	SCONJ
ajmsi-1283	143	17	they	they	PRON
ajmsi-1283	143	18	carry	carry	VERB
ajmsi-1283	143	19	out	out	ADP
ajmsi-1283	143	20	day	day	NOUN
ajmsi-1283	143	21	to	to	ADP
ajmsi-1283	143	22	day	day	NOUN
ajmsi-1283	143	23	activities	activity	NOUN
ajmsi-1283	143	24	in	in	ADP
ajmsi-1283	143	25	potentially	potentially	ADV
ajmsi-1283	143	26	infected	infect	VERB
ajmsi-1283	143	27	s.	s.	PROPN
ajmsi-1283	143	28	haematobium	haematobium	PROPN
ajmsi-1283	143	29	water	water	NOUN
ajmsi-1283	143	30	bodies	body	NOUN
ajmsi-1283	143	31	and	and	CCONJ
ajmsi-1283	143	32	this	this	PRON
ajmsi-1283	143	33	could	could	AUX
ajmsi-1283	143	34	make	make	VERB
ajmsi-1283	143	35	them	they	PRON
ajmsi-1283	143	36	more	more	ADV
ajmsi-1283	143	37	likely	likely	ADJ
ajmsi-1283	143	38	to	to	PART
ajmsi-1283	143	39	present	present	VERB
ajmsi-1283	143	40	with	with	ADP
ajmsi-1283	143	41	the	the	DET
ajmsi-1283	143	42	markers	marker	NOUN
ajmsi-1283	143	43	.	.	PUNCT
ajmsi-1283	144	1	this	this	PRON
ajmsi-1283	144	2	is	be	AUX
ajmsi-1283	144	3	in	in	ADP
ajmsi-1283	144	4	line	line	NOUN
ajmsi-1283	144	5	with	with	ADP
ajmsi-1283	144	6	other	other	ADJ
ajmsi-1283	144	7	studies	study	NOUN
ajmsi-1283	144	8	on	on	ADP
ajmsi-1283	144	9	fgfr3	fgfr3	PROPN
ajmsi-1283	144	10	gene	gene	NOUN
ajmsi-1283	144	11	mutation	mutation	NOUN
ajmsi-1283	144	12	studies	study	NOUN
ajmsi-1283	144	13	that	that	PRON
ajmsi-1283	144	14	identified	identify	VERB
ajmsi-1283	144	15	that	that	SCONJ
ajmsi-1283	144	16	female	female	ADJ
ajmsi-1283	144	17	patients	patient	NOUN
ajmsi-1283	144	18	tend	tend	VERB
ajmsi-1283	144	19	to	to	PART
ajmsi-1283	144	20	show	show	VERB
ajmsi-1283	144	21	increased	increase	VERB
ajmsi-1283	144	22	frequency	frequency	NOUN
ajmsi-1283	144	23	of	of	ADP
ajmsi-1283	144	24	fgfr3	fgfr3	NOUN
ajmsi-1283	144	25	mutations	mutation	NOUN
ajmsi-1283	144	26	(	(	PUNCT
ajmsi-1283	144	27	beukers	beuker	NOUN
ajmsi-1283	144	28	et	et	PROPN
ajmsi-1283	144	29	al	al	PROPN
ajmsi-1283	144	30	.	.	PROPN
ajmsi-1283	144	31	,	,	PUNCT
ajmsi-1283	144	32	2017	2017	NUM
ajmsi-1283	144	33	;	;	PUNCT
ajmsi-1283	144	34	ahmad	ahmad	PROPN
ajmsi-1283	144	35	et	et	PROPN
ajmsi-1283	144	36	al	al	PROPN
ajmsi-1283	144	37	.	.	PROPN
ajmsi-1283	144	38	,	,	PUNCT
ajmsi-1283	144	39	2018	2018	NUM
ajmsi-1283	144	40	)	)	PUNCT
ajmsi-1283	144	41	.	.	PUNCT
ajmsi-1283	145	1	in	in	ADP
ajmsi-1283	145	2	contrast	contrast	NOUN
ajmsi-1283	145	3	,	,	PUNCT
ajmsi-1283	145	4	another	another	DET
ajmsi-1283	145	5	study	study	NOUN
ajmsi-1283	145	6	had	have	AUX
ajmsi-1283	145	7	reported	report	VERB
ajmsi-1283	145	8	that	that	SCONJ
ajmsi-1283	145	9	the	the	DET
ajmsi-1283	145	10	presentation	presentation	NOUN
ajmsi-1283	145	11	of	of	ADP
ajmsi-1283	145	12	this	this	DET
ajmsi-1283	145	13	marker	marker	NOUN
ajmsi-1283	145	14	is	be	AUX
ajmsi-1283	145	15	more	more	ADV
ajmsi-1283	145	16	common	common	ADJ
ajmsi-1283	145	17	in	in	ADP
ajmsi-1283	145	18	male	male	NOUN
ajmsi-1283	145	19	than	than	ADP
ajmsi-1283	145	20	female	female	ADJ
ajmsi-1283	145	21	(	(	PUNCT
ajmsi-1283	145	22	akanksha	akanksha	PROPN
ajmsi-1283	145	23	and	and	CCONJ
ajmsi-1283	145	24	sandhya	sandhya	PROPN
ajmsi-1283	145	25	,	,	PUNCT
ajmsi-1283	145	26	2019	2019	NUM
ajmsi-1283	145	27	)	)	PUNCT
ajmsi-1283	145	28	.	.	PUNCT
ajmsi-1283	146	1	however	however	ADV
ajmsi-1283	146	2	,	,	PUNCT
ajmsi-1283	146	3	table	table	NOUN
ajmsi-1283	146	4	4	4	NUM
ajmsi-1283	146	5	:	:	PUNCT
ajmsi-1283	146	6	gapdh	gapdh	NOUN
ajmsi-1283	146	7	and	and	CCONJ
ajmsi-1283	146	8	fgfr3	fgfr3	NOUN
ajmsi-1283	146	9	prevalence	prevalence	NOUN
ajmsi-1283	146	10	for	for	ADP
ajmsi-1283	146	11	individuals	individual	NOUN
ajmsi-1283	146	12	positive	positive	ADJ
ajmsi-1283	146	13	for	for	ADP
ajmsi-1283	146	14	s.	s.	PROPN
ajmsi-1283	146	15	haematobium	haematobium	PROPN
ajmsi-1283	146	16	in	in	ADP
ajmsi-1283	146	17	various	various	ADJ
ajmsi-1283	146	18	age	age	NOUN
ajmsi-1283	146	19	group	group	NOUN
ajmsi-1283	146	20	gapdh	gapdh	NOUN
ajmsi-1283	146	21	fgfr3	fgfr3	PROPN
ajmsi-1283	146	22	overall	overall	ADJ
ajmsi-1283	146	23	female	female	ADJ
ajmsi-1283	146	24	male	male	NOUN
ajmsi-1283	146	25	overall	overall	ADJ
ajmsi-1283	146	26	female	female	ADJ
ajmsi-1283	146	27	male	male	NOUN
ajmsi-1283	146	28	average	average	NOUN
ajmsi-1283	146	29	od	od	ADP
ajmsi-1283	146	30	0.956	0.956	NUM
ajmsi-1283	146	31	1.155	1.155	NUM
ajmsi-1283	146	32	0.694	0.694	NUM
ajmsi-1283	146	33	0.896	0.896	NUM
ajmsi-1283	146	34	1.018	1.018	NUM
ajmsi-1283	146	35	0.782	0.782	NUM
ajmsi-1283	146	36	maximum	maximum	ADJ
ajmsi-1283	146	37	od	od	ADP
ajmsi-1283	146	38	4.507	4.507	NUM
ajmsi-1283	146	39	4.027	4.027	NUM
ajmsi-1283	146	40	4.507	4.507	NUM
ajmsi-1283	146	41	2.882	2.882	NUM
ajmsi-1283	146	42	2.882	2.882	NUM
ajmsi-1283	146	43	2.26	2.26	NUM
ajmsi-1283	146	44	minimum	minimum	NOUN
ajmsi-1283	146	45	od	od	ADP
ajmsi-1283	146	46	0.119	0.119	NUM
ajmsi-1283	146	47	0.229	0.229	NUM
ajmsi-1283	146	48	0.119	0.119	NUM
ajmsi-1283	146	49	0.28	0.28	NUM
ajmsi-1283	146	50	0.364	0.364	NUM
ajmsi-1283	146	51	0.28	0.28	NUM
ajmsi-1283	146	52	prevalence	prevalence	NOUN
ajmsi-1283	146	53	(	(	PUNCT
ajmsi-1283	146	54	%	%	INTJ
ajmsi-1283	146	55	)	)	PUNCT
ajmsi-1283	146	56	6(16.7	6(16.7	PROPN
ajmsi-1283	146	57	)	)	PUNCT
ajmsi-1283	146	58	4(11.1	4(11.1	NOUN
ajmsi-1283	146	59	)	)	PUNCT
ajmsi-1283	146	60	2(5.6	2(5.6	NUM
ajmsi-1283	146	61	)	)	PUNCT
ajmsi-1283	146	62	13(36.1	13(36.1	NUM
ajmsi-1283	146	63	)	)	PUNCT
ajmsi-1283	146	64	9(25	9(25	NOUN
ajmsi-1283	146	65	)	)	PUNCT
ajmsi-1283	146	66	4(11.1	4(11.1	NOUN
ajmsi-1283	146	67	)	)	PUNCT
ajmsi-1283	146	68	this	this	DET
ajmsi-1283	146	69	study	study	NOUN
ajmsi-1283	146	70	noted	note	VERB
ajmsi-1283	146	71	that	that	SCONJ
ajmsi-1283	146	72	there	there	PRON
ajmsi-1283	146	73	is	be	VERB
ajmsi-1283	146	74	no	no	DET
ajmsi-1283	146	75	relationship	relationship	NOUN
ajmsi-1283	146	76	between	between	ADP
ajmsi-1283	146	77	sex	sex	NOUN
ajmsi-1283	146	78	and	and	CCONJ
ajmsi-1283	146	79	the	the	DET
ajmsi-1283	146	80	presence	presence	NOUN
ajmsi-1283	146	81	of	of	ADP
ajmsi-1283	146	82	the	the	DET
ajmsi-1283	146	83	markers	marker	NOUN
ajmsi-1283	146	84	in	in	ADP
ajmsi-1283	146	85	participants	participant	NOUN
ajmsi-1283	146	86	that	that	PRON
ajmsi-1283	146	87	are	be	AUX
ajmsi-1283	146	88	positive	positive	ADJ
ajmsi-1283	146	89	for	for	ADP
ajmsi-1283	146	90	s.	s.	PROPN
ajmsi-1283	146	91	haematobium	haematobium	PROPN
ajmsi-1283	146	92	.	.	PUNCT
ajmsi-1283	147	1	moreover	moreover	ADV
ajmsi-1283	147	2	,	,	PUNCT
ajmsi-1283	147	3	the	the	DET
ajmsi-1283	147	4	international	international	ADJ
ajmsi-1283	147	5	agency	agency	NOUN
ajmsi-1283	147	6	for	for	ADP
ajmsi-1283	147	7	research	research	NOUN
ajmsi-1283	147	8	on	on	ADP
ajmsi-1283	147	9	cancer	cancer	NOUN
ajmsi-1283	147	10	has	have	AUX
ajmsi-1283	147	11	stated	state	VERB
ajmsi-1283	147	12	that	that	SCONJ
ajmsi-1283	147	13	bladder	bladder	NOUN
ajmsi-1283	147	14	cancer	cancer	NOUN
ajmsi-1283	147	15	could	could	AUX
ajmsi-1283	147	16	be	be	AUX
ajmsi-1283	147	17	associated	associate	VERB
ajmsi-1283	147	18	with	with	ADP
ajmsi-1283	147	19	the	the	DET
ajmsi-1283	147	20	profession	profession	NOUN
ajmsi-1283	147	21	of	of	ADP
ajmsi-1283	147	22	an	an	DET
ajmsi-1283	147	23	individual	individual	NOUN
ajmsi-1283	147	24	and	and	CCONJ
ajmsi-1283	147	25	is	be	AUX
ajmsi-1283	147	26	more	more	ADV
ajmsi-1283	147	27	related	related	ADJ
ajmsi-1283	147	28	to	to	ADP
ajmsi-1283	147	29	agricultural	agricultural	ADJ
ajmsi-1283	147	30	farmer	farmer	NOUN
ajmsi-1283	147	31	(	(	PUNCT
ajmsi-1283	147	32	iarc	iarc	NOUN
ajmsi-1283	147	33	,	,	PUNCT
ajmsi-1283	147	34	2012	2012	NUM
ajmsi-1283	147	35	)	)	PUNCT
ajmsi-1283	147	36	because	because	SCONJ
ajmsi-1283	147	37	of	of	ADP
ajmsi-1283	147	38	their	their	PRON
ajmsi-1283	147	39	contact	contact	NOUN
ajmsi-1283	147	40	with	with	ADP
ajmsi-1283	147	41	infected	infected	ADJ
ajmsi-1283	147	42	water	water	NOUN
ajmsi-1283	147	43	.	.	PUNCT
ajmsi-1283	148	1	conclusions	conclusion	NOUN
ajmsi-1283	148	2	the	the	DET
ajmsi-1283	148	3	study	study	NOUN
ajmsi-1283	148	4	has	have	AUX
ajmsi-1283	148	5	produced	produce	VERB
ajmsi-1283	148	6	evidence	evidence	NOUN
ajmsi-1283	148	7	showing	show	VERB
ajmsi-1283	148	8	that	that	SCONJ
ajmsi-1283	148	9	there	there	PRON
ajmsi-1283	148	10	are	be	VERB
ajmsi-1283	148	11	children	child	NOUN
ajmsi-1283	148	12	that	that	PRON
ajmsi-1283	148	13	are	be	AUX
ajmsi-1283	148	14	positive	positive	ADJ
ajmsi-1283	148	15	for	for	ADP
ajmsi-1283	148	16	the	the	DET
ajmsi-1283	148	17	cancer	cancer	NOUN
ajmsi-1283	148	18	genetic	genetic	ADJ
ajmsi-1283	148	19	markers	marker	NOUN
ajmsi-1283	148	20	fgfr3	fgfr3	NOUN
ajmsi-1283	148	21	and	and	CCONJ
ajmsi-1283	148	22	gapdh	gapdh	NOUN
ajmsi-1283	148	23	with	with	ADP
ajmsi-1283	148	24	more	more	ADJ
ajmsi-1283	148	25	females	female	NOUN
ajmsi-1283	148	26	being	be	AUX
ajmsi-1283	148	27	positive	positive	ADJ
ajmsi-1283	148	28	for	for	ADP
ajmsi-1283	148	29	the	the	DET
ajmsi-1283	148	30	markers	marker	NOUN
ajmsi-1283	148	31	.	.	PUNCT
ajmsi-1283	149	1	the	the	DET
ajmsi-1283	149	2	presence	presence	NOUN
ajmsi-1283	149	3	of	of	ADP
ajmsi-1283	149	4	these	these	DET
ajmsi-1283	149	5	markers	marker	NOUN
ajmsi-1283	149	6	are	be	AUX
ajmsi-1283	149	7	an	an	DET
ajmsi-1283	149	8	indicator	indicator	NOUN
ajmsi-1283	149	9	that	that	SCONJ
ajmsi-1283	149	10	children	child	NOUN
ajmsi-1283	149	11	in	in	ADP
ajmsi-1283	149	12	the	the	DET
ajmsi-1283	149	13	selected	select	VERB
ajmsi-1283	149	14	communities	community	NOUN
ajmsi-1283	149	15	maybe	maybe	ADV
ajmsi-1283	149	16	at	at	ADP
ajmsi-1283	149	17	risk	risk	NOUN
ajmsi-1283	149	18	of	of	ADP
ajmsi-1283	149	19	developing	develop	VERB
ajmsi-1283	149	20	bladder	bladder	NOUN
ajmsi-1283	149	21	cancer	cancer	NOUN
ajmsi-1283	149	22	in	in	ADP
ajmsi-1283	149	23	the	the	DET
ajmsi-1283	149	24	future	future	ADJ
ajmsi-1283	149	25	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	149	26	pa	pa	PROPN
ajmsi-1283	149	27	ge	ge	PROPN
ajmsi-1283	149	28	31	31	NUM
ajmsi-1283	149	29	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	149	30	am	be	AUX
ajmsi-1283	149	31	.	.	PUNCT
ajmsi-1283	150	1	j.	j.	PROPN
ajmsi-1283	150	2	med	med	PROPN
ajmsi-1283	150	3	.	.	PUNCT
ajmsi-1283	151	1	sci	sci	PROPN
ajmsi-1283	151	2	.	.	PUNCT
ajmsi-1283	151	3	innov	innov	PROPN
ajmsi-1283	151	4	.	.	PUNCT
ajmsi-1283	152	1	2(1	2(1	NUM
ajmsi-1283	152	2	)	)	PUNCT
ajmsi-1283	152	3	26	26	NUM
ajmsi-1283	152	4	-	-	SYM
ajmsi-1283	152	5	31	31	NUM
ajmsi-1283	152	6	,	,	PUNCT
ajmsi-1283	152	7	2023	2023	NUM
ajmsi-1283	152	8	if	if	SCONJ
ajmsi-1283	152	9	the	the	DET
ajmsi-1283	152	10	disease	disease	NOUN
ajmsi-1283	152	11	is	be	AUX
ajmsi-1283	152	12	not	not	PART
ajmsi-1283	152	13	properly	properly	ADV
ajmsi-1283	152	14	managed	manage	VERB
ajmsi-1283	152	15	and	and	CCONJ
ajmsi-1283	152	16	controlled	control	VERB
ajmsi-1283	152	17	.	.	PUNCT
ajmsi-1283	153	1	also	also	ADV
ajmsi-1283	153	2	,	,	PUNCT
ajmsi-1283	153	3	there	there	PRON
ajmsi-1283	153	4	is	be	VERB
ajmsi-1283	153	5	need	need	NOUN
ajmsi-1283	153	6	for	for	ADP
ajmsi-1283	153	7	more	more	ADJ
ajmsi-1283	153	8	studies	study	NOUN
ajmsi-1283	153	9	on	on	ADP
ajmsi-1283	153	10	these	these	DET
ajmsi-1283	153	11	identified	identify	VERB
ajmsi-1283	153	12	immune	immune	ADJ
ajmsi-1283	153	13	markers	marker	NOUN
ajmsi-1283	153	14	which	which	PRON
ajmsi-1283	153	15	may	may	AUX
ajmsi-1283	153	16	serve	serve	VERB
ajmsi-1283	153	17	as	as	ADP
ajmsi-1283	153	18	prognostic	prognostic	ADJ
ajmsi-1283	153	19	markers	marker	NOUN
ajmsi-1283	153	20	for	for	ADP
ajmsi-1283	153	21	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	153	22	progression	progression	NOUN
ajmsi-1283	153	23	or	or	CCONJ
ajmsi-1283	153	24	urogenital	urogenital	ADJ
ajmsi-1283	153	25	cancer	cancer	NOUN
ajmsi-1283	153	26	development	development	NOUN
ajmsi-1283	153	27	in	in	ADP
ajmsi-1283	153	28	at	at	ADP
ajmsi-1283	153	29	risk	risk	NOUN
ajmsi-1283	153	30	population	population	NOUN
ajmsi-1283	153	31	.	.	PUNCT
ajmsi-1283	154	1	this	this	DET
ajmsi-1283	154	2	study	study	NOUN
ajmsi-1283	154	3	has	have	VERB
ajmsi-1283	154	4	potential	potential	ADJ
ajmsi-1283	154	5	limitations	limitation	NOUN
ajmsi-1283	154	6	.	.	PUNCT
ajmsi-1283	155	1	this	this	DET
ajmsi-1283	155	2	study	study	NOUN
ajmsi-1283	155	3	does	do	AUX
ajmsi-1283	155	4	not	not	PART
ajmsi-1283	155	5	have	have	VERB
ajmsi-1283	155	6	age	age	NOUN
ajmsi-1283	155	7	representation	representation	NOUN
ajmsi-1283	155	8	for	for	ADP
ajmsi-1283	155	9	children	child	NOUN
ajmsi-1283	155	10	0	0	NUM
ajmsi-1283	155	11	-	-	SYM
ajmsi-1283	155	12	5	5	NUM
ajmsi-1283	155	13	years	year	NOUN
ajmsi-1283	155	14	.	.	PUNCT
ajmsi-1283	156	1	though	though	ADV
ajmsi-1283	156	2	,	,	PUNCT
ajmsi-1283	156	3	this	this	PRON
ajmsi-1283	156	4	has	have	VERB
ajmsi-1283	156	5	no	no	DET
ajmsi-1283	156	6	direct	direct	ADJ
ajmsi-1283	156	7	impact	impact	NOUN
ajmsi-1283	156	8	on	on	ADP
ajmsi-1283	156	9	the	the	DET
ajmsi-1283	156	10	result	result	NOUN
ajmsi-1283	156	11	of	of	ADP
ajmsi-1283	156	12	the	the	DET
ajmsi-1283	156	13	findings	finding	NOUN
ajmsi-1283	156	14	for	for	ADP
ajmsi-1283	156	15	the	the	DET
ajmsi-1283	156	16	other	other	ADJ
ajmsi-1283	156	17	age	age	NOUN
ajmsi-1283	156	18	groups	group	NOUN
ajmsi-1283	156	19	represented	represent	VERB
ajmsi-1283	156	20	.	.	PUNCT
ajmsi-1283	157	1	however	however	ADV
ajmsi-1283	157	2	,	,	PUNCT
ajmsi-1283	157	3	further	further	ADJ
ajmsi-1283	157	4	research	research	NOUN
ajmsi-1283	157	5	can	can	AUX
ajmsi-1283	157	6	be	be	AUX
ajmsi-1283	157	7	done	do	VERB
ajmsi-1283	157	8	to	to	PART
ajmsi-1283	157	9	include	include	VERB
ajmsi-1283	157	10	the	the	DET
ajmsi-1283	157	11	age	age	NOUN
ajmsi-1283	157	12	group	group	NOUN
ajmsi-1283	157	13	0	0	NUM
ajmsi-1283	157	14	-	-	SYM
ajmsi-1283	157	15	5years	5years	NUM
ajmsi-1283	157	16	to	to	PART
ajmsi-1283	157	17	ascertain	ascertain	VERB
ajmsi-1283	157	18	the	the	DET
ajmsi-1283	157	19	representation	representation	NOUN
ajmsi-1283	157	20	of	of	ADP
ajmsi-1283	157	21	the	the	DET
ajmsi-1283	157	22	cancer	cancer	NOUN
ajmsi-1283	157	23	genetic	genetic	ADJ
ajmsi-1283	157	24	markers	marker	NOUN
ajmsi-1283	157	25	of	of	ADP
ajmsi-1283	157	26	the	the	DET
ajmsi-1283	157	27	group	group	NOUN
ajmsi-1283	157	28	.	.	PUNCT
ajmsi-1283	158	1	also	also	ADV
ajmsi-1283	158	2	,	,	PUNCT
ajmsi-1283	158	3	determining	determine	VERB
ajmsi-1283	158	4	the	the	DET
ajmsi-1283	158	5	marker	marker	NOUN
ajmsi-1283	158	6	concentration	concentration	NOUN
ajmsi-1283	158	7	using	use	VERB
ajmsi-1283	158	8	a	a	DET
ajmsi-1283	158	9	standard	standard	ADJ
ajmsi-1283	158	10	curve	curve	NOUN
ajmsi-1283	158	11	will	will	AUX
ajmsi-1283	158	12	help	help	VERB
ajmsi-1283	158	13	elucidate	elucidate	VERB
ajmsi-1283	158	14	more	more	ADV
ajmsi-1283	158	15	on	on	ADP
ajmsi-1283	158	16	the	the	DET
ajmsi-1283	158	17	relationship	relationship	NOUN
ajmsi-1283	158	18	between	between	ADP
ajmsi-1283	158	19	concentration	concentration	NOUN
ajmsi-1283	158	20	and	and	CCONJ
ajmsi-1283	158	21	the	the	DET
ajmsi-1283	158	22	different	different	ADJ
ajmsi-1283	158	23	categories	category	NOUN
ajmsi-1283	158	24	assayed	assay	VERB
ajmsi-1283	158	25	in	in	ADP
ajmsi-1283	158	26	this	this	DET
ajmsi-1283	158	27	study	study	NOUN
ajmsi-1283	158	28	.	.	PUNCT
ajmsi-1283	159	1	references	reference	NOUN
ajmsi-1283	159	2	ahmad	ahmad	PROPN
ajmsi-1283	159	3	,	,	PUNCT
ajmsi-1283	159	4	f.	f.	PROPN
ajmsi-1283	159	5	,	,	PUNCT
ajmsi-1283	159	6	mahal	mahal	PROPN
ajmsi-1283	159	7	,	,	PUNCT
ajmsi-1283	159	8	v.	v.	PROPN
ajmsi-1283	159	9	,	,	PUNCT
ajmsi-1283	159	10	verma	verma	PROPN
ajmsi-1283	159	11	,	,	PUNCT
ajmsi-1283	159	12	g.	g.	PROPN
ajmsi-1283	159	13	,	,	PUNCT
ajmsi-1283	159	14	bhatia	bhatia	PROPN
ajmsi-1283	159	15	,	,	PUNCT
ajmsi-1283	159	16	s.	s.	PROPN
ajmsi-1283	159	17	,	,	PUNCT
ajmsi-1283	159	18	and	and	CCONJ
ajmsi-1283	159	19	das	das	PROPN
ajmsi-1283	159	20	,	,	PUNCT
ajmsi-1283	159	21	b.r	b.r	PROPN
ajmsi-1283	159	22	.	.	PROPN
ajmsi-1283	159	23	(	(	PUNCT
ajmsi-1283	159	24	2018	2018	NUM
ajmsi-1283	159	25	)	)	PUNCT
ajmsi-1283	159	26	.	.	PUNCT
ajmsi-1283	160	1	molecular	molecular	ADJ
ajmsi-1283	160	2	investigation	investigation	NOUN
ajmsi-1283	160	3	of	of	ADP
ajmsi-1283	160	4	fgfr3	fgfr3	PROPN
ajmsi-1283	160	5	gene	gene	NOUN
ajmsi-1283	160	6	mutation	mutation	NOUN
ajmsi-1283	160	7	and	and	CCONJ
ajmsi-1283	160	8	its	its	PRON
ajmsi-1283	160	9	correlation	correlation	NOUN
ajmsi-1283	160	10	with	with	ADP
ajmsi-1283	160	11	clinicopathological	clinicopathological	ADJ
ajmsi-1283	160	12	findings	finding	NOUN
ajmsi-1283	160	13	in	in	ADP
ajmsi-1283	160	14	indian	indian	ADJ
ajmsi-1283	160	15	bladder	bladder	NOUN
ajmsi-1283	160	16	cancer	cancer	NOUN
ajmsi-1283	160	17	patients	patient	NOUN
ajmsi-1283	160	18	.	.	PUNCT
ajmsi-1283	161	1	cancer	cancer	NOUN
ajmsi-1283	161	2	reports	report	NOUN
ajmsi-1283	161	3	,	,	PUNCT
ajmsi-1283	161	4	1(3	1(3	NUM
ajmsi-1283	161	5	)	)	PUNCT
ajmsi-1283	161	6	,	,	PUNCT
ajmsi-1283	161	7	e1130	e1130	NOUN
ajmsi-1283	161	8	.	.	PUNCT
ajmsi-1283	162	1	akanksha	akanksha	PROPN
ajmsi-1283	162	2	,	,	PUNCT
ajmsi-1283	162	3	m.	m.	NOUN
ajmsi-1283	162	4	,	,	PUNCT
ajmsi-1283	162	5	and	and	CCONJ
ajmsi-1283	162	6	sandhya	sandhya	PROPN
ajmsi-1283	162	7	,	,	PUNCT
ajmsi-1283	162	8	s.	s.	PROPN
ajmsi-1283	162	9	(	(	PUNCT
ajmsi-1283	162	10	2019	2019	NUM
ajmsi-1283	162	11	)	)	PUNCT
ajmsi-1283	162	12	.	.	PUNCT
ajmsi-1283	163	1	role	role	NOUN
ajmsi-1283	163	2	of	of	ADP
ajmsi-1283	163	3	fgfr3	fgfr3	NOUN
ajmsi-1283	163	4	in	in	ADP
ajmsi-1283	163	5	urothelial	urothelial	ADJ
ajmsi-1283	163	6	carcinoma	carcinoma	NOUN
ajmsi-1283	163	7	.	.	PUNCT
ajmsi-1283	164	1	iranian	iranian	ADJ
ajmsi-1283	164	2	journal	journal	PROPN
ajmsi-1283	164	3	of	of	ADP
ajmsi-1283	164	4	pathology	pathology	PROPN
ajmsi-1283	164	5	,	,	PUNCT
ajmsi-1283	164	6	14	14	NUM
ajmsi-1283	164	7	,	,	PUNCT
ajmsi-1283	164	8	148–155	148–155	NUM
ajmsi-1283	164	9	.	.	PROPN
ajmsi-1283	164	10	altenberg	altenberg	PROPN
ajmsi-1283	164	11	,	,	PUNCT
ajmsi-1283	164	12	b.	b.	PROPN
ajmsi-1283	164	13	,	,	PUNCT
ajmsi-1283	164	14	and	and	CCONJ
ajmsi-1283	164	15	greulich	greulich	PROPN
ajmsi-1283	164	16	,	,	PUNCT
ajmsi-1283	164	17	k.o	k.o	PROPN
ajmsi-1283	164	18	.	.	PUNCT
ajmsi-1283	164	19	(	(	PUNCT
ajmsi-1283	164	20	2004	2004	NUM
ajmsi-1283	164	21	)	)	PUNCT
ajmsi-1283	164	22	.	.	PUNCT
ajmsi-1283	165	1	genes	gene	NOUN
ajmsi-1283	165	2	of	of	ADP
ajmsi-1283	165	3	glycolysis	glycolysis	NOUN
ajmsi-1283	165	4	are	be	AUX
ajmsi-1283	165	5	ubiquitously	ubiquitously	ADV
ajmsi-1283	165	6	overexpressed	overexpresse	VERB
ajmsi-1283	165	7	in	in	ADP
ajmsi-1283	165	8	24	24	NUM
ajmsi-1283	165	9	cancer	cancer	NOUN
ajmsi-1283	165	10	classes	class	NOUN
ajmsi-1283	165	11	.	.	PUNCT
ajmsi-1283	166	1	genomics	genomic	NOUN
ajmsi-1283	166	2	,	,	PUNCT
ajmsi-1283	166	3	84	84	NUM
ajmsi-1283	166	4	,	,	PUNCT
ajmsi-1283	166	5	1014	1014	NUM
ajmsi-1283	166	6	-	-	SYM
ajmsi-1283	166	7	1020	1020	NUM
ajmsi-1283	166	8	.	.	PUNCT
ajmsi-1283	167	1	barosum	barosum	PROPN
ajmsi-1283	167	2	,	,	PUNCT
ajmsi-1283	167	3	r.s	r.s	PROPN
ajmsi-1283	167	4	.	.	PROPN
ajmsi-1283	167	5	(	(	PUNCT
ajmsi-1283	167	6	2021	2021	NUM
ajmsi-1283	167	7	)	)	PUNCT
ajmsi-1283	167	8	.	.	PUNCT
ajmsi-1283	168	1	the	the	DET
ajmsi-1283	168	2	kidney	kidney	NOUN
ajmsi-1283	168	3	in	in	ADP
ajmsi-1283	168	4	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	168	5	:	:	PUNCT
ajmsi-1283	168	6	chapter	chapter	NOUN
ajmsi-1283	168	7	56	56	NUM
ajmsi-1283	168	8	.	.	PUNCT
ajmsi-1283	168	9	retrieved	retrieve	VERB
ajmsi-1283	168	10	on	on	ADP
ajmsi-1283	168	11	may	may	PROPN
ajmsi-1283	168	12	01	01	NUM
ajmsi-1283	168	13	,	,	PUNCT
ajmsi-1283	168	14	2021	2021	NUM
ajmsi-1283	168	15	.	.	PUNCT
ajmsi-1283	169	1	https://	https://	PROPN
ajmsi-1283	169	2	abdominalkey.com/the-kidney-in-schistosomiasis/	abdominalkey.com/the-kidney-in-schistosomiasis/	PART
ajmsi-1283	169	3	beukers	beuker	NOUN
ajmsi-1283	169	4	,	,	PUNCT
ajmsi-1283	169	5	w.	w.	PROPN
ajmsi-1283	169	6	,	,	PUNCT
ajmsi-1283	169	7	van	van	PROPN
ajmsi-1283	169	8	der	der	PROPN
ajmsi-1283	169	9	keur	keur	PROPN
ajmsi-1283	169	10	,	,	PUNCT
ajmsi-1283	169	11	k.a	k.a	PROPN
ajmsi-1283	169	12	.	.	PROPN
ajmsi-1283	169	13	,	,	PUNCT
ajmsi-1283	169	14	kandimalla	kandimalla	PROPN
ajmsi-1283	169	15	,	,	PUNCT
ajmsi-1283	169	16	r.	r.	PROPN
ajmsi-1283	169	17	,vergouwe	,vergouwe	PROPN
ajmsi-1283	169	18	,	,	PUNCT
ajmsi-1283	169	19	y.	y.	PROPN
ajmsi-1283	169	20	,	,	PUNCT
ajmsi-1283	169	21	steyerberg	steyerberg	PROPN
ajmsi-1283	169	22	,	,	PUNCT
ajmsi-1283	169	23	e.w	e.w	PROPN
ajmsi-1283	169	24	.	.	PROPN
ajmsi-1283	169	25	,	,	PUNCT
ajmsi-1283	169	26	boormans	boorman	NOUN
ajmsi-1283	169	27	,	,	PUNCT
ajmsi-1283	169	28	j.l	j.l	PROPN
ajmsi-1283	169	29	.	.	PROPN
ajmsi-1283	169	30	,	,	PUNCT
ajmsi-1283	169	31	jensen	jensen	PROPN
ajmsi-1283	169	32	,	,	PUNCT
ajmsi-1283	169	33	j.b.lorente	j.b.lorente	PROPN
ajmsi-1283	169	34	,	,	PUNCT
ajmsi-1283	169	35	j.a	j.a	PROPN
ajmsi-1283	169	36	.	.	PROPN
ajmsi-1283	169	37	,	,	PUNCT
ajmsi-1283	169	38	real	real	ADJ
ajmsi-1283	169	39	,	,	PUNCT
ajmsi-1283	169	40	f.x	f.x	PROPN
ajmsi-1283	169	41	.	.	PROPN
ajmsi-1283	169	42	,	,	PUNCT
ajmsi-1283	169	43	segersten	segersten	PROPN
ajmsi-1283	169	44	,	,	PUNCT
ajmsi-1283	169	45	u.	u.	PROPN
ajmsi-1283	169	46	,	,	PUNCT
ajmsi-1283	169	47	orntoft	orntoft	PROPN
ajmsi-1283	169	48	,	,	PUNCT
ajmsi-1283	169	49	t.f	t.f	PROPN
ajmsi-1283	169	50	.	.	PROPN
ajmsi-1283	169	51	,	,	PUNCT
ajmsi-1283	169	52	malats	malat	NOUN
ajmsi-1283	169	53	,	,	PUNCT
ajmsi-1283	169	54	n.	n.	NOUN
ajmsi-1283	169	55	,	,	PUNCT
ajmsi-1283	169	56	malmström	malmström	NOUN
ajmsi-1283	169	57	,	,	PUNCT
ajmsi-1283	169	58	p	p	PROPN
ajmsi-1283	169	59	-	-	PUNCT
ajmsi-1283	169	60	u.	u.	NOUN
ajmsi-1283	169	61	,	,	PUNCT
ajmsi-1283	169	62	dyrskjot	dyrskjot	PROPN
ajmsi-1283	169	63	l.	l.	PROPN
ajmsi-1283	169	64	and	and	CCONJ
ajmsi-1283	169	65	zwarthoff	zwarthoff	PROPN
ajmsi-1283	169	66	,	,	PUNCT
ajmsi-1283	169	67	e.c	e.c	PROPN
ajmsi-1283	169	68	.	.	PROPN
ajmsi-1283	169	69	(	(	PUNCT
ajmsi-1283	169	70	2017	2017	NUM
ajmsi-1283	169	71	)	)	PUNCT
ajmsi-1283	169	72	.	.	PUNCT
ajmsi-1283	170	1	fgfr3	fgfr3	PROPN
ajmsi-1283	170	2	,	,	PUNCT
ajmsi-1283	170	3	tert	tert	NOUN
ajmsi-1283	170	4	and	and	CCONJ
ajmsi-1283	170	5	otx1	otx1	NOUN
ajmsi-1283	170	6	as	as	ADP
ajmsi-1283	170	7	a	a	DET
ajmsi-1283	170	8	urinary	urinary	ADJ
ajmsi-1283	170	9	biomarker	biomarker	NOUN
ajmsi-1283	170	10	combination	combination	NOUN
ajmsi-1283	170	11	for	for	ADP
ajmsi-1283	170	12	surveillance	surveillance	NOUN
ajmsi-1283	170	13	of	of	ADP
ajmsi-1283	170	14	patients	patient	NOUN
ajmsi-1283	170	15	with	with	ADP
ajmsi-1283	170	16	bladder	bladder	NOUN
ajmsi-1283	170	17	cancer	cancer	NOUN
ajmsi-1283	170	18	in	in	ADP
ajmsi-1283	170	19	a	a	DET
ajmsi-1283	170	20	large	large	ADJ
ajmsi-1283	170	21	prospective	prospective	ADJ
ajmsi-1283	170	22	multicenter	multicenter	NOUN
ajmsi-1283	170	23	study	study	NOUN
ajmsi-1283	170	24	.	.	PUNCT
ajmsi-1283	171	1	journal	journal	PROPN
ajmsi-1283	171	2	of	of	ADP
ajmsi-1283	171	3	urology	urology	NOUN
ajmsi-1283	171	4	,	,	PUNCT
ajmsi-1283	171	5	197(6),14101418	197(6),14101418	PROPN
ajmsi-1283	171	6	.	.	PUNCT
ajmsi-1283	172	1	brooks	brooks	PROPN
ajmsi-1283	172	2	,	,	PUNCT
ajmsi-1283	172	3	g.f	g.f	PROPN
ajmsi-1283	172	4	.	.	PROPN
ajmsi-1283	172	5	,	,	PUNCT
ajmsi-1283	172	6	carroll	carroll	PROPN
ajmsi-1283	172	7	,	,	PUNCT
ajmsi-1283	172	8	k.c	k.c	PROPN
ajmsi-1283	172	9	.	.	PROPN
ajmsi-1283	172	10	,	,	PUNCT
ajmsi-1283	172	11	butel	butel	NOUN
ajmsi-1283	172	12	,	,	PUNCT
ajmsi-1283	172	13	j.s	j.s	PROPN
ajmsi-1283	172	14	.	.	PROPN
ajmsi-1283	172	15	,	,	PUNCT
ajmsi-1283	172	16	morse	morse	PROPN
ajmsi-1283	172	17	,	,	PUNCT
ajmsi-1283	172	18	s.a	s.a	PROPN
ajmsi-1283	172	19	.	.	PROPN
ajmsi-1283	172	20	,	,	PUNCT
ajmsi-1283	172	21	mietzner	mietzner	NOUN
ajmsi-1283	172	22	.	.	PUNCT
ajmsi-1283	173	1	t.a	t.a	PROPN
ajmsi-1283	173	2	.	.	PROPN
ajmsi-1283	173	3	,	,	PUNCT
ajmsi-1283	173	4	(	(	PUNCT
ajmsi-1283	173	5	2010	2010	NUM
ajmsi-1283	173	6	)	)	PUNCT
ajmsi-1283	173	7	.	.	PUNCT
ajmsi-1283	174	1	jawetz	jawetz	ADJ
ajmsi-1283	174	2	,	,	PUNCT
ajmsi-1283	174	3	melnick	melnick	PROPN
ajmsi-1283	174	4	&	&	CCONJ
ajmsi-1283	174	5	adelberg	adelberg	PROPN
ajmsi-1283	174	6	’s	’s	PART
ajmsi-1283	174	7	medical	medical	ADJ
ajmsi-1283	174	8	microbiology	microbiology	NOUN
ajmsi-1283	174	9	(	(	PUNCT
ajmsi-1283	174	10	25th	25th	NOUN
ajmsi-1283	174	11	edition	edition	NOUN
ajmsi-1283	174	12	)	)	PUNCT
ajmsi-1283	174	13	.	.	PUNCT
ajmsi-1283	175	1	mcgraw	mcgraw	PROPN
ajmsi-1283	175	2	hill	hill	PROPN
ajmsi-1283	175	3	,	,	PUNCT
ajmsi-1283	175	4	new	new	PROPN
ajmsi-1283	175	5	york	york	PROPN
ajmsi-1283	175	6	.	.	PUNCT
ajmsi-1283	176	1	bundy	bundy	PROPN
ajmsi-1283	176	2	,	,	PUNCT
ajmsi-1283	176	3	d.a.p	d.a.p	NOUN
ajmsi-1283	176	4	.	.	PROPN
ajmsi-1283	176	5	,	,	PUNCT
ajmsi-1283	176	6	walson	walson	PROPN
ajmsi-1283	176	7	,	,	PUNCT
ajmsi-1283	176	8	j.l	j.l	PROPN
ajmsi-1283	176	9	.	.	PROPN
ajmsi-1283	176	10	and	and	CCONJ
ajmsi-1283	176	11	watkins	watkins	PROPN
ajmsi-1283	176	12	,	,	PUNCT
ajmsi-1283	176	13	k.l	k.l	PROPN
ajmsi-1283	176	14	.	.	PROPN
ajmsi-1283	176	15	(	(	PUNCT
ajmsi-1283	176	16	2013	2013	NUM
ajmsi-1283	176	17	)	)	PUNCT
ajmsi-1283	176	18	.	.	PUNCT
ajmsi-1283	177	1	worms	worm	NOUN
ajmsi-1283	177	2	,	,	PUNCT
ajmsi-1283	177	3	wisdom	wisdom	NOUN
ajmsi-1283	177	4	,	,	PUNCT
ajmsi-1283	177	5	and	and	CCONJ
ajmsi-1283	177	6	wealth	wealth	NOUN
ajmsi-1283	177	7	:	:	PUNCT
ajmsi-1283	177	8	why	why	SCONJ
ajmsi-1283	177	9	deworming	deworming	NOUN
ajmsi-1283	177	10	can	can	AUX
ajmsi-1283	177	11	make	make	VERB
ajmsi-1283	177	12	economic	economic	ADJ
ajmsi-1283	177	13	sense	sense	NOUN
ajmsi-1283	177	14	.	.	PUNCT
ajmsi-1283	178	1	trends	trend	NOUN
ajmsi-1283	178	2	in	in	ADP
ajmsi-1283	178	3	parasitolology	parasitolology	NOUN
ajmsi-1283	178	4	,	,	PUNCT
ajmsi-1283	178	5	29	29	NUM
ajmsi-1283	178	6	,	,	PUNCT
ajmsi-1283	178	7	142148	142148	NUM
ajmsi-1283	178	8	.	.	PUNCT
ajmsi-1283	179	1	cheesbrough	cheesbrough	NOUN
ajmsi-1283	179	2	m.	m.	NOUN
ajmsi-1283	179	3	(	(	PUNCT
ajmsi-1283	179	4	2009	2009	NUM
ajmsi-1283	179	5	)	)	PUNCT
ajmsi-1283	179	6	.	.	PUNCT
ajmsi-1283	180	1	district	district	NOUN
ajmsi-1283	180	2	laboratory	laboratory	NOUN
ajmsi-1283	180	3	practice	practice	NOUN
ajmsi-1283	180	4	in	in	ADP
ajmsi-1283	180	5	tropical	tropical	ADJ
ajmsi-1283	180	6	countries	country	NOUN
ajmsi-1283	180	7	,	,	PUNCT
ajmsi-1283	180	8	part	part	NOUN
ajmsi-1283	180	9	1	1	NUM
ajmsi-1283	180	10	.	.	PUNCT
ajmsi-1283	181	1	2nd	2nd	ADJ
ajmsi-1283	181	2	edn	edn	PROPN
ajmsi-1283	181	3	cambridge	cambridge	PROPN
ajmsi-1283	181	4	:	:	PUNCT
ajmsi-1283	181	5	cambridge	cambridge	PROPN
ajmsi-1283	181	6	university	university	PROPN
ajmsi-1283	181	7	press	press	NOUN
ajmsi-1283	181	8	.	.	PUNCT
ajmsi-1283	182	1	colell	colell	PROPN
ajmsi-1283	182	2	a.	a.	PROPN
ajmsi-1283	182	3	,	,	PUNCT
ajmsi-1283	182	4	green	green	PROPN
ajmsi-1283	182	5	d.r	d.r	PROPN
ajmsi-1283	182	6	.	.	PROPN
ajmsi-1283	182	7	and	and	CCONJ
ajmsi-1283	182	8	ricci	ricci	PROPN
ajmsi-1283	182	9	j.e	j.e	PROPN
ajmsi-1283	182	10	.	.	PROPN
ajmsi-1283	182	11	(	(	PUNCT
ajmsi-1283	182	12	2009	2009	NUM
ajmsi-1283	182	13	)	)	PUNCT
ajmsi-1283	182	14	.	.	PUNCT
ajmsi-1283	183	1	novel	novel	ADJ
ajmsi-1283	183	2	roles	role	NOUN
ajmsi-1283	183	3	for	for	ADP
ajmsi-1283	183	4	gapdh	gapdh	NOUN
ajmsi-1283	183	5	in	in	ADP
ajmsi-1283	183	6	cell	cell	NOUN
ajmsi-1283	183	7	death	death	NOUN
ajmsi-1283	183	8	and	and	CCONJ
ajmsi-1283	183	9	carcinogenesis	carcinogenesis	NOUN
ajmsi-1283	183	10	.	.	PUNCT
ajmsi-1283	184	1	cell	cell	NOUN
ajmsi-1283	184	2	death	death	NOUN
ajmsi-1283	184	3	differ	differ	VERB
ajmsi-1283	184	4	,	,	PUNCT
ajmsi-1283	184	5	16	16	NUM
ajmsi-1283	184	6	,	,	PUNCT
ajmsi-1283	184	7	1573	1573	NUM
ajmsi-1283	184	8	-	-	SYM
ajmsi-1283	184	9	1581	1581	NUM
ajmsi-1283	184	10	.	.	PUNCT
ajmsi-1283	185	1	critelli	critelli	PROPN
ajmsi-1283	185	2	r	r	NOUN
ajmsi-1283	185	3	,	,	PUNCT
ajmsi-1283	185	4	fasanelli	fasanelli	PROPN
ajmsi-1283	185	5	f	f	X
ajmsi-1283	185	6	,	,	PUNCT
ajmsi-1283	185	7	oderda	oderda	PROPN
ajmsi-1283	185	8	m	m	PROPN
ajmsi-1283	185	9	,	,	PUNCT
ajmsi-1283	185	10	polidoro	polidoro	PROPN
ajmsi-1283	185	11	s	s	PROPN
ajmsi-1283	185	12	,	,	PUNCT
ajmsi-1283	185	13	assumma	assumma	PROPN
ajmsi-1283	185	14	mb	mb	NOUN
ajmsi-1283	185	15	,	,	PUNCT
ajmsi-1283	185	16	viberti	viberti	PROPN
ajmsi-1283	185	17	c	c	NOUN
ajmsi-1283	185	18	,	,	PUNCT
ajmsi-1283	185	19	preto	preto	NOUN
ajmsi-1283	185	20	m	m	PROPN
ajmsi-1283	185	21	,	,	PUNCT
ajmsi-1283	185	22	gontero	gontero	NOUN
ajmsi-1283	185	23	p	p	NOUN
ajmsi-1283	185	24	,	,	PUNCT
ajmsi-1283	185	25	cucchiarale	cucchiarale	NOUN
ajmsi-1283	185	26	g	g	NOUN
ajmsi-1283	185	27	,	,	PUNCT
ajmsi-1283	185	28	lurkin	lurkin	NOUN
ajmsi-1283	185	29	i	i	PRON
ajmsi-1283	185	30	,	,	PUNCT
ajmsi-1283	185	31	zwarthoff	zwarthoff	PROPN
ajmsi-1283	185	32	ec	ec	PROPN
ajmsi-1283	185	33	,	,	PUNCT
ajmsi-1283	185	34	vineis	vineis	NOUN
ajmsi-1283	185	35	p	p	NOUN
ajmsi-1283	185	36	,	,	PUNCT
ajmsi-1283	185	37	sacerdote	sacerdote	VERB
ajmsi-1283	185	38	c	c	NOUN
ajmsi-1283	185	39	,	,	PUNCT
ajmsi-1283	185	40	matullo	matullo	NOUN
ajmsi-1283	185	41	g	g	NOUN
ajmsi-1283	185	42	,	,	PUNCT
ajmsi-1283	185	43	and	and	CCONJ
ajmsi-1283	185	44	naccarati	naccarati	PROPN
ajmsi-1283	185	45	a.	a.	PROPN
ajmsi-1283	185	46	(	(	PUNCT
ajmsi-1283	185	47	2016	2016	NUM
ajmsi-1283	185	48	)	)	PUNCT
ajmsi-1283	185	49	.	.	PUNCT
ajmsi-1283	186	1	detection	detection	NOUN
ajmsi-1283	186	2	of	of	ADP
ajmsi-1283	186	3	multiple	multiple	ADJ
ajmsi-1283	186	4	mutations	mutation	NOUN
ajmsi-1283	186	5	in	in	ADP
ajmsi-1283	186	6	urinary	urinary	ADJ
ajmsi-1283	186	7	exfoliated	exfoliated	ADJ
ajmsi-1283	186	8	cells	cell	NOUN
ajmsi-1283	186	9	from	from	ADP
ajmsi-1283	186	10	male	male	ADJ
ajmsi-1283	186	11	bladder	bladder	NOUN
ajmsi-1283	186	12	cancer	cancer	NOUN
ajmsi-1283	186	13	patients	patient	NOUN
ajmsi-1283	186	14	at	at	ADP
ajmsi-1283	186	15	diagnosis	diagnosis	NOUN
ajmsi-1283	186	16	and	and	CCONJ
ajmsi-1283	186	17	during	during	ADP
ajmsi-1283	186	18	follow	follow	NOUN
ajmsi-1283	186	19	-	-	PUNCT
ajmsi-1283	186	20	up	up	NOUN
ajmsi-1283	186	21	.	.	PUNCT
ajmsi-1283	187	1	oncotarget	oncotarget	NOUN
ajmsi-1283	187	2	,	,	PUNCT
ajmsi-1283	187	3	7(41	7(41	NUM
ajmsi-1283	187	4	)	)	PUNCT
ajmsi-1283	187	5	,	,	PUNCT
ajmsi-1283	187	6	67435–67448	67435–67448	NUM
ajmsi-1283	187	7	.	.	PUNCT
ajmsi-1283	188	1	crompton	crompton	PROPN
ajmsi-1283	188	2	,	,	PUNCT
ajmsi-1283	188	3	d.w.t	d.w.t	PROPN
ajmsi-1283	188	4	.	.	PROPN
ajmsi-1283	188	5	and	and	CCONJ
ajmsi-1283	188	6	nesheim	nesheim	PROPN
ajmsi-1283	188	7	,	,	PUNCT
ajmsi-1283	188	8	m.c	m.c	PROPN
ajmsi-1283	188	9	.	.	PROPN
ajmsi-1283	188	10	(	(	PUNCT
ajmsi-1283	188	11	2002	2002	NUM
ajmsi-1283	188	12	)	)	PUNCT
ajmsi-1283	188	13	.	.	PUNCT
ajmsi-1283	189	1	nutritional	nutritional	ADJ
ajmsi-1283	189	2	impact	impact	NOUN
ajmsi-1283	189	3	of	of	ADP
ajmsi-1283	189	4	intestinal	intestinal	ADJ
ajmsi-1283	189	5	helminthiasis	helminthiasis	NOUN
ajmsi-1283	189	6	during	during	ADP
ajmsi-1283	189	7	the	the	DET
ajmsi-1283	189	8	human	human	ADJ
ajmsi-1283	189	9	life	life	NOUN
ajmsi-1283	189	10	cycle	cycle	NOUN
ajmsi-1283	189	11	.	.	PUNCT
ajmsi-1283	190	1	annual	annual	ADJ
ajmsi-1283	190	2	review	review	NOUN
ajmsi-1283	190	3	of	of	ADP
ajmsi-1283	190	4	nutrition	nutrition	NOUN
ajmsi-1283	190	5	,	,	PUNCT
ajmsi-1283	190	6	22	22	NUM
ajmsi-1283	190	7	,	,	PUNCT
ajmsi-1283	190	8	35	35	NUM
ajmsi-1283	190	9	-	-	SYM
ajmsi-1283	190	10	59	59	NUM
ajmsi-1283	190	11	.	.	PUNCT
ajmsi-1283	191	1	ekwunife	ekwunife	PROPN
ajmsi-1283	191	2	,	,	PUNCT
ajmsi-1283	191	3	c.a	c.a	PROPN
ajmsi-1283	191	4	.	.	PROPN
ajmsi-1283	191	5	,	,	PUNCT
ajmsi-1283	191	6	okafor	okafor	PROPN
ajmsi-1283	191	7	,	,	PUNCT
ajmsi-1283	191	8	f.c	f.c	PROPN
ajmsi-1283	191	9	.	.	PROPN
ajmsi-1283	191	10	and	and	CCONJ
ajmsi-1283	191	11	nwaorgu	nwaorgu	PROPN
ajmsi-1283	191	12	,	,	PUNCT
ajmsi-1283	191	13	o.c	o.c	PROPN
ajmsi-1283	191	14	.	.	PROPN
ajmsi-1283	191	15	(	(	PUNCT
ajmsi-1283	191	16	2009	2009	NUM
ajmsi-1283	191	17	)	)	PUNCT
ajmsi-1283	191	18	.	.	PUNCT
ajmsi-1283	192	1	ultrasonographic	ultrasonographic	ADJ
ajmsi-1283	192	2	screening	screening	NOUN
ajmsi-1283	192	3	of	of	ADP
ajmsi-1283	192	4	urinary	urinary	ADJ
ajmsi-1283	192	5	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	192	6	infected	infect	VERB
ajmsi-1283	192	7	patients	patient	NOUN
ajmsi-1283	192	8	in	in	ADP
ajmsi-1283	192	9	agulu	agulu	ADJ
ajmsi-1283	192	10	community	community	NOUN
ajmsi-1283	192	11	,	,	PUNCT
ajmsi-1283	192	12	anambra	anambra	PROPN
ajmsi-1283	192	13	state	state	PROPN
ajmsi-1283	192	14	,	,	PUNCT
ajmsi-1283	192	15	southeast	southeast	PROPN
ajmsi-1283	192	16	nigeria	nigeria	PROPN
ajmsi-1283	192	17	.	.	PUNCT
ajmsi-1283	193	1	international	international	ADJ
ajmsi-1283	193	2	archives	archive	NOUN
ajmsi-1283	193	3	of	of	ADP
ajmsi-1283	193	4	medicine	medicine	NOUN
ajmsi-1283	193	5	,	,	PUNCT
ajmsi-1283	193	6	2	2	NUM
ajmsi-1283	193	7	,	,	PUNCT
ajmsi-1283	193	8	34	34	NUM
ajmsi-1283	193	9	.	.	PUNCT
ajmsi-1283	193	10	ekwunife	ekwunife	PROPN
ajmsi-1283	193	11	,	,	PUNCT
ajmsi-1283	193	12	c.a	c.a	PROPN
ajmsi-1283	193	13	.	.	PROPN
ajmsi-1283	193	14	,	,	PUNCT
ajmsi-1283	193	15	ukaga	ukaga	NOUN
ajmsi-1283	193	16	,	,	PUNCT
ajmsi-1283	193	17	c.n	c.n	PROPN
ajmsi-1283	193	18	.	.	PROPN
ajmsi-1283	193	19	and	and	CCONJ
ajmsi-1283	193	20	okafor	okafor	PROPN
ajmsi-1283	193	21	,	,	PUNCT
ajmsi-1283	193	22	f.	f.	PROPN
ajmsi-1283	193	23	(	(	PUNCT
ajmsi-1283	193	24	2004	2004	NUM
ajmsi-1283	193	25	)	)	PUNCT
ajmsi-1283	193	26	.	.	PUNCT
ajmsi-1283	194	1	urinary	urinary	ADJ
ajmsi-1283	194	2	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	194	3	in	in	ADP
ajmsi-1283	194	4	anambra	anambra	PROPN
ajmsi-1283	194	5	state	state	PROPN
ajmsi-1283	194	6	,	,	PUNCT
ajmsi-1283	194	7	nigeria	nigeria	PROPN
ajmsi-1283	194	8	.	.	PUNCT
ajmsi-1283	195	1	nigerian	nigerian	PROPN
ajmsi-1283	195	2	journal	journal	PROPN
ajmsi-1283	195	3	of	of	ADP
ajmsi-1283	195	4	parasitology	parasitology	NOUN
ajmsi-1283	195	5	,	,	PUNCT
ajmsi-1283	195	6	25(1	25(1	NUM
ajmsi-1283	195	7	)	)	PUNCT
ajmsi-1283	195	8	,	,	PUNCT
ajmsi-1283	195	9	127	127	NUM
ajmsi-1283	195	10	-	-	SYM
ajmsi-1283	195	11	131	131	NUM
ajmsi-1283	195	12	.	.	PUNCT
ajmsi-1283	196	1	frantzi	frantzi	NOUN
ajmsi-1283	196	2	,	,	PUNCT
ajmsi-1283	196	3	m.	m.	NOUN
ajmsi-1283	196	4	,	,	PUNCT
ajmsi-1283	196	5	makridakis	makridakis	PROPN
ajmsi-1283	196	6	,	,	PUNCT
ajmsi-1283	196	7	m.	m.	NOUN
ajmsi-1283	196	8	and	and	CCONJ
ajmsi-1283	196	9	vlahou	vlahou	NOUN
ajmsi-1283	196	10	,	,	PUNCT
ajmsi-1283	196	11	a.	a.	NOUN
ajmsi-1283	196	12	(	(	PUNCT
ajmsi-1283	196	13	2012	2012	NUM
ajmsi-1283	196	14	)	)	PUNCT
ajmsi-1283	196	15	.	.	PUNCT
ajmsi-1283	197	1	biomarkers	biomarker	NOUN
ajmsi-1283	197	2	for	for	ADP
ajmsi-1283	197	3	bladder	bladder	NOUN
ajmsi-1283	197	4	cancer	cancer	NOUN
ajmsi-1283	197	5	aggressiveness	aggressiveness	NOUN
ajmsi-1283	197	6	.	.	PUNCT
ajmsi-1283	198	1	current	current	ADJ
ajmsi-1283	198	2	opinion	opinion	NOUN
ajmsi-1283	198	3	urology	urology	NOUN
ajmsi-1283	198	4	,	,	PUNCT
ajmsi-1283	198	5	22(5	22(5	NOUN
ajmsi-1283	198	6	)	)	PUNCT
ajmsi-1283	198	7	,	,	PUNCT
ajmsi-1283	198	8	390–396	390–396	NUM
ajmsi-1283	198	9	.	.	PUNCT
ajmsi-1283	199	1	gea	gea	NOUN
ajmsi-1283	199	2	-	-	PUNCT
ajmsi-1283	199	3	sorlí	sorlí	NOUN
ajmsi-1283	199	4	,	,	PUNCT
ajmsi-1283	199	5	s.	s.	PROPN
ajmsi-1283	199	6	and	and	CCONJ
ajmsi-1283	199	7	closa	closa	PROPN
ajmsi-1283	199	8	,	,	PUNCT
ajmsi-1283	199	9	d.	d.	PROPN
ajmsi-1283	199	10	(	(	PUNCT
ajmsi-1283	199	11	2009	2009	NUM
ajmsi-1283	199	12	)	)	PUNCT
ajmsi-1283	199	13	.	.	PUNCT
ajmsi-1283	200	1	in	in	ADP
ajmsi-1283	200	2	vitro	vitro	X
ajmsi-1283	200	3	,	,	PUNCT
ajmsi-1283	200	4	but	but	CCONJ
ajmsi-1283	200	5	not	not	PART
ajmsi-1283	200	6	in	in	ADP
ajmsi-1283	200	7	vivo	vivo	NOUN
ajmsi-1283	200	8	,	,	PUNCT
ajmsi-1283	200	9	reversibility	reversibility	NOUN
ajmsi-1283	200	10	of	of	ADP
ajmsi-1283	200	11	peritoneal	peritoneal	ADJ
ajmsi-1283	200	12	macrophages	macrophage	NOUN
ajmsi-1283	200	13	activation	activation	NOUN
ajmsi-1283	200	14	during	during	ADP
ajmsi-1283	200	15	experimental	experimental	ADJ
ajmsi-1283	200	16	acute	acute	PROPN
ajmsi-1283	200	17	pancreatitis	pancreatitis	PROPN
ajmsi-1283	200	18	.	.	PUNCT
ajmsi-1283	201	1	bmc	bmc	ADJ
ajmsi-1283	201	2	immunology	immunology	NOUN
ajmsi-1283	201	3	,	,	PUNCT
ajmsi-1283	201	4	10	10	NUM
ajmsi-1283	201	5	,	,	PUNCT
ajmsi-1283	201	6	42	42	NUM
ajmsi-1283	201	7	.	.	PUNCT
ajmsi-1283	201	8	groeneveld	groeneveld	NOUN
ajmsi-1283	201	9	,	,	PUNCT
ajmsi-1283	201	10	a.e	a.e	PROPN
ajmsi-1283	201	11	.	.	PROPN
ajmsi-1283	201	12	,	,	PUNCT
ajmsi-1283	201	13	marszalek	marszalek	PROPN
ajmsi-1283	201	14	,	,	PUNCT
ajmsi-1283	201	15	w.w	w.w	PROPN
ajmsi-1283	201	16	.	.	PROPN
ajmsi-1283	201	17	and	and	CCONJ
ajmsi-1283	201	18	heyns	heyns	PROPN
ajmsi-1283	201	19	,	,	PUNCT
ajmsi-1283	201	20	c.f	c.f	PROPN
ajmsi-1283	201	21	.	.	PROPN
ajmsi-1283	201	22	(	(	PUNCT
ajmsi-1283	201	23	1996	1996	NUM
ajmsi-1283	201	24	)	)	PUNCT
ajmsi-1283	201	25	.	.	PUNCT
ajmsi-1283	202	1	bladder	bladder	NOUN
ajmsi-1283	202	2	cancer	cancer	NOUN
ajmsi-1283	202	3	in	in	ADP
ajmsi-1283	202	4	various	various	ADJ
ajmsi-1283	202	5	population	population	NOUN
ajmsi-1283	202	6	groups	group	NOUN
ajmsi-1283	202	7	in	in	ADP
ajmsi-1283	202	8	the	the	DET
ajmsi-1283	202	9	greater	great	ADJ
ajmsi-1283	202	10	durban	durban	PROPN
ajmsi-1283	202	11	area	area	NOUN
ajmsi-1283	202	12	of	of	ADP
ajmsi-1283	202	13	kwazulu	kwazulu	PROPN
ajmsi-1283	202	14	-	-	PUNCT
ajmsi-1283	202	15	natal	natal	ADJ
ajmsi-1283	202	16	,	,	PUNCT
ajmsi-1283	202	17	south	south	PROPN
ajmsi-1283	202	18	africa	africa	PROPN
ajmsi-1283	202	19	.	.	PUNCT
ajmsi-1283	203	1	british	british	PROPN
ajmsi-1283	203	2	journal	journal	PROPN
ajmsi-1283	203	3	of	of	ADP
ajmsi-1283	203	4	urology	urology	NOUN
ajmsi-1283	203	5	,	,	PUNCT
ajmsi-1283	203	6	78	78	NUM
ajmsi-1283	203	7	,	,	PUNCT
ajmsi-1283	203	8	205–208	205–208	NUM
ajmsi-1283	203	9	.	.	PUNCT
ajmsi-1283	204	1	guo	guo	PROPN
ajmsi-1283	204	2	c.	c.	PROPN
ajmsi-1283	204	3	,	,	PUNCT
ajmsi-1283	204	4	liu	liu	PROPN
ajmsi-1283	204	5	s.	s.	PROPN
ajmsi-1283	204	6	and	and	CCONJ
ajmsi-1283	204	7	sun	sun	PROPN
ajmsi-1283	204	8	m	m	PROPN
ajmsi-1283	204	9	-	-	PROPN
ajmsi-1283	204	10	z	z	X
ajmsi-1283	204	11	(	(	PUNCT
ajmsi-1283	204	12	2013	2013	NUM
ajmsi-1283	204	13	)	)	PUNCT
ajmsi-1283	204	14	.	.	PUNCT
ajmsi-1283	205	1	novel	novel	NOUN
ajmsi-1283	205	2	insight	insight	NOUN
ajmsi-1283	205	3	into	into	ADP
ajmsi-1283	205	4	the	the	DET
ajmsi-1283	205	5	role	role	NOUN
ajmsi-1283	205	6	of	of	ADP
ajmsi-1283	205	7	gapdh	gapdh	NOUN
ajmsi-1283	205	8	playing	play	VERB
ajmsi-1283	205	9	in	in	ADP
ajmsi-1283	205	10	tumor	tumor	NOUN
ajmsi-1283	205	11	.	.	PUNCT
ajmsi-1283	206	1	clinical	clinical	ADJ
ajmsi-1283	206	2	and	and	CCONJ
ajmsi-1283	206	3	translational	translational	ADJ
ajmsi-1283	206	4	oncology	oncology	NOUN
ajmsi-1283	206	5	,	,	PUNCT
ajmsi-1283	206	6	15(3	15(3	NUM
ajmsi-1283	206	7	)	)	PUNCT
ajmsi-1283	206	8	,	,	PUNCT
ajmsi-1283	206	9	167	167	NUM
ajmsi-1283	206	10	-	-	SYM
ajmsi-1283	206	11	72	72	NUM
ajmsi-1283	206	12	.	.	PUNCT
ajmsi-1283	207	1	hokke	hokke	PROPN
ajmsi-1283	207	2	,	,	PUNCT
ajmsi-1283	207	3	c.h	c.h	PROPN
ajmsi-1283	207	4	.	.	PROPN
ajmsi-1283	207	5	and	and	CCONJ
ajmsi-1283	207	6	yazdanbakhsh	yazdanbakhsh	NOUN
ajmsi-1283	207	7	,	,	PUNCT
ajmsi-1283	207	8	m.	m.	NOUN
ajmsi-1283	207	9	,	,	PUNCT
ajmsi-1283	207	10	(	(	PUNCT
ajmsi-1283	207	11	2005).schistosome	2005).schistosome	NUM
ajmsi-1283	207	12	glycans	glycan	NOUN
ajmsi-1283	207	13	and	and	CCONJ
ajmsi-1283	207	14	innate	innate	ADJ
ajmsi-1283	207	15	immunity	immunity	NOUN
ajmsi-1283	207	16	.	.	PUNCT
ajmsi-1283	208	1	parasite	parasite	ADJ
ajmsi-1283	208	2	immunology	immunology	NOUN
ajmsi-1283	208	3	,	,	PUNCT
ajmsi-1283	208	4	27	27	NUM
ajmsi-1283	208	5	,	,	PUNCT
ajmsi-1283	208	6	257–264	257–264	NUM
ajmsi-1283	208	7	.	.	PUNCT
ajmsi-1283	208	8	iarc	iarc	NOUN
ajmsi-1283	208	9	(	(	PUNCT
ajmsi-1283	208	10	2012	2012	NUM
ajmsi-1283	208	11	)	)	PUNCT
ajmsi-1283	208	12	.	.	PUNCT
ajmsi-1283	209	1	biological	biological	ADJ
ajmsi-1283	209	2	agents	agent	NOUN
ajmsi-1283	209	3	.	.	PUNCT
ajmsi-1283	210	1	volume	volume	NOUN
ajmsi-1283	210	2	100	100	NUM
ajmsi-1283	210	3	b.	b.	PROPN
ajmsi-1283	210	4	a	a	DET
ajmsi-1283	210	5	review	review	NOUN
ajmsi-1283	210	6	of	of	ADP
ajmsi-1283	210	7	human	human	ADJ
ajmsi-1283	210	8	carcinogens	carcinogen	NOUN
ajmsi-1283	210	9	.	.	PUNCT
ajmsi-1283	211	1	iarc	iarc	NOUN
ajmsi-1283	211	2	monographs	monograph	NOUN
ajmsi-1283	211	3	on	on	ADP
ajmsi-1283	211	4	the	the	DET
ajmsi-1283	211	5	evaluation	evaluation	NOUN
ajmsi-1283	211	6	of	of	ADP
ajmsi-1283	211	7	carcinogenic	carcinogenic	ADJ
ajmsi-1283	211	8	risks	risk	NOUN
ajmsi-1283	211	9	to	to	ADP
ajmsi-1283	211	10	humans	human	NOUN
ajmsi-1283	211	11	/	/	SYM
ajmsi-1283	211	12	world	world	NOUN
ajmsi-1283	211	13	health	health	NOUN
ajmsi-1283	211	14	organization	organization	NOUN
ajmsi-1283	211	15	.	.	PUNCT
ajmsi-1283	212	1	international	international	ADJ
ajmsi-1283	212	2	agency	agency	NOUN
ajmsi-1283	212	3	for	for	ADP
ajmsi-1283	212	4	research	research	NOUN
ajmsi-1283	212	5	on	on	ADP
ajmsi-1283	212	6	cancer	cancer	NOUN
ajmsi-1283	212	7	,	,	PUNCT
ajmsi-1283	212	8	100	100	NUM
ajmsi-1283	212	9	,	,	PUNCT
ajmsi-1283	212	10	1–441	1–441	NUM
ajmsi-1283	212	11	.	.	PUNCT
ajmsi-1283	213	1	ishida	ishida	PROPN
ajmsi-1283	213	2	,	,	PUNCT
ajmsi-1283	213	3	k.	k.	PROPN
ajmsi-1283	213	4	and	and	CCONJ
ajmsi-1283	213	5	hsieh	hsieh	PROPN
ajmsi-1283	213	6	,	,	PUNCT
ajmsi-1283	213	7	m.h	m.h	PROPN
ajmsi-1283	213	8	.	.	PROPN
ajmsi-1283	213	9	(	(	PUNCT
ajmsi-1283	213	10	2018	2018	NUM
ajmsi-1283	213	11	)	)	PUNCT
ajmsi-1283	213	12	.	.	PUNCT
ajmsi-1283	214	1	understanding	understand	VERB
ajmsi-1283	214	2	urogenital	urogenital	ADJ
ajmsi-1283	214	3	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	214	4	-	-	PUNCT
ajmsi-1283	214	5	related	relate	VERB
ajmsi-1283	214	6	bladder	bladder	NOUN
ajmsi-1283	214	7	cancer	cancer	NOUN
ajmsi-1283	214	8	:	:	PUNCT
ajmsi-1283	214	9	an	an	DET
ajmsi-1283	214	10	update	update	NOUN
ajmsi-1283	214	11	.	.	PUNCT
ajmsi-1283	215	1	kamat	kamat	PROPN
ajmsi-1283	215	2	,	,	PUNCT
ajmsi-1283	215	3	a.m.	a.m.	ADV
ajmsi-1283	215	4	,	,	PUNCT
ajmsi-1283	215	5	hegarty	hegarty	PROPN
ajmsi-1283	215	6	,	,	PUNCT
ajmsi-1283	215	7	p.k	p.k	PROPN
ajmsi-1283	215	8	.	.	PROPN
ajmsi-1283	215	9	,	,	PUNCT
ajmsi-1283	215	10	gee	gee	PROPN
ajmsi-1283	215	11	,	,	PUNCT
ajmsi-1283	215	12	j.r	j.r	PROPN
ajmsi-1283	215	13	.	.	PROPN
ajmsi-1283	215	14	,	,	PUNCT
ajmsi-1283	215	15	clark	clark	PROPN
ajmsi-1283	215	16	,	,	PUNCT
ajmsi-1283	215	17	p.e	p.e	PROPN
ajmsi-1283	215	18	.	.	PROPN
ajmsi-1283	215	19	,	,	PUNCT
ajmsi-1283	215	20	svatek	svatek	PROPN
ajmsi-1283	215	21	,	,	PUNCT
ajmsi-1283	215	22	r.s	r.s	PROPN
ajmsi-1283	215	23	.	.	PROPN
ajmsi-1283	215	24	,	,	PUNCT
ajmsi-1283	215	25	hegarty	hegarty	PROPN
ajmsi-1283	215	26	,	,	PUNCT
ajmsi-1283	215	27	n.	n.	NOUN
ajmsi-1283	215	28	,	,	PUNCT
ajmsi-1283	215	29	shariat	shariat	PROPN
ajmsi-1283	215	30	,	,	PUNCT
ajmsi-1283	215	31	s.f	s.f	PROPN
ajmsi-1283	215	32	.	.	PROPN
ajmsi-1283	215	33	,	,	PUNCT
ajmsi-1283	215	34	xylinas	xylinas	PROPN
ajmsi-1283	215	35	,	,	PUNCT
ajmsi-1283	215	36	e.	e.	PROPN
ajmsi-1283	215	37	,	,	PUNCT
ajmsi-1283	215	38	schmitzdräger	schmitzdräger	PROPN
ajmsi-1283	215	39	,	,	PUNCT
ajmsi-1283	215	40	b.j	b.j	PROPN
ajmsi-1283	215	41	.	.	PROPN
ajmsi-1283	215	42	,	,	PUNCT
ajmsi-1283	215	43	lotan	lotan	PROPN
ajmsi-1283	215	44	,	,	PUNCT
ajmsi-1283	215	45	y.	y.	PROPN
ajmsi-1283	215	46	,	,	PUNCT
ajmsi-1283	215	47	jenkins	jenkins	PROPN
ajmsi-1283	215	48	,	,	PUNCT
ajmsi-1283	215	49	l.c	l.c	PROPN
ajmsi-1283	215	50	.	.	PROPN
ajmsi-1283	215	51	,	,	PUNCT
ajmsi-1283	215	52	droller	droller	NOUN
ajmsi-1283	215	53	,	,	PUNCT
ajmsi-1283	215	54	m.	m.	NOUN
ajmsi-1283	215	55	,	,	PUNCT
ajmsi-1283	215	56	van	van	PROPN
ajmsi-1283	215	57	rhijn	rhijn	PROPN
ajmsi-1283	215	58	,	,	PUNCT
ajmsi-1283	215	59	b.w	b.w	PROPN
ajmsi-1283	215	60	.	.	PROPN
ajmsi-1283	215	61	and	and	CCONJ
ajmsi-1283	215	62	karakiewicz	karakiewicz	NOUN
ajmsi-1283	215	63	,	,	PUNCT
ajmsi-1283	215	64	p.i	p.i	PROPN
ajmsi-1283	215	65	.	.	PUNCT
ajmsi-1283	216	1	(	(	PUNCT
ajmsi-1283	216	2	2013	2013	NUM
ajmsi-1283	216	3	)	)	PUNCT
ajmsi-1283	216	4	icud	icud	NOUN
ajmsi-1283	216	5	–	–	PUNCT
ajmsi-1283	216	6	eau	eau	PROPN
ajmsi-1283	216	7	international	international	ADJ
ajmsi-1283	216	8	consultation	consultation	NOUN
ajmsi-1283	216	9	on	on	ADP
ajmsi-1283	216	10	bladder	bladder	NOUN
ajmsi-1283	216	11	cancer	cancer	NOUN
ajmsi-1283	216	12	2012	2012	NUM
ajmsi-1283	216	13	:	:	PUNCT
ajmsi-1283	217	1	screening	screening	NOUN
ajmsi-1283	217	2	,	,	PUNCT
ajmsi-1283	217	3	diagnosis	diagnosis	NOUN
ajmsi-1283	217	4	,	,	PUNCT
ajmsi-1283	217	5	and	and	CCONJ
ajmsi-1283	217	6	molecular	molecular	ADJ
ajmsi-1283	217	7	markers	marker	NOUN
ajmsi-1283	217	8	.	.	PUNCT
ajmsi-1283	218	1	eur	eur	PROPN
ajmsi-1283	218	2	urol	urol	PROPN
ajmsi-1283	218	3	,	,	PUNCT
ajmsi-1283	218	4	63	63	NUM
ajmsi-1283	218	5	,	,	PUNCT
ajmsi-1283	218	6	4–15	4–15	NOUN
ajmsi-1283	218	7	.	.	PUNCT
ajmsi-1283	219	1	klion	klion	PROPN
ajmsi-1283	219	2	,	,	PUNCT
ajmsi-1283	219	3	a.d	a.d	PROPN
ajmsi-1283	219	4	.	.	PROPN
ajmsi-1283	219	5	and	and	CCONJ
ajmsi-1283	219	6	nutman	nutman	PROPN
ajmsi-1283	219	7	,	,	PUNCT
ajmsi-1283	219	8	t.b	t.b	PROPN
ajmsi-1283	219	9	.	.	PROPN
ajmsi-1283	219	10	(	(	PUNCT
ajmsi-1283	219	11	2002	2002	NUM
ajmsi-1283	219	12	)	)	PUNCT
ajmsi-1283	219	13	.	.	PUNCT
ajmsi-1283	220	1	immunity	immunity	NOUN
ajmsi-1283	220	2	to	to	ADP
ajmsi-1283	220	3	parasitic	parasitic	ADJ
ajmsi-1283	220	4	worms	worm	NOUN
ajmsi-1283	220	5	.	.	PUNCT
ajmsi-1283	221	1	encyclopedia	encyclopedia	NOUN
ajmsi-1283	221	2	of	of	ADP
ajmsi-1283	221	3	life	life	NOUN
ajmsi-1283	221	4	science	science	NOUN
ajmsi-1283	221	5	:	:	PUNCT
ajmsi-1283	221	6	macmillian	macmillian	PROPN
ajmsi-1283	221	7	publishers	publisher	NOUN
ajmsi-1283	221	8	limited	limit	VERB
ajmsi-1283	221	9	.	.	PUNCT
ajmsi-1283	222	1	mickum	mickum	NOUN
ajmsi-1283	222	2	,	,	PUNCT
ajmsi-1283	222	3	m.l	m.l	PROPN
ajmsi-1283	222	4	.	.	PROPN
ajmsi-1283	222	5	,	,	PUNCT
ajmsi-1283	222	6	prasanphanich	prasanphanich	NOUN
ajmsi-1283	222	7	,	,	PUNCT
ajmsi-1283	222	8	n.s	n.s	PROPN
ajmsi-1283	222	9	.	.	PROPN
ajmsi-1283	222	10	,	,	PUNCT
ajmsi-1283	222	11	heimburgmolinaro	heimburgmolinaro	NOUN
ajmsi-1283	222	12	,	,	PUNCT
ajmsi-1283	222	13	j.	j.	PROPN
ajmsi-1283	222	14	,	,	PUNCT
ajmsi-1283	222	15	leon	leon	PROPN
ajmsi-1283	222	16	,	,	PUNCT
ajmsi-1283	222	17	k.e	k.e	PROPN
ajmsi-1283	222	18	.	.	PROPN
ajmsi-1283	222	19	and	and	CCONJ
ajmsi-1283	222	20	cummings	cummings	PROPN
ajmsi-1283	222	21	,	,	PUNCT
ajmsi-1283	222	22	r.d	r.d	PROPN
ajmsi-1283	222	23	.	.	PROPN
ajmsi-1283	222	24	(	(	PUNCT
ajmsi-1283	222	25	2014	2014	NUM
ajmsi-1283	222	26	)	)	PUNCT
ajmsi-1283	222	27	.	.	PUNCT
ajmsi-1283	223	1	deciphering	decipher	VERB
ajmsi-1283	223	2	the	the	DET
ajmsi-1283	223	3	glycogenome	glycogenome	NOUN
ajmsi-1283	223	4	of	of	ADP
ajmsi-1283	223	5	schistosomes	schistosome	NOUN
ajmsi-1283	223	6	.	.	PUNCT
ajmsi-1283	224	1	frontiers	frontier	NOUN
ajmsi-1283	224	2	in	in	ADP
ajmsi-1283	224	3	genetics	genetic	NOUN
ajmsi-1283	224	4	,	,	PUNCT
ajmsi-1283	224	5	5(262	5(262	NUM
ajmsi-1283	224	6	)	)	PUNCT
ajmsi-1283	224	7	,	,	PUNCT
ajmsi-1283	224	8	1	1	NUM
ajmsi-1283	224	9	-	-	SYM
ajmsi-1283	224	10	15	15	NUM
ajmsi-1283	224	11	.	.	PUNCT
ajmsi-1283	225	1	mictu	mictu	ADJ
ajmsi-1283	225	2	/	/	SYM
ajmsi-1283	225	3	unizik	unizik	NOUN
ajmsi-1283	225	4	(	(	PUNCT
ajmsi-1283	225	5	2019	2019	NUM
ajmsi-1283	225	6	)	)	PUNCT
ajmsi-1283	225	7	.	.	PUNCT
ajmsi-1283	226	1	centre	centre	NOUN
ajmsi-1283	226	2	for	for	ADP
ajmsi-1283	226	3	community	community	NOUN
ajmsi-1283	226	4	and	and	CCONJ
ajmsi-1283	226	5	rural	rural	ADJ
ajmsi-1283	226	6	development	development	NOUN
ajmsi-1283	226	7	:	:	PUNCT
ajmsi-1283	226	8	anambra	anambra	PROPN
ajmsi-1283	226	9	north	north	PROPN
ajmsi-1283	226	10	senatorial	senatorial	ADJ
ajmsi-1283	226	11	district	district	NOUN
ajmsi-1283	226	12	.	.	PUNCT
ajmsi-1283	227	1	retrived	retrive	VERB
ajmsi-1283	227	2	on	on	ADP
ajmsi-1283	227	3	april	april	PROPN
ajmsi-1283	227	4	14	14	NUM
ajmsi-1283	227	5	,	,	PUNCT
ajmsi-1283	227	6	2019	2019	NUM
ajmsi-1283	227	7	.	.	PUNCT
ajmsi-1283	228	1	https://ccrd	https://ccrd	PROPN
ajmsi-1283	228	2	.	.	PUNCT
ajmsi-1283	229	1	unizik.edu.ng/anambra-senetorial-districts/anambranorth-senetorial-district/	unizik.edu.ng/anambra-senetorial-districts/anambranorth-senetorial-district/	PROPN
ajmsi-1283	229	2	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	229	3	pa	pa	PROPN
ajmsi-1283	229	4	ge	ge	PROPN
ajmsi-1283	229	5	32	32	NUM
ajmsi-1283	229	6	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-1283	229	7	am	be	AUX
ajmsi-1283	229	8	.	.	PUNCT
ajmsi-1283	230	1	j.	j.	PROPN
ajmsi-1283	230	2	med	med	PROPN
ajmsi-1283	230	3	.	.	PUNCT
ajmsi-1283	231	1	sci	sci	PROPN
ajmsi-1283	231	2	.	.	PUNCT
ajmsi-1283	231	3	innov	innov	PROPN
ajmsi-1283	231	4	.	.	PUNCT
ajmsi-1283	232	1	2(1	2(1	NUM
ajmsi-1283	232	2	)	)	PUNCT
ajmsi-1283	232	3	26	26	NUM
ajmsi-1283	232	4	-	-	SYM
ajmsi-1283	232	5	31	31	NUM
ajmsi-1283	232	6	,	,	PUNCT
ajmsi-1283	232	7	2023	2023	NUM
ajmsi-1283	232	8	miguel	miguel	PROPN
ajmsi-1283	232	9	,	,	PUNCT
ajmsi-1283	232	10	e.	e.	PROPN
ajmsi-1283	232	11	and	and	CCONJ
ajmsi-1283	232	12	kremer	kremer	PROPN
ajmsi-1283	232	13	,	,	PUNCT
ajmsi-1283	232	14	m.	m.	NOUN
ajmsi-1283	232	15	(	(	PUNCT
ajmsi-1283	232	16	2004	2004	NUM
ajmsi-1283	232	17	)	)	PUNCT
ajmsi-1283	232	18	.	.	PUNCT
ajmsi-1283	233	1	worms	worm	NOUN
ajmsi-1283	233	2	:	:	PUNCT
ajmsi-1283	233	3	identifying	identify	VERB
ajmsi-1283	233	4	impacts	impact	NOUN
ajmsi-1283	233	5	on	on	ADP
ajmsi-1283	233	6	education	education	NOUN
ajmsi-1283	233	7	and	and	CCONJ
ajmsi-1283	233	8	health	health	NOUN
ajmsi-1283	233	9	in	in	ADP
ajmsi-1283	233	10	the	the	DET
ajmsi-1283	233	11	presence	presence	NOUN
ajmsi-1283	233	12	of	of	ADP
ajmsi-1283	233	13	treatment	treatment	NOUN
ajmsi-1283	233	14	externalities	externality	NOUN
ajmsi-1283	233	15	.	.	PUNCT
ajmsi-1283	234	1	econometrica	econometrica	PROPN
ajmsi-1283	234	2	,	,	PUNCT
ajmsi-1283	234	3	72	72	NUM
ajmsi-1283	234	4	,	,	PUNCT
ajmsi-1283	234	5	159	159	NUM
ajmsi-1283	234	6	-	-	SYM
ajmsi-1283	234	7	217	217	NUM
ajmsi-1283	234	8	.	.	PUNCT
ajmsi-1283	235	1	ndukwe	ndukwe	ADJ
ajmsi-1283	235	2	,	,	PUNCT
ajmsi-1283	235	3	y.e	y.e	PROPN
ajmsi-1283	235	4	.	.	PROPN
ajmsi-1283	235	5	,	,	PUNCT
ajmsi-1283	235	6	obiezue	obiezue	PROPN
ajmsi-1283	235	7	,	,	PUNCT
ajmsi-1283	235	8	r.n.n	r.n.n	PROPN
ajmsi-1283	235	9	.	.	PROPN
ajmsi-1283	235	10	,	,	PUNCT
ajmsi-1283	235	11	aguzie	aguzie	NOUN
ajmsi-1283	235	12	,	,	PUNCT
ajmsi-1283	235	13	i.o.n	i.o.n	NOUN
ajmsi-1283	235	14	.	.	PROPN
ajmsi-1283	235	15	,	,	PUNCT
ajmsi-1283	235	16	anunobi	anunobi	PROPN
ajmsi-1283	235	17	,	,	PUNCT
ajmsi-1283	235	18	j.t	j.t	PROPN
ajmsi-1283	235	19	.	.	PROPN
ajmsi-1283	235	20	and	and	CCONJ
ajmsi-1283	235	21	okafor	okafor	PROPN
ajmsi-1283	235	22	,	,	PUNCT
ajmsi-1283	235	23	f.c	f.c	PROPN
ajmsi-1283	235	24	.	.	PROPN
ajmsi-1283	235	25	(	(	PUNCT
ajmsi-1283	235	26	2019	2019	NUM
ajmsi-1283	235	27	)	)	PUNCT
ajmsi-1283	235	28	.	.	PUNCT
ajmsi-1283	236	1	mapping	mapping	NOUN
ajmsi-1283	236	2	of	of	ADP
ajmsi-1283	236	3	urinary	urinary	ADJ
ajmsi-1283	236	4	schistosomiasis	schistosomiasis	NOUN
ajmsi-1283	236	5	in	in	ADP
ajmsi-1283	236	6	anambra	anambra	PROPN
ajmsi-1283	236	7	state	state	PROPN
ajmsi-1283	236	8	,	,	PUNCT
ajmsi-1283	236	9	nigeria	nigeria	PROPN
ajmsi-1283	236	10	.	.	PUNCT
ajmsi-1283	237	1	annals	annal	NOUN
ajmsi-1283	237	2	of	of	ADP
ajmsi-1283	237	3	global	global	ADJ
ajmsi-1283	237	4	health	health	NOUN
ajmsi-1283	237	5	,	,	PUNCT
ajmsi-1283	237	6	85(1	85(1	NOUN
ajmsi-1283	237	7	)	)	PUNCT
ajmsi-1283	237	8	,	,	PUNCT
ajmsi-1283	237	9	1–10	1–10	NOUN
ajmsi-1283	237	10	.	.	PUNCT
ajmsi-1283	238	1	park	park	PROPN
ajmsi-1283	238	2	,	,	PUNCT
ajmsi-1283	238	3	h.	h.	PROPN
ajmsi-1283	238	4	,	,	PUNCT
ajmsi-1283	238	5	li	li	PROPN
ajmsi-1283	238	6	,	,	PUNCT
ajmsi-1283	238	7	z.	z.	PROPN
ajmsi-1283	238	8	,	,	PUNCT
ajmsi-1283	238	9	yang	yang	PROPN
ajmsi-1283	238	10	,	,	PUNCT
ajmsi-1283	238	11	x.o	x.o	PROPN
ajmsi-1283	238	12	.	.	PROPN
ajmsi-1283	238	13	,	,	PUNCT
ajmsi-1283	238	14	chang	chang	PROPN
ajmsi-1283	238	15	,	,	PUNCT
ajmsi-1283	238	16	s.h	s.h	PROPN
ajmsi-1283	238	17	.	.	PROPN
ajmsi-1283	238	18	,	,	PUNCT
ajmsi-1283	238	19	nurieva	nurieva	PROPN
ajmsi-1283	238	20	,	,	PUNCT
ajmsi-1283	238	21	r.	r.	PROPN
ajmsi-1283	238	22	,	,	PUNCT
ajmsi-1283	238	23	wang	wang	PROPN
ajmsi-1283	238	24	,	,	PUNCT
ajmsi-1283	238	25	y.h	y.h	PROPN
ajmsi-1283	238	26	.	.	PROPN
ajmsi-1283	238	27	,	,	PUNCT
ajmsi-1283	238	28	wang	wang	PROPN
ajmsi-1283	238	29	,	,	PUNCT
ajmsi-1283	238	30	y.	y.	PROPN
ajmsi-1283	238	31	,	,	PUNCT
ajmsi-1283	238	32	hood	hood	PROPN
ajmsi-1283	238	33	,	,	PUNCT
ajmsi-1283	238	34	l.	l.	PROPN
ajmsi-1283	238	35	,	,	PUNCT
ajmsi-1283	238	36	zhu	zhu	PROPN
ajmsi-1283	238	37	,	,	PUNCT
ajmsi-1283	238	38	z.	z.	PROPN
ajmsi-1283	238	39	,	,	PUNCT
ajmsi-1283	238	40	tian	tian	PROPN
ajmsi-1283	238	41	,	,	PUNCT
ajmsi-1283	238	42	q.	q.	PROPN
ajmsi-1283	238	43	and	and	CCONJ
ajmsi-1283	238	44	dong	dong	PROPN
ajmsi-1283	238	45	,	,	PUNCT
ajmsi-1283	238	46	c.	c.	PROPN
ajmsi-1283	238	47	(	(	PUNCT
ajmsi-1283	238	48	2005	2005	NUM
ajmsi-1283	238	49	)	)	PUNCT
ajmsi-1283	238	50	.	.	PUNCT
ajmsi-1283	239	1	a	a	DET
ajmsi-1283	239	2	distinct	distinct	ADJ
ajmsi-1283	239	3	lineage	lineage	NOUN
ajmsi-1283	239	4	of	of	ADP
ajmsi-1283	239	5	cd4	cd4	PROPN
ajmsi-1283	239	6	t	t	PROPN
ajmsi-1283	239	7	cells	cell	NOUN
ajmsi-1283	239	8	regulates	regulate	VERB
ajmsi-1283	239	9	tissue	tissue	NOUN
ajmsi-1283	239	10	inflammation	inflammation	NOUN
ajmsi-1283	239	11	by	by	ADP
ajmsi-1283	239	12	producing	produce	VERB
ajmsi-1283	239	13	interleukin	interleukin	NOUN
ajmsi-1283	239	14	17	17	NUM
ajmsi-1283	239	15	.	.	PUNCT
ajmsi-1283	240	1	nature	nature	NOUN
ajmsi-1283	240	2	immunology	immunology	NOUN
ajmsi-1283	240	3	,	,	PUNCT
ajmsi-1283	240	4	6	6	NUM
ajmsi-1283	240	5	,	,	PUNCT
ajmsi-1283	240	6	1133	1133	NUM
ajmsi-1283	240	7	-	-	SYM
ajmsi-1283	240	8	1141	1141	NUM
ajmsi-1283	240	9	.	.	PUNCT
ajmsi-1283	241	1	pirovich	pirovich	NOUN
ajmsi-1283	241	2	,	,	PUNCT
ajmsi-1283	241	3	d.b	d.b	PROPN
ajmsi-1283	241	4	.	.	PROPN
ajmsi-1283	241	5	,	,	PUNCT
ajmsi-1283	241	6	da’dara	da’dara	PROPN
ajmsi-1283	241	7	,	,	PUNCT
ajmsi-1283	241	8	a.a	a.a	PROPN
ajmsi-1283	241	9	.	.	PROPN
ajmsi-1283	241	10	and	and	CCONJ
ajmsi-1283	241	11	skelly	skelly	ADV
ajmsi-1283	241	12	,	,	PUNCT
ajmsi-1283	241	13	p.j	p.j	PROPN
ajmsi-1283	241	14	.	.	PROPN
ajmsi-1283	241	15	(	(	PUNCT
ajmsi-1283	241	16	2020	2020	NUM
ajmsi-1283	241	17	)	)	PUNCT
ajmsi-1283	241	18	.	.	PUNCT
ajmsi-1283	242	1	schistosoma	schistosoma	ADJ
ajmsi-1283	242	2	mansoni	mansoni	ADJ
ajmsi-1283	242	3	glyceraldehyde-3	glyceraldehyde-3	VERB
ajmsi-1283	242	4	-	-	ADJ
ajmsi-1283	242	5	phosphate	phosphate	ADJ
ajmsi-1283	242	6	dehydrogenase	dehydrogenase	NOUN
ajmsi-1283	242	7	enhances	enhance	VERB
ajmsi-1283	242	8	formation	formation	NOUN
ajmsi-1283	242	9	of	of	ADP
ajmsi-1283	242	10	the	the	DET
ajmsi-1283	242	11	bloodclot	bloodclot	NOUN
ajmsi-1283	242	12	lysis	lysis	NOUN
ajmsi-1283	242	13	protein	protein	NOUN
ajmsi-1283	242	14	plasmin	plasmin	NOUN
ajmsi-1283	242	15	.	.	PUNCT
ajmsi-1283	243	1	biology	biology	NOUN
ajmsi-1283	243	2	open	open	ADJ
ajmsi-1283	243	3	,	,	PUNCT
ajmsi-1283	243	4	9	9	NUM
ajmsi-1283	243	5	.	.	PUNCT
ajmsi-1283	244	1	https://doi	https://doi	NOUN
ajmsi-1283	244	2	.	.	PUNCT
ajmsi-1283	244	3	org/10.1242	org/10.1242	PROPN
ajmsi-1283	244	4	/	/	SYM
ajmsi-1283	244	5	bio.050385	bio.050385	PROPN
ajmsi-1283	244	6	saini	saini	PROPN
ajmsi-1283	244	7	,	,	PUNCT
ajmsi-1283	244	8	a.	a.	PROPN
ajmsi-1283	244	9	,	,	PUNCT
ajmsi-1283	244	10	kumar	kumar	PROPN
ajmsi-1283	244	11	,	,	PUNCT
ajmsi-1283	244	12	m.	m.	NOUN
ajmsi-1283	244	13	,	,	PUNCT
ajmsi-1283	244	14	bhatt	bhatt	PROPN
ajmsi-1283	244	15	,	,	PUNCT
ajmsi-1283	244	16	s.	s.	PROPN
ajmsi-1283	244	17	,	,	PUNCT
ajmsi-1283	244	18	saini	saini	PROPN
ajmsi-1283	244	19	,	,	PUNCT
ajmsi-1283	244	20	v.	v.	PROPN
ajmsi-1283	244	21	and	and	CCONJ
ajmsi-1283	244	22	malik	malik	PROPN
ajmsi-1283	244	23	,	,	PUNCT
ajmsi-1283	244	24	a.	a.	NOUN
ajmsi-1283	244	25	(	(	PUNCT
ajmsi-1283	244	26	2020	2020	NUM
ajmsi-1283	244	27	)	)	PUNCT
ajmsi-1283	244	28	.	.	PUNCT
ajmsi-1283	245	1	cancer	cancer	NOUN
ajmsi-1283	245	2	causes	cause	NOUN
ajmsi-1283	245	3	and	and	CCONJ
ajmsi-1283	245	4	treatment	treatment	NOUN
ajmsi-1283	245	5	.	.	PUNCT
ajmsi-1283	246	1	international	international	ADJ
ajmsi-1283	246	2	journal	journal	PROPN
ajmsi-1283	246	3	of	of	ADP
ajmsi-1283	246	4	pharmaceutical	pharmaceutical	NOUN
ajmsi-1283	246	5	science	science	NOUN
ajmsi-1283	246	6	and	and	CCONJ
ajmsi-1283	246	7	research	research	NOUN
ajmsi-1283	246	8	11(7	11(7	NUM
ajmsi-1283	246	9	)	)	PUNCT
ajmsi-1283	246	10	,	,	PUNCT
ajmsi-1283	246	11	31213134	31213134	NUM
ajmsi-1283	246	12	.	.	PUNCT
ajmsi-1283	247	1	shariat	shariat	PROPN
ajmsi-1283	247	2	s.f	s.f	PROPN
ajmsi-1283	247	3	.	.	PROPN
ajmsi-1283	247	4	,	,	PUNCT
ajmsi-1283	247	5	sfakianos	sfakianos	PROPN
ajmsi-1283	247	6	j.p	j.p	PROPN
ajmsi-1283	247	7	.	.	PROPN
ajmsi-1283	247	8	,	,	PUNCT
ajmsi-1283	247	9	droller	droller	PROPN
ajmsi-1283	247	10	m.j	m.j	PROPN
ajmsi-1283	247	11	.	.	PROPN
ajmsi-1283	247	12	,karakiewicz	,karakiewicz	PROPN
ajmsi-1283	247	13	p.i	p.i	PROPN
ajmsi-1283	247	14	.	.	PROPN
ajmsi-1283	247	15	,meryn	,meryn	PUNCT
ajmsi-1283	247	16	s.	s.	PROPN
ajmsi-1283	247	17	,	,	PUNCT
ajmsi-1283	247	18	and	and	CCONJ
ajmsi-1283	247	19	bochner	bochner	PROPN
ajmsi-1283	247	20	b.h	b.h	PROPN
ajmsi-1283	247	21	.	.	PUNCT
ajmsi-1283	248	1	(	(	PUNCT
ajmsi-1283	248	2	2019	2019	NUM
ajmsi-1283	248	3	)	)	PUNCT
ajmsi-1283	248	4	.	.	PUNCT
ajmsi-1283	249	1	the	the	DET
ajmsi-1283	249	2	effect	effect	NOUN
ajmsi-1283	249	3	of	of	ADP
ajmsi-1283	249	4	age	age	NOUN
ajmsi-1283	249	5	and	and	CCONJ
ajmsi-1283	249	6	gender	gender	NOUN
ajmsi-1283	249	7	on	on	ADP
ajmsi-1283	249	8	bladder	bladder	NOUN
ajmsi-1283	249	9	cancer	cancer	NOUN
ajmsi-1283	249	10	:	:	PUNCT
ajmsi-1283	249	11	a	a	DET
ajmsi-1283	249	12	critical	critical	ADJ
ajmsi-1283	249	13	review	review	NOUN
ajmsi-1283	249	14	of	of	ADP
ajmsi-1283	249	15	the	the	DET
ajmsi-1283	249	16	literature	literature	NOUN
ajmsi-1283	249	17	.	.	PUNCT
ajmsi-1283	250	1	bju	bju	PROPN
ajmsi-1283	250	2	international	international	PROPN
ajmsi-1283	250	3	,	,	PUNCT
ajmsi-1283	250	4	105(3	105(3	NUM
ajmsi-1283	250	5	)	)	PUNCT
ajmsi-1283	250	6	,	,	PUNCT
ajmsi-1283	250	7	300–308	300–308	NUM
ajmsi-1283	250	8	.	.	PUNCT
ajmsi-1283	251	1	siegel	siegel	PROPN
ajmsi-1283	251	2	,	,	PUNCT
ajmsi-1283	251	3	r.l	r.l	PROPN
ajmsi-1283	251	4	.	.	PROPN
ajmsi-1283	251	5	,	,	PUNCT
ajmsi-1283	251	6	miller	miller	PROPN
ajmsi-1283	251	7	,	,	PUNCT
ajmsi-1283	251	8	k.d	k.d	PROPN
ajmsi-1283	251	9	.	.	PROPN
ajmsi-1283	251	10	and	and	CCONJ
ajmsi-1283	251	11	jemal	jemal	ADJ
ajmsi-1283	251	12	,	,	PUNCT
ajmsi-1283	251	13	a.	a.	NOUN
ajmsi-1283	251	14	(	(	PUNCT
ajmsi-1283	251	15	2015	2015	NUM
ajmsi-1283	251	16	)	)	PUNCT
ajmsi-1283	251	17	.	.	PUNCT
ajmsi-1283	252	1	cancer	cancer	NOUN
ajmsi-1283	252	2	statistics	statistic	NOUN
ajmsi-1283	252	3	.	.	PUNCT
ajmsi-1283	253	1	ca	can	AUX
ajmsi-1283	253	2	:	:	PUNCT
ajmsi-1283	253	3	a	a	DET
ajmsi-1283	253	4	cancer	cancer	NOUN
ajmsi-1283	253	5	journal	journal	NOUN
ajmsi-1283	253	6	for	for	ADP
ajmsi-1283	253	7	clinicians	clinician	NOUN
ajmsi-1283	253	8	.	.	PUNCT
ajmsi-1283	254	1	american	american	ADJ
ajmsi-1283	254	2	cancer	cancer	NOUN
ajmsi-1283	254	3	society	society	PROPN
ajmsi-1283	254	4	,	,	PUNCT
ajmsi-1283	254	5	65(1	65(1	NOUN
ajmsi-1283	254	6	)	)	PUNCT
ajmsi-1283	254	7	,	,	PUNCT
ajmsi-1283	254	8	5	5	NUM
ajmsi-1283	254	9	-	-	SYM
ajmsi-1283	254	10	29	29	NUM
ajmsi-1283	254	11	.	.	PUNCT
ajmsi-1283	255	1	soria	soria	PROPN
ajmsi-1283	255	2	,	,	PUNCT
ajmsi-1283	255	3	f.	f.	PROPN
ajmsi-1283	255	4	,	,	PUNCT
ajmsi-1283	255	5	krabbe	krabbe	NOUN
ajmsi-1283	255	6	,	,	PUNCT
ajmsi-1283	255	7	l	l	NOUN
ajmsi-1283	255	8	-	-	NOUN
ajmsi-1283	255	9	m.	m.	NOUN
ajmsi-1283	255	10	,	,	PUNCT
ajmsi-1283	255	11	todenhöfer	todenhöfer	NOUN
ajmsi-1283	255	12	,	,	PUNCT
ajmsi-1283	255	13	t.	t.	NOUN
ajmsi-1283	255	14	,	,	PUNCT
ajmsi-1283	255	15	dobruch	dobruch	ADJ
ajmsi-1283	255	16	,	,	PUNCT
ajmsi-1283	255	17	j.	j.	PROPN
ajmsi-1283	255	18	,	,	PUNCT
ajmsi-1283	255	19	mitra	mitra	PROPN
ajmsi-1283	255	20	,	,	PUNCT
ajmsi-1283	255	21	a.p	a.p	PROPN
ajmsi-1283	255	22	.	.	PROPN
ajmsi-1283	255	23	,	,	PUNCT
ajmsi-1283	255	24	inman	inman	PROPN
ajmsi-1283	255	25	,	,	PUNCT
ajmsi-1283	255	26	b.a	b.a	PROPN
ajmsi-1283	255	27	.	.	PROPN
ajmsi-1283	255	28	,	,	PUNCT
ajmsi-1283	255	29	gust	gust	PROPN
ajmsi-1283	255	30	,	,	PUNCT
ajmsi-1283	255	31	k.m	k.m	PROPN
ajmsi-1283	255	32	.	.	PROPN
ajmsi-1283	255	33	,	,	PUNCT
ajmsi-1283	255	34	lotan	lotan	PROPN
ajmsi-1283	255	35	,	,	PUNCT
ajmsi-1283	255	36	y.	y.	PROPN
ajmsi-1283	255	37	and	and	CCONJ
ajmsi-1283	255	38	shariat	shariat	PROPN
ajmsi-1283	255	39	,	,	PUNCT
ajmsi-1283	255	40	s.f	s.f	PROPN
ajmsi-1283	255	41	.	.	PROPN
ajmsi-1283	255	42	(	(	PUNCT
ajmsi-1283	255	43	2019	2019	NUM
ajmsi-1283	255	44	)	)	PUNCT
ajmsi-1283	255	45	.	.	PUNCT
ajmsi-1283	256	1	molecular	molecular	ADJ
ajmsi-1283	256	2	markers	marker	NOUN
ajmsi-1283	256	3	in	in	ADP
ajmsi-1283	256	4	bladder	bladder	NOUN
ajmsi-1283	256	5	cancer	cancer	NOUN
ajmsi-1283	256	6	.	.	PUNCT
ajmsi-1283	257	1	world	world	PROPN
ajmsi-1283	257	2	journal	journal	PROPN
ajmsi-1283	257	3	of	of	ADP
ajmsi-1283	257	4	urology	urology	NOUN
ajmsi-1283	257	5	,	,	PUNCT
ajmsi-1283	257	6	37	37	NUM
ajmsi-1283	257	7	,	,	PUNCT
ajmsi-1283	257	8	31–40	31–40	NUM
ajmsi-1283	257	9	.	.	PUNCT
ajmsi-1283	258	1	tevelde	tevelde	PROPN
ajmsi-1283	258	2	,	,	PUNCT
ajmsi-1283	258	3	a.a	a.a	PROPN
ajmsi-1283	258	4	.	.	PROPN
ajmsi-1283	258	5	,	,	PUNCT
ajmsi-1283	258	6	huijbens	huijbens	PROPN
ajmsi-1283	258	7	,	,	PUNCT
ajmsi-1283	258	8	r.j	r.j	PROPN
ajmsi-1283	258	9	.	.	PROPN
ajmsi-1283	258	10	,	,	PUNCT
ajmsi-1283	258	11	heije	heije	PROPN
ajmsi-1283	258	12	,	,	PUNCT
ajmsi-1283	258	13	k.	k.	PROPN
ajmsi-1283	258	14	,	,	PUNCT
ajmsi-1283	258	15	de	de	PROPN
ajmsi-1283	258	16	vries	vries	PROPN
ajmsi-1283	258	17	,	,	PUNCT
ajmsi-1283	258	18	j.e	j.e	PROPN
ajmsi-1283	258	19	.	.	PROPN
ajmsi-1283	258	20	and	and	CCONJ
ajmsi-1283	258	21	figdor	figdor	PROPN
ajmsi-1283	258	22	,	,	PUNCT
ajmsi-1283	258	23	c.g	c.g	PROPN
ajmsi-1283	258	24	.	.	PROPN
ajmsi-1283	258	25	(	(	PUNCT
ajmsi-1283	258	26	1990	1990	NUM
ajmsi-1283	258	27	)	)	PUNCT
ajmsi-1283	258	28	.	.	PUNCT
ajmsi-1283	259	1	interleukin-4	interleukin-4	NUM
ajmsi-1283	259	2	(	(	PUNCT
ajmsi-1283	259	3	il-4	il-4	NOUN
ajmsi-1283	259	4	)	)	PUNCT
ajmsi-1283	259	5	inhibits	inhibit	VERB
ajmsi-1283	259	6	secretion	secretion	NOUN
ajmsi-1283	259	7	of	of	ADP
ajmsi-1283	259	8	il-1	il-1	ADP
ajmsi-1283	259	9	beta	beta	NOUN
ajmsi-1283	259	10	,	,	PUNCT
ajmsi-1283	259	11	tumor	tumor	NOUN
ajmsi-1283	259	12	necrosis	necrosis	NOUN
ajmsi-1283	259	13	factor	factor	NOUN
ajmsi-1283	259	14	alpha	alpha	NOUN
ajmsi-1283	259	15	,	,	PUNCT
ajmsi-1283	259	16	and	and	CCONJ
ajmsi-1283	259	17	il-6	il-6	NOUN
ajmsi-1283	259	18	by	by	ADP
ajmsi-1283	259	19	human	human	ADJ
ajmsi-1283	259	20	monocytes	monocyte	NOUN
ajmsi-1283	259	21	.	.	PUNCT
ajmsi-1283	260	1	blood	blood	NOUN
ajmsi-1283	260	2	,	,	PUNCT
ajmsi-1283	260	3	76	76	NUM
ajmsi-1283	260	4	,	,	PUNCT
ajmsi-1283	260	5	1392	1392	NUM
ajmsi-1283	260	6	-	-	SYM
ajmsi-1283	260	7	1397	1397	NUM
ajmsi-1283	260	8	.	.	PUNCT
ajmsi-1283	261	1	thermo	thermo	PROPN
ajmsi-1283	261	2	fisher	fisher	PROPN
ajmsi-1283	261	3	scientific	scientific	PROPN
ajmsi-1283	261	4	inc	inc	PROPN
ajmsi-1283	261	5	.	.	PROPN
ajmsi-1283	261	6	(	(	PUNCT
ajmsi-1283	261	7	2010	2010	NUM
ajmsi-1283	261	8	)	)	PUNCT
ajmsi-1283	261	9	.	.	PUNCT
ajmsi-1283	262	1	elisa	elisa	PROPN
ajmsi-1283	262	2	technical	technical	PROPN
ajmsi-1283	262	3	guide	guide	NOUN
ajmsi-1283	262	4	and	and	CCONJ
ajmsi-1283	262	5	protocols	protocol	NOUN
ajmsi-1283	262	6	.	.	PUNCT
ajmsi-1283	263	1	http://tools.thermofisher.com/	http://tools.thermofisher.com/	PROPN
ajmsi-1283	263	2	content	content	PROPN
ajmsi-1283	263	3	/	/	SYM
ajmsi-1283	263	4	sfs	sfs	ADJ
ajmsi-1283	263	5	/	/	SYM
ajmsi-1283	263	6	brochures	brochure	NOUN
ajmsi-1283	263	7	/	/	SYM
ajmsi-1283	263	8	tr0065	tr0065	NOUN
ajmsi-1283	263	9	-	-	PUNCT
ajmsi-1283	263	10	elisa	elisa	NOUN
ajmsi-1283	263	11	-	-	PUNCT
ajmsi-1283	263	12	guide.pdf	guide.pdf	PROPN
ajmsi-1283	263	13	.	.	PUNCT
ajmsi-1283	264	1	thomas	thomas	PROPN
ajmsi-1283	264	2	,	,	PUNCT
ajmsi-1283	264	3	p.g	p.g	PROPN
ajmsi-1283	264	4	.	.	PROPN
ajmsi-1283	264	5	and	and	CCONJ
ajmsi-1283	264	6	harn	harn	PROPN
ajmsi-1283	264	7	,	,	PUNCT
ajmsi-1283	264	8	d.a	d.a	PROPN
ajmsi-1283	264	9	.	.	PROPN
ajmsi-1283	264	10	(	(	PUNCT
ajmsi-1283	264	11	2004	2004	NUM
ajmsi-1283	264	12	)	)	PUNCT
ajmsi-1283	264	13	.	.	PUNCT
ajmsi-1283	265	1	immune	immune	ADJ
ajmsi-1283	265	2	biasingby	biasingby	NOUN
ajmsi-1283	265	3	helminth	helminth	NOUN
ajmsi-1283	265	4	glycans	glycan	NOUN
ajmsi-1283	265	5	.	.	PUNCT
ajmsi-1283	266	1	cellular	cellular	ADJ
ajmsi-1283	266	2	microbiology	microbiology	NOUN
ajmsi-1283	266	3	,	,	PUNCT
ajmsi-1283	266	4	6	6	NUM
ajmsi-1283	266	5	,	,	PUNCT
ajmsi-1283	266	6	13–22	13–22	NUM
ajmsi-1283	266	7	.	.	PUNCT
ajmsi-1283	267	1	van	van	PROPN
ajmsi-1283	267	2	die	die	PROPN
ajmsi-1283	267	3	,	,	PUNCT
ajmsi-1283	267	4	i.	i.	NOUN
ajmsi-1283	267	5	and	and	CCONJ
ajmsi-1283	267	6	cummings	cummings	PROPN
ajmsi-1283	267	7	,	,	PUNCT
ajmsi-1283	267	8	r.d	r.d	PROPN
ajmsi-1283	267	9	.	.	PROPN
ajmsi-1283	267	10	(	(	PUNCT
ajmsi-1283	267	11	2006	2006	NUM
ajmsi-1283	267	12	)	)	PUNCT
ajmsi-1283	267	13	.	.	PUNCT
ajmsi-1283	268	1	glycans	glycan	NOUN
ajmsi-1283	268	2	modulate	modulate	VERB
ajmsi-1283	268	3	immune	immune	ADJ
ajmsi-1283	268	4	responses	response	NOUN
ajmsi-1283	268	5	in	in	ADP
ajmsi-1283	268	6	helminth	helminth	NOUN
ajmsi-1283	268	7	infections	infection	NOUN
ajmsi-1283	268	8	and	and	CCONJ
ajmsi-1283	268	9	allergy	allergy	NOUN
ajmsi-1283	268	10	.	.	PUNCT
ajmsi-1283	269	1	chemical	chemical	ADJ
ajmsi-1283	269	2	immunology	immunology	NOUN
ajmsi-1283	269	3	and	and	CCONJ
ajmsi-1283	269	4	allergy	allergy	NOUN
ajmsi-1283	269	5	,	,	PUNCT
ajmsi-1283	269	6	90	90	NUM
ajmsi-1283	269	7	,	,	PUNCT
ajmsi-1283	269	8	91	91	NUM
ajmsi-1283	269	9	–	–	PUNCT
ajmsi-1283	269	10	112	112	NUM
ajmsi-1283	269	11	.	.	PUNCT
ajmsi-1283	270	1	waknine	waknine	NOUN
ajmsi-1283	270	2	-	-	PUNCT
ajmsi-1283	270	3	grinberg	grinberg	PROPN
ajmsi-1283	270	4	,	,	PUNCT
ajmsi-1283	270	5	j.h	j.h	PROPN
ajmsi-1283	270	6	.	.	PROPN
ajmsi-1283	270	7	,	,	PUNCT
ajmsi-1283	270	8	gold	gold	NOUN
ajmsi-1283	270	9	,	,	PUNCT
ajmsi-1283	270	10	d.	d.	PROPN
ajmsi-1283	270	11	,	,	PUNCT
ajmsi-1283	270	12	ohayon	ohayon	PROPN
ajmsi-1283	270	13	,	,	PUNCT
ajmsi-1283	270	14	a.	a.	NOUN
ajmsi-1283	270	15	,	,	PUNCT
ajmsi-1283	270	16	flescher	flescher	PROPN
ajmsi-1283	270	17	,	,	PUNCT
ajmsi-1283	270	18	e.	e.	PROPN
ajmsi-1283	270	19	,	,	PUNCT
ajmsi-1283	270	20	heyfets	heyfet	NOUN
ajmsi-1283	270	21	,	,	PUNCT
ajmsi-1283	270	22	a.	a.	NOUN
ajmsi-1283	270	23	,	,	PUNCT
ajmsi-1283	270	24	doenhoff	doenhoff	NOUN
ajmsi-1283	270	25	,	,	PUNCT
ajmsi-1283	270	26	m.j	m.j	PROPN
ajmsi-1283	270	27	.	.	PROPN
ajmsi-1283	270	28	,	,	PUNCT
ajmsi-1283	270	29	schramm	schramm	PROPN
ajmsi-1283	270	30	,	,	PUNCT
ajmsi-1283	270	31	g.	g.	PROPN
ajmsi-1283	270	32	,	,	PUNCT
ajmsi-1283	270	33	haas	haas	PROPN
ajmsi-1283	270	34	,	,	PUNCT
ajmsi-1283	270	35	h.	h.	PROPN
ajmsi-1283	270	36	and	and	CCONJ
ajmsi-1283	270	37	golenser	golenser	PROPN
ajmsi-1283	270	38	,	,	PUNCT
ajmsi-1283	270	39	j.	j.	PROPN
ajmsi-1283	270	40	(	(	PUNCT
ajmsi-1283	270	41	2010	2010	NUM
ajmsi-1283	270	42	)	)	PUNCT
ajmsi-1283	270	43	.	.	PUNCT
ajmsi-1283	271	1	schistosoma	schistosoma	ADJ
ajmsi-1283	271	2	mansoni	mansoni	ADJ
ajmsi-1283	271	3	infection	infection	NOUN
ajmsi-1283	271	4	reduces	reduce	VERB
ajmsi-1283	271	5	the	the	DET
ajmsi-1283	271	6	incidence	incidence	NOUN
ajmsi-1283	271	7	of	of	ADP
ajmsi-1283	271	8	murine	murine	ADJ
ajmsi-1283	271	9	cerebral	cerebral	ADJ
ajmsi-1283	271	10	malaria	malaria	NOUN
ajmsi-1283	271	11	.	.	PUNCT
ajmsi-1283	272	1	malaria	malaria	PROPN
ajmsi-1283	272	2	journal	journal	PROPN
ajmsi-1283	272	3	,	,	PUNCT
ajmsi-1283	272	4	9	9	NUM
ajmsi-1283	272	5	,	,	PUNCT
ajmsi-1283	272	6	5	5	NUM
ajmsi-1283	272	7	.	.	PUNCT
ajmsi-1283	272	8	zhang	zhang	PROPN
ajmsi-1283	272	9	x	x	PUNCT
ajmsi-1283	272	10	and	and	CCONJ
ajmsi-1283	272	11	zhang	zhang	PROPN
ajmsi-1283	272	12	y	y	PROPN
ajmsi-1283	272	13	(	(	PUNCT
ajmsi-1283	272	14	2015	2015	NUM
ajmsi-1283	272	15	)	)	PUNCT
ajmsi-1283	272	16	.	.	PUNCT
ajmsi-1283	273	1	bladder	bladder	NOUN
ajmsi-1283	273	2	cancer	cancer	NOUN
ajmsi-1283	273	3	and	and	CCONJ
ajmsi-1283	273	4	genetic	genetic	ADJ
ajmsi-1283	273	5	mutations	mutation	NOUN
ajmsi-1283	273	6	.	.	PUNCT
ajmsi-1283	274	1	cell	cell	NOUN
ajmsi-1283	274	2	biochemistry	biochemistry	NOUN
ajmsi-1283	274	3	and	and	CCONJ
ajmsi-1283	274	4	biophysis	biophysis	VERB
ajmsi-1283	274	5	73	73	NUM
ajmsi-1283	274	6	,	,	PUNCT
ajmsi-1283	274	7	65–69	65–69	NUM
ajmsi-1283	274	8	.	.	PUNCT
ajmsi-1283	275	1	https://doi.org/10.1007/s12013-015-0574-z	https://doi.org/10.1007/s12013-015-0574-z	PROPN
ajmsi-1283	275	2	zhang	zhang	PROPN
ajmsi-1283	275	3	,	,	PUNCT
ajmsi-1283	275	4	j	j	PROPN
ajmsi-1283	275	5	-	-	PUNCT
ajmsi-1283	275	6	y.	y.	PROPN
ajmsi-1283	275	7	,	,	PUNCT
ajmsi-1283	275	8	zhang	zhang	PROPN
ajmsi-1283	275	9	,	,	PUNCT
ajmsi-1283	275	10	f.	f.	PROPN
ajmsi-1283	275	11	,	,	PUNCT
ajmsi-1283	275	12	hong	hong	PROPN
ajmsi-1283	275	13	,	,	PUNCT
ajmsi-1283	275	14	c	c	NOUN
ajmsi-1283	275	15	-	-	PUNCT
ajmsi-1283	275	16	q.	q.	PROPN
ajmsi-1283	275	17	,	,	PUNCT
ajmsi-1283	275	18	giuliano	giuliano	PROPN
ajmsi-1283	275	19	,	,	PUNCT
ajmsi-1283	275	20	a.e	a.e	PROPN
ajmsi-1283	275	21	.	.	PROPN
ajmsi-1283	275	22	,	,	PUNCT
ajmsi-1283	275	23	cui	cui	PROPN
ajmsi-1283	275	24	,	,	PUNCT
ajmsi-1283	275	25	x	x	PROPN
ajmsi-1283	275	26	-	-	PUNCT
ajmsi-1283	275	27	j.	j.	PROPN
ajmsi-1283	275	28	,	,	PUNCT
ajmsi-1283	275	29	zhou	zhou	PROPN
ajmsi-1283	275	30	,	,	PUNCT
ajmsi-1283	275	31	g	g	PROPN
ajmsi-1283	275	32	-	-	PUNCT
ajmsi-1283	275	33	j.	j.	PROPN
ajmsi-1283	275	34	,	,	PUNCT
ajmsi-1283	275	35	zhang	zhang	PROPN
ajmsi-1283	275	36	,	,	PUNCT
ajmsi-1283	275	37	g	g	PROPN
ajmsi-1283	275	38	-	-	PUNCT
ajmsi-1283	275	39	j.	j.	PROPN
ajmsi-1283	275	40	and	and	CCONJ
ajmsi-1283	275	41	cui	cui	PROPN
ajmsi-1283	275	42	,	,	PUNCT
ajmsi-1283	275	43	y	y	PROPN
ajmsi-1283	275	44	-	-	PUNCT
ajmsi-1283	275	45	k.	k.	PROPN
ajmsi-1283	275	46	(	(	PUNCT
ajmsi-1283	275	47	2015	2015	NUM
ajmsi-1283	275	48	)	)	PUNCT
ajmsi-1283	275	49	.	.	PUNCT
ajmsi-1283	276	1	critical	critical	ADJ
ajmsi-1283	276	2	protein	protein	NOUN
ajmsi-1283	276	3	gapdh	gapdh	NOUN
ajmsi-1283	276	4	and	and	CCONJ
ajmsi-1283	276	5	its	its	PRON
ajmsi-1283	276	6	regulatory	regulatory	ADJ
ajmsi-1283	276	7	mechanisms	mechanism	NOUN
ajmsi-1283	276	8	in	in	ADP
ajmsi-1283	276	9	cancer	cancer	NOUN
ajmsi-1283	276	10	cells	cell	NOUN
ajmsi-1283	276	11	.	.	PUNCT
ajmsi-1283	277	1	cancer	cancer	NOUN
ajmsi-1283	277	2	biology	biology	NOUN
ajmsi-1283	277	3	and	and	CCONJ
ajmsi-1283	277	4	medicine	medicine	NOUN
ajmsi-1283	277	5	,	,	PUNCT
ajmsi-1283	277	6	12	12	NUM
ajmsi-1283	277	7	,	,	PUNCT
ajmsi-1283	277	8	10	10	NUM
ajmsi-1283	277	9	-	-	SYM
ajmsi-1283	277	10	22	22	NUM
ajmsi-1283	277	11	.	.	PUNCT
ajmsi-1283	278	1	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	NOUN